var title_f34_50_35616="Multiple bedbug bites";
var content_f34_50_35616=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F75123&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F75123&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bedbug bites",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple erythematous papules are present on the trunk of this patient with bedbug bites.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_50_35616=[""].join("\n");
var outline_f34_50_35616=null;
var title_f34_50_35617="Heme biosynthetic pathway";
var content_f34_50_35617=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F57890&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F57890&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 551px\">",
"   <div class=\"ttl\">",
"    Biosynthetic pathway of heme",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 531px; height: 501px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This figure illustrates the biochemical steps in the formation of heme, starting with glycine and succinyl CoA and ending with the insertion of iron into protoporphyrin IX to form heme. Each of the eight enzymatic steps involved in this process is shown as a number inside of a circle, and the locations (ie, mitochondial or cytoplasmic) where these steps take place are also shown.",
"    <div class=\"footnotes\">",
"     A: acetate; P: propionate; M: methyl; V: vinyl.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_50_35617=[""].join("\n");
var outline_f34_50_35617=null;
var title_f34_50_35618="Ginkgo biloba";
var content_f34_50_35618=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F57799&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F57799&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ginkgo biloba",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 487px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Martin Wall/herbslides.com.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_50_35618=[""].join("\n");
var outline_f34_50_35618=null;
var title_f34_50_35619="Calculator: CDC weight for height percentiles for boys (77 to 121 cm tall)";
var content_f34_50_35619=[" <div id=\"topicText\">",
"  <div id=\"mc3k\">",
"   <form action=\"\" id=\"CDCWeightForHeightBoys_form\" name=\"CDCWeightForHeightBoys_form\" onkeydown=\"clrResults();\" onkeyup=\"CDCWeightForHeightBoys_fx();\" onreset=\"rrclr();\" onsubmit=\"return false;\">",
"    <table cellpadding=\"4\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"100%\">",
"     <tr>",
"      <td bgcolor=\"#eeeeee\" width=\"1%\">",
"       <br/>",
"      </td>",
"      <td align=\"left\" bgcolor=\"#eeeeee\">",
"       <span class=\"medCalcFontTitleBox\">",
"        Calculator: CDC weight for height percentiles for boys (77 to 121 cm tall)",
"       </span>",
"      </td>",
"     </tr>",
"    </table>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_main\">",
"     <center>",
"      <table cellpadding=\"6\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"95%\">",
"       <tr>",
"        <td align=\"right\" width=\"50%\">",
"         <center>",
"          <span class=\"medCalcFontIO\">",
"           Input:",
"          </span>",
"          <br/>",
"          &nbsp;",
"          <br/>",
"          <table cellpadding=\"3\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\">",
"           <tr>",
"            <td align=\"right\" width=\"42%\">",
"             <span class=\"medCalcFontOneBold\">",
"              Height",
"             </span>",
"            </td>",
"            <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"             &nbsp;",
"             <input name=\"Height_param\" onblur=\"CDCWeightForHeightBoys_fx(); minMaxCheck();\" onchange=\"CDCWeightForHeightBoys_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"            </td>",
"            <td align=\"left\" valign=\"top\" width=\"115\">",
"             <select class=\"medCalcFontSelect\" name=\"Height_unit\" onchange=\"CDCWeightForHeightBoys_fx();\" style=\"width:105px;\">",
"              <option selected=\"selected\" value=\"1|0|cm\">",
"               cm",
"              </option>",
"              <option value=\"30.48|0|ft\">",
"               ft",
"              </option>",
"              <option value=\"2.54|0|in\">",
"               in",
"              </option>",
"              <option value=\"0.0001|0|micm\">",
"               micm",
"              </option>",
"              <option value=\"0.1|0|mm\">",
"               mm",
"              </option>",
"              <option value=\"100|0|m\">",
"               m",
"              </option>",
"              <option value=\"1e-07|0|nm\">",
"               nm",
"              </option>",
"              <option value=\"91.44|0|yd\">",
"               yd",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\" width=\"42%\">",
"             <span class=\"medCalcFontOneBold\">",
"              Weight",
"             </span>",
"            </td>",
"            <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"             &nbsp;",
"             <input name=\"Weight_param\" onblur=\"CDCWeightForHeightBoys_fx(); minMaxCheck();\" onchange=\"CDCWeightForHeightBoys_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"            </td>",
"            <td align=\"left\" valign=\"top\" width=\"115\">",
"             <select class=\"medCalcFontSelect\" name=\"Weight_unit\" onchange=\"CDCWeightForHeightBoys_fx();\" style=\"width:105px;\">",
"              <option value=\"0.001|0|gm\">",
"               gm",
"              </option>",
"              <option selected=\"selected\" value=\"1|0|kg\">",
"               kg",
"              </option>",
"              <option value=\"0.45359237|0|lb\">",
"               lb",
"              </option>",
"              <option value=\"1e-06|0|mg\">",
"               mg",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"          </table>",
"         </center>",
"        </td>",
"        <td align=\"left\" bgcolor=\"#eeeeee\">",
"         <center>",
"          <span class=\"medCalcFontIO\">",
"           Results:",
"          </span>",
"          <br/>",
"          &nbsp;",
"          <br/>",
"          <table bgcolor=\"#eeeeee\" cellspacing=\"4\" summary=\"MedCalc 3000 Table\">",
"           <tr>",
"            <td align=\"right\">",
"             <span class=\"medCalcFontOneBold\">",
"              Z Score",
"             </span>",
"            </td>",
"            <td nowrap=\"nowrap\" valign=\"top\">",
"             &nbsp;",
"             <input name=\"Z_Score_param\" onfocus=\"blur();\" size=\"6\" type=\"text\"/>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\">",
"             <span class=\"medCalcFontOneBold\">",
"              Percentile",
"             </span>",
"            </td>",
"            <td nowrap=\"nowrap\" valign=\"top\">",
"             &nbsp;",
"             <input name=\"Percentile_param\" onfocus=\"blur();\" size=\"6\" type=\"text\"/>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td colspan=\"3\">",
"             &nbsp;",
"             <br/>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"center\" colspan=\"3\">",
"             <span class=\"medCalcFontOneBold\">",
"              Decimal Precision:",
"             </span>",
"             <select class=\"medCalcFontSelect\" name=\"decpts\" onchange=\"CDCWeightForHeightBoys_fx();\">",
"              <option>",
"               0",
"              </option>",
"              <option selected=\"selected\">",
"               1",
"              </option>",
"              <option>",
"               2",
"              </option>",
"              <option>",
"               3",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"          </table>",
"         </center>",
"         <br/>",
"         &nbsp;",
"         <br/>",
"         <center>",
"          <span class=\"medCalcFontOne\">",
"           <input name=\"reset\" type=\"reset\" value=\"Reset form\"/>",
"          </span>",
"         </center>",
"        </td>",
"       </tr>",
"      </table>",
"     </center>",
"     <br/>",
"     &nbsp;",
"     <br/>",
"     <table cellpadding=\"4\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"70%\">",
"      <tr>",
"       <td bgcolor=\"#eeeeee\" width=\"1%\">",
"        <br/>",
"       </td>",
"       <td align=\"left\" bgcolor=\"#eeeeee\">",
"        <span class=\"medCalcFontTitleBox\">",
"         Weight for Height Percentile Interpretation",
"        </span>",
"       </td>",
"      </tr>",
"     </table>",
"     <br/>",
"     &nbsp;",
"     <br/>",
"     <center>",
"      <table border=\"1\" cellpadding=\"4\" cellspacing=\"0\" summary=\"RRTable\">",
"       <tr id=\"rr1_1\">",
"        <td align=\"right\" nowrap=\"nowrap\" style=\"border-right: 0px\">",
"         <span class=\"medCalcFontOneBold\">",
"          Percentile &lt; 5:",
"         </span>",
"        </td>",
"        <td align=\"left\" style=\"border-left: 0px;\">",
"         <span class=\"medCalcFontOne\">",
"          Underweight",
"         </span>",
"        </td>",
"       </tr>",
"       <tr id=\"rr1_2\">",
"        <td align=\"right\" nowrap=\"nowrap\" style=\"border-right: 0px\">",
"         <span class=\"medCalcFontOneBold\">",
"          Percentile &gt;= 5 and &lt; 85:",
"         </span>",
"        </td>",
"        <td align=\"left\" style=\"border-left: 0px;\">",
"         <span class=\"medCalcFontOne\">",
"          Healthy weight",
"         </span>",
"        </td>",
"       </tr>",
"       <tr id=\"rr1_3\">",
"        <td align=\"right\" nowrap=\"nowrap\" style=\"border-right: 0px\">",
"         <span class=\"medCalcFontOneBold\">",
"          Percentile &gt;= 85 and &lt; 95:",
"         </span>",
"        </td>",
"        <td align=\"left\" style=\"border-left: 0px;\">",
"         <span class=\"medCalcFontOne\">",
"          At risk of overweight",
"         </span>",
"        </td>",
"       </tr>",
"       <tr id=\"rr1_4\">",
"        <td align=\"right\" nowrap=\"nowrap\" style=\"border-right: 0px\">",
"         <span class=\"medCalcFontOneBold\">",
"          Percentile &gt;= 95:",
"         </span>",
"        </td>",
"        <td align=\"left\" style=\"border-left: 0px;\">",
"         <span class=\"medCalcFontOne\">",
"          Overweight",
"         </span>",
"        </td>",
"       </tr>",
"      </table>",
"     </center>",
"    </div>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_hints\">",
"     <br/>",
"     &nbsp;",
"     <br/>",
"     <span class=\"medCalcFontOneBold\">",
"      Notes",
"     </span>",
"     <ul class=\"medCalcFontOne\">",
"      <li>",
"       These weight-for-stature standards are available as an alternative to BMI for assessment of over or undernutrition",
"in children ages 2-5 years. However, health care providers should consider using the BMI-for-age charts to be",
"consistent with current recommendations.",
"      </li>",
"      <li>",
"       This calculator uses measured standing height for children ages 2 to 5 years, and is not",
"valid for recumbent length.",
"      </li>",
"     </ul>",
"    </div>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_refs\">",
"     <span class=\"medCalcFontRef\">",
"      <b>",
"       References",
"      </b>",
"     </span>",
"     <ol>",
"      <li>",
"       <span class=\"medCalcFontRef\">",
"        Percentile conversion from Z-Score is done by table look-up in the standard Normal Table. Percentiles are provided for Z Scores between -3.09 and 3.09.  Values beyond these extremes return percentiles of 0.1 and 99.9 respectively.",
"       </span>",
"      </li>",
"      <li>",
"       <span class=\"medCalcFontRef\">",
"        LMS Parameters for Boys: Weight for Height. National health and nutrition survey (NHANES), CDC/National Center for Health Statistics.",
"       </span>",
"      </li>",
"     </ol>",
"    </div>",
"   </form>",
"  </div>",
" </div>",
" <div id=\"topicAgreement\">",
"  Use of UpToDate is subject to the",
"  <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"   Subscription and License Agreement",
"  </a>",
"  .",
" </div>",
" <div id=\"printDisclaimer\">",
"  Information on this page may not appear correctly if printed.",
" </div>",
" <div id=\"disclaimerCalculator\">",
"  <div class=\"medCalcFontTwo\">",
"   <p class=\"header\">",
"    Legal Notices and Disclaimer",
"   </p>",
"   <p>",
"    All information contained in and produced by the MedCalc 3000 system is provided",
"			for educational purposes only. This information should not be used for the diagnosis or treatment",
"			of any health problem or disease.",
"    <b>",
"     THIS INFORMATION IS NOT INTENDED TO REPLACE CLINICAL JUDGMENT OR",
"			GUIDE INDIVIDUAL PATIENT CARE IN ANY MANNER.",
"    </b>",
"    <a class=\"medCalcDisclaimerLink\" href=\"./med-calc-disclaimer\">",
"     Click here for",
"				full notice and disclaimer.",
"    </a>",
"   </p>",
"   <p class=\"copy\">",
"    MedCalc 3000 is Copyright &copy; 1998-2013 Foundation Internet Services",
"   </p>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_50_35619=[" ",
"",
"",
"function log(i){",
"return Math.log(i) * Math.LOG10E;   ",
"}",
"",
"function ln(i){",
"return Math.log(i);",
"}",
"",
"function sq(i){",
"return i * i;",
"}",
"",
"function sqr(i){",
"return Math.sqrt(i);",
"}",
"",
"",
"function power(x,y){",
"return Math.pow(x,y);",
"}",
"",
"function eTo(x){",
"return Math.exp(x);",
"}",
"",
"",
"function fixDP(r, dps) {",
"if (isNaN(r)) return \"NaN\";",
"var msign = '';",
"if (r < 0) msign = '-';",
"x = Math.abs(r);",
"if (x > Math.pow(10, 21)) return msign + x.toString();",
"var m = Math.round(x * Math.pow(10, dps)).toString();",
"if (dps == 0) return msign + m;",
"while (m.length <= dps) m = \"0\" + m;",
"return msign + m.substring(0, m.length - dps) + \".\" + m.substring(m.length - dps);",
"}",
"",
"var currenttimeout;",
"",
"n = new Array;",
"var L = 0;",
"var M = 0;",
"var S = 0;",
"",
"n[0] = 50;",
"n[1] = 50.399;",
"n[2] = 50.798;",
"n[3] = 51.197;",
"n[4] = 51.595;",
"n[5] = 51.994;",
"n[6] = 52.392;",
"n[7] = 52.79;",
"n[8] = 53.188;",
"n[9] = 53.586;",
"n[10] = 53.983;",
"n[11] = 54.38;",
"n[12] = 54.776;",
"n[13] = 55.172;",
"n[14] = 55.567;",
"n[15] = 55.962;",
"n[16] = 56.356;",
"n[17] = 56.749;",
"n[18] = 57.142;",
"n[19] = 57.535;",
"n[20] = 57.926;",
"n[21] = 58.317;",
"n[22] = 58.706;",
"n[23] = 59.095;",
"n[24] = 59.483;",
"n[25] = 59.871;",
"n[26] = 60.257;",
"n[27] = 60.642;",
"n[28] = 61.026;",
"n[29] = 61.409;",
"n[30] = 61.791;",
"n[31] = 62.172;",
"n[32] = 62.552;",
"n[33] = 62.93;",
"n[34] = 63.307;",
"n[35] = 63.683;",
"n[36] = 64.058;",
"n[37] = 64.431;",
"n[38] = 64.803;",
"n[39] = 65.173;",
"n[40] = 65.542;",
"n[41] = 65.91;",
"n[42] = 66.276;",
"n[43] = 66.64;",
"n[44] = 67.003;",
"n[45] = 67.364;",
"n[46] = 67.724;",
"n[47] = 68.082;",
"n[48] = 68.439;",
"n[49] = 68.793;",
"n[50] = 69.146;",
"n[51] = 69.497;",
"n[52] = 69.847;",
"n[53] = 70.194;",
"n[54] = 70.54;",
"n[55] = 70.884;",
"n[56] = 71.226;",
"n[57] = 71.566;",
"n[58] = 71.904;",
"n[59] = 72.24;",
"n[60] = 72.575;",
"n[61] = 72.907;",
"n[62] = 73.237;",
"n[63] = 73.565;",
"n[64] = 73.891;",
"n[65] = 74.215;",
"n[66] = 74.537;",
"n[67] = 74.857;",
"n[68] = 75.175;",
"n[69] = 75.49;",
"n[70] = 75.804;",
"n[71] = 76.115;",
"n[72] = 76.424;",
"n[73] = 76.73;",
"n[74] = 77.035;",
"n[75] = 77.337;",
"n[76] = 77.637;",
"n[77] = 77.935;",
"n[78] = 78.23;",
"n[79] = 78.524;",
"n[80] = 78.814;",
"n[81] = 79.103;",
"n[82] = 79.389;",
"n[83] = 79.673;",
"n[84] = 79.955;",
"n[85] = 80.234;",
"n[86] = 80.511;",
"n[87] = 80.785;",
"n[88] = 81.057;",
"n[89] = 81.327;",
"n[90] = 81.594;",
"n[91] = 81.859;",
"n[92] = 82.121;",
"n[93] = 82.381;",
"n[94] = 82.639;",
"n[95] = 82.894;",
"n[96] = 83.147;",
"n[97] = 83.398;",
"n[98] = 83.646;",
"n[99] = 83.891;",
"n[100] = 84.134;",
"n[101] = 84.375;",
"n[102] = 84.614;",
"n[103] = 84.849;",
"n[104] = 85.083;",
"n[105] = 85.314;",
"n[106] = 85.543;",
"n[107] = 85.769;",
"n[108] = 85.993;",
"n[109] = 86.214;",
"n[110] = 86.433;",
"n[111] = 86.65;",
"n[112] = 86.864;",
"n[113] = 87.076;",
"n[114] = 87.286;",
"n[115] = 87.493;",
"n[116] = 87.698;",
"n[117] = 87.9;",
"n[118] = 88.1;",
"n[119] = 88.298;",
"n[120] = 88.493;",
"n[121] = 88.686;",
"n[122] = 88.877;",
"n[123] = 89.065;",
"n[124] = 89.251;",
"n[125] = 89.435;",
"n[126] = 89.617;",
"n[127] = 89.796;",
"n[128] = 89.973;",
"n[129] = 90.147;",
"n[130] = 90.32;",
"n[131] = 90.49;",
"n[132] = 90.658;",
"n[133] = 90.824;",
"n[134] = 90.988;",
"n[135] = 91.149;",
"n[136] = 91.308;",
"n[137] = 91.466;",
"n[138] = 91.621;",
"n[139] = 91.774;",
"n[140] = 91.924;",
"n[141] = 92.073;",
"n[142] = 92.22;",
"n[143] = 92.364;",
"n[144] = 92.507;",
"n[145] = 92.647;",
"n[146] = 92.785;",
"n[147] = 92.922;",
"n[148] = 93.056;",
"n[149] = 93.189;",
"n[150] = 93.319;",
"n[151] = 93.448;",
"n[152] = 93.574;",
"n[153] = 93.699;",
"n[154] = 93.822;",
"n[155] = 93.943;",
"n[156] = 94.062;",
"n[157] = 94.179;",
"n[158] = 94.295;",
"n[159] = 94.408;",
"n[160] = 94.52;",
"n[161] = 94.63;",
"n[162] = 94.738;",
"n[163] = 94.845;",
"n[164] = 94.95;",
"n[165] = 95.053;",
"n[166] = 95.154;",
"n[167] = 95.254;",
"n[168] = 95.352;",
"n[169] = 95.449;",
"n[170] = 95.543;",
"n[171] = 95.637;",
"n[172] = 95.728;",
"n[173] = 95.818;",
"n[174] = 95.907;",
"n[175] = 95.994;",
"n[176] = 96.08;",
"n[177] = 96.164;",
"n[178] = 96.246;",
"n[179] = 96.327;",
"n[180] = 96.407;",
"n[181] = 96.485;",
"n[182] = 96.562;",
"n[183] = 96.638;",
"n[184] = 96.712;",
"n[185] = 96.784;",
"n[186] = 96.856;",
"n[187] = 96.926;",
"n[188] = 96.995;",
"n[189] = 97.062;",
"n[190] = 97.128;",
"n[191] = 97.193;",
"n[192] = 97.257;",
"n[193] = 97.32;",
"n[194] = 97.381;",
"n[195] = 97.441;",
"n[196] = 97.5;",
"n[197] = 97.558;",
"n[198] = 97.615;",
"n[199] = 97.67;",
"n[200] = 97.725;",
"n[201] = 97.778;",
"n[202] = 97.831;",
"n[203] = 97.882;",
"n[204] = 97.932;",
"n[205] = 97.982;",
"n[206] = 98.03;",
"n[207] = 98.077;",
"n[208] = 98.124;",
"n[209] = 98.169;",
"n[210] = 98.214;",
"n[211] = 98.257;",
"n[212] = 98.3;",
"n[213] = 98.341;",
"n[214] = 98.382;",
"n[215] = 98.422;",
"n[216] = 98.461;",
"n[217] = 98.5;",
"n[218] = 98.537;",
"n[219] = 98.574;",
"n[220] = 98.61;",
"n[221] = 98.645;",
"n[222] = 98.679;",
"n[223] = 98.713;",
"n[224] = 98.745;",
"n[225] = 98.778;",
"n[226] = 98.809;",
"n[227] = 98.84;",
"n[228] = 98.87;",
"n[229] = 98.899;",
"n[230] = 98.928;",
"n[231] = 98.956;",
"n[232] = 98.983;",
"n[233] = 99.01;",
"n[234] = 99.036;",
"n[235] = 99.061;",
"n[236] = 99.086;",
"n[237] = 99.111;",
"n[238] = 99.134;",
"n[239] = 99.158;",
"n[240] = 99.18;",
"n[241] = 99.202;",
"n[242] = 99.224;",
"n[243] = 99.245;",
"n[244] = 99.266;",
"n[245] = 99.286;",
"n[246] = 99.305;",
"n[247] = 99.324;",
"n[248] = 99.343;",
"n[249] = 99.361;",
"n[250] = 99.379;",
"n[251] = 99.396;",
"n[252] = 99.413;",
"n[253] = 99.43;",
"n[254] = 99.446;",
"n[255] = 99.461;",
"n[256] = 99.477;",
"n[257] = 99.492;",
"n[258] = 99.506;",
"n[259] = 99.52;",
"n[260] = 99.534;",
"n[261] = 99.547;",
"n[262] = 99.56;",
"n[263] = 99.573;",
"n[264] = 99.585;",
"n[265] = 99.598;",
"n[266] = 99.609;",
"n[267] = 99.621;",
"n[268] = 99.632;",
"n[269] = 99.643;",
"n[270] = 99.653;",
"n[271] = 99.664;",
"n[272] = 99.674;",
"n[273] = 99.683;",
"n[274] = 99.693;",
"n[275] = 99.702;",
"n[276] = 99.711;",
"n[277] = 99.72;",
"n[278] = 99.728;",
"n[279] = 99.736;",
"n[280] = 99.744;",
"n[281] = 99.752;",
"n[282] = 99.76;",
"n[283] = 99.767;",
"n[284] = 99.774;",
"n[285] = 99.781;",
"n[286] = 99.788;",
"n[287] = 99.795;",
"n[288] = 99.801;",
"n[289] = 99.807;",
"n[290] = 99.813;",
"n[291] = 99.819;",
"n[292] = 99.825;",
"n[293] = 99.831;",
"n[294] = 99.836;",
"n[295] = 99.841;",
"n[296] = 99.846;",
"n[297] = 99.851;",
"n[298] = 99.856;",
"n[299] = 99.861;",
"n[300] = 99.865;",
"n[301] = 99.869;",
"n[302] = 99.874;",
"n[303] = 99.878;",
"n[304] = 99.882;",
"n[305] = 99.886;",
"n[306] = 99.889;",
"n[307] = 99.893;",
"n[308] = 99.896;",
"n[309] = 99.9;",
"",
"function ZtoPercentile(z){",
"with (document.CDCWeightForHeightBoys_form){",
"az = Math.abs(z);",
"if (z < -3.09) return 0.1;",
"if (z > 3.09) return 99.9;",
"thispercentile = n[Math.round(az * 100)];",
"if (z >= 0) { return thispercentile }",
"else { return 100 - thispercentile }",
"}}",
"",
"var calctxt = ''; ",
"var xmltxt = ''; ",
"var htmtxt = ''; ",
"",
"",
"",
"function CDCWeightForHeightBoys_fx() {",
"",
"currenttimeout = self.setTimeout('minMaxCheck();', 3000);",
"",
"with(document.CDCWeightForHeightBoys_form){",
"",
"",
"doCalc = true;",
"if (Height_param.value.indexOf(',') >= 0){ Height_param.value = ''; doCalc = false; alert('Comma character not allowed'); }",
"param_value = parseFloat(Height_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = Height_unit.options[Height_unit.selectedIndex].value.split('|');",
"Height = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"if (Weight_param.value.indexOf(',') >= 0){ Weight_param.value = ''; doCalc = false; alert('Comma character not allowed'); }",
"param_value = parseFloat(Weight_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = Weight_unit.options[Weight_unit.selectedIndex].value.split('|');",
"Weight = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"if(Height >= 77 && Height < 78){L = -0.979897716; M = 10.38901871; S = 0.076995353;};",
"if(Height >= 78 && Height < 79){L = -0.943555181; M = 10.61724901; S = 0.076769511;};",
"if(Height >= 79 && Height < 80){L = -0.91080778; M = 10.84432907; S = 0.076564374;};",
"if(Height >= 80 && Height < 81){L = -0.882026316; M = 11.07048885; S = 0.076380766;};",
"if(Height >= 81 && Height < 82){L = -0.857561667; M = 11.29597453; S = 0.076219662;};",
"if(Height >= 82 && Height < 83){L = -0.837750377; M = 11.52104655; S = 0.07608215;};",
"if(Height >= 83 && Height < 84){L = -0.822919198; M = 11.74597768; S = 0.075969382;};",
"if(Height >= 84 && Height < 85){L = -0.813388595; M = 11.97105103; S = 0.075882537;};",
"if(Height >= 85 && Height < 86){L = -0.809475279; M = 12.19655799; S = 0.075822785;};",
"if(Height >= 86 && Height < 87){L = -0.811493792; M = 12.4227963; S = 0.075791244;};",
"if(Height >= 87 && Height < 88){L = -0.8197572; M = 12.65006791; S = 0.075788944;};",
"if(Height >= 88 && Height < 89){L = -0.834576932; M = 12.87867701; S = 0.07581679;};",
"if(Height >= 89 && Height < 90){L = -0.856261805; M = 13.10892794; S = 0.075875517;};",
"if(Height >= 90 && Height < 91){L = -0.885116299; M = 13.34112314; S = 0.075965652;};",
"if(Height >= 91 && Height < 92){L = -0.921432943; M = 13.5755615; S = 0.076087468;};",
"if(Height >= 92 && Height < 93){L = -0.965501267; M = 13.81253552; S = 0.076240931;};",
"if(Height >= 93 && Height < 94){L = -1.017588552; M = 14.05233041; S = 0.076425662;};",
"if(Height >= 94 && Height < 95){L = -1.077941994; M = 14.29522185; S = 0.07664088;};",
"if(Height >= 95 && Height < 96){L = -1.146773671; M = 14.54147499; S = 0.076885365;};",
"if(Height >= 96 && Height < 97){L = -1.224269596; M = 14.79134177; S = 0.07715739;};",
"if(Height >= 97 && Height < 98){L = -1.310558831; M = 15.04506152; S = 0.077454707;};",
"if(Height >= 98 && Height < 99){L = -1.405713355; M = 15.30285949; S = 0.077774507;};",
"if(Height >= 99 && Height < 100){L = -1.509717075; M = 15.56494815; S = 0.078113436;};",
"if(Height >= 100 && Height < 101){L = -1.622491233; M = 15.83152429; S = 0.078467542;};",
"if(Height >= 101 && Height < 102){L = -1.743825743; M = 16.10277448; S = 0.078832409;};",
"if(Height >= 102 && Height < 103){L = -1.873365511; M = 16.37887678; S = 0.079203258;};",
"if(Height >= 103 && Height < 104){L = -2.010641647; M = 16.65999867; S = 0.079574978;};",
"if(Height >= 104 && Height < 105){L = -2.154957918; M = 16.94630912; S = 0.079942558;};",
"if(Height >= 105 && Height < 106){L = -2.305458316; M = 17.23797444; S = 0.08030117;};",
"if(Height >= 106 && Height < 107){L = -2.461019713; M = 17.53517134; S = 0.080646757;};",
"if(Height >= 107 && Height < 108){L = -2.62033059; M = 17.83808212; S = 0.080976208;};",
"if(Height >= 108 && Height < 109){L = -2.781787762; M = 18.14690821; S = 0.0812881;};",
"if(Height >= 109 && Height < 110){L = -2.943638944; M = 18.46185811; S = 0.081582687;};",
"if(Height >= 110 && Height < 111){L = -3.103888502; M = 18.78315936; S = 0.081862656;};",
"if(Height >= 111 && Height < 112){L = -3.260482798; M = 19.11103983; S = 0.082132791;};",
"if(Height >= 112 && Height < 113){L = -3.411305599; M = 19.44572803; S = 0.082400213;};",
"if(Height >= 113 && Height < 114){L = -3.554288672; M = 19.78744004; S = 0.082674023;};",
"if(Height >= 114 && Height < 115){L = -3.687600863; M = 20.13635563; S = 0.082964333;};",
"if(Height >= 115 && Height < 116){L = -3.809599339; M = 20.49262111; S = 0.083282267;};",
"if(Height >= 116 && Height < 117){L = -3.919005213; M = 20.85632542; S = 0.083638758;};",
"if(Height >= 117 && Height < 118){L = -4.014882272; M = 21.2274989; S = 0.084044246;};",
"if(Height >= 118 && Height < 119){L = -4.096683061; M = 21.60610366; S = 0.084508001;};",
"if(Height >= 119 && Height < 120){L = -4.164160421; M = 21.9920407; S = 0.085038256;};",
"if(Height >= 120 && Height < 121){L = -4.217425718; M = 22.3851382; S = 0.085641503;};",
"if(Height >= 121 && Height < 122){L = -4.256802224; M = 22.78516628; S = 0.086323118;};",
"dp = decpts.options[decpts.selectedIndex].text;",
"Z_Score =  (power((Weight / M), L) - 1) / (L * S);",
"",
"if (doCalc) Z_Score_param.value = fixDP(Z_Score, dp);",
"",
"",
"",
"Percentile =  ZtoPercentile(Z_Score);",
"",
"if (doCalc) Percentile_param.value = fixDP(Percentile, dp);",
"",
"",
"",
"",
"if (doCalc){",
"",
"rrclr();",
"if (Percentile < 5){ document.getElementById('rr1_1').bgColor = \"#cccccc\";",
"}",
"if ((Percentile >= 5) && (Percentile < 85)){ document.getElementById('rr1_2').bgColor = \"#cccccc\";",
"}",
"if ((Percentile >= 85) && (Percentile < 95)){ document.getElementById('rr1_3').bgColor = \"#cccccc\";",
"}",
"if (Percentile >= 95){ document.getElementById('rr1_4').bgColor = \"#cccccc\";",
"}",
"",
"",
"",
"}",
"",
"",
"}",
"",
"}",
"",
"function minMaxCheck(){",
"",
"if (currenttimeout) self.clearTimeout(currenttimeout);",
"",
"with(document.CDCWeightForHeightBoys_form){",
"",
"if (Height_param.value && Height < 77) {",
"Height = 0;",
"Height_param.value = \"\";",
"clrResults();",
"doCalc = false;",
"alert(\"The minimum value for Height is 77 cm.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (Height_param.value && Height > 121.99) {",
"Height_param.value = \"\";",
"clrResults();",
"Height = 0;",
"doCalc = false;",
"alert(\"The maximum value for Height is 121.99 cm.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (Weight_param.value && Weight < 5) {",
"Weight = 0;",
"Weight_param.value = \"\";",
"clrResults();",
"doCalc = false;",
"alert(\"The minimum value for Weight is 5 kg.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (Weight_param.value && Weight > 200) {",
"Weight_param.value = \"\";",
"clrResults();",
"Weight = 0;",
"doCalc = false;",
"alert(\"The maximum value for Weight is 200 kg.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"",
"",
"}",
"",
"}",
"",
"",
"function clrResults(){",
"",
"if (currenttimeout) self.clearTimeout(currenttimeout);",
"",
"with(document.CDCWeightForHeightBoys_form){",
"",
"Z_Score_param.value = '';",
"Percentile_param.value = '';",
"",
"rrclr();",
"",
"}",
"",
"}",
"",
"",
"",
"",
"",
"",
"",
"",
"",
"function rrclr(){",
"document.getElementById('rr1_1').bgColor = \"\";",
"document.getElementById('rr1_2').bgColor = \"\";",
"document.getElementById('rr1_3').bgColor = \"\";",
"document.getElementById('rr1_4').bgColor = \"\";",
"}",
"",
"",
""].join("\n");
var outline_f34_50_35619=null;
var title_f34_50_35620="Barretts esophagus OCT";
var content_f34_50_35620=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F56571&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F56571&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Barrett's esophagus (optical coherence tomography)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 450px; height: 229px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Endoscopic view with optical coherence tomography (OCT) catheter probe placed adjacent to segment of Barrett's mucosa; (B) OCT image demonstrating multiple crypt- and band-like structures; (C) highly-magnified view of the portion of the OCT image outlined in the box in (B); (C) corresponding histological section of Barrett's mucosa.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Shai Friedland, MD and Jacques Van Dam, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_50_35620=[""].join("\n");
var outline_f34_50_35620=null;
var title_f34_50_35621="Small cell ca";
var content_f34_50_35621=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F56613&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F56613&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 644px\">",
"   <div class=\"ttl\">",
"    Small cell carcinoma (poorly differentiated neuroendocrine carcinoma)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 624px; height: 165px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A-B: In poorly differentiated neuroendocrine carcinoma, the cells are small, rather uniform, hyperchromatic, with nuclear molding, scant cytoplasm and inconspicuous nucleoli. C: Approximately half of small cell carcinomas are associated with areas of urothelial carcinoma and less frequently squamous cell carcinoma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Cristina Magi-Galluzzi, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_50_35621=[""].join("\n");
var outline_f34_50_35621=null;
var title_f34_50_35622="Submandibular space infections (Ludwig's angina)";
var content_f34_50_35622=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Submandibular space infections (Ludwig's angina)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/50/35622/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/50/35622/contributors\">",
"     Anthony W Chow, MD, FRCPC, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/50/35622/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/50/35622/contributors\">",
"     Stephen B Calderwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/50/35622/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/50/35622/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?34/50/35622/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 17, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H975545592\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ludwig's angina is a bilateral infection of the submandibular space that consists of two compartments in the floor of the mouth, the sublingual space and the submylohyoid (also known as submaxillary) space (",
"    <a class=\"graphic graphic_figure graphicRef81946 \" href=\"mobipreview.htm?4/57/5012\">",
"     figure 1",
"    </a>",
"    ). It was first described by the German physician, Wilhelm Frederick von Ludwig in 1836. This infection most commonly arises from an infected second or third mandibular molar tooth. It is an aggressive, rapidly spreading cellulitis without lymphadenopathy with potential for airway obstruction and requires careful monitoring and rapid intervention for prevention of asphyxia and aspiration pneumonia.",
"   </p>",
"   <p>",
"    The anatomy, microbiology, clinical manifestations, imaging, and treatment of submandibular space infections (Ludwig's angina) will be reviewed here. Other deep neck space infections are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/45/36569?source=see_link\">",
"     \"Deep neck space infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H975545600\">",
"    <span class=\"h1\">",
"     DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the term Ludwig's angina has been loosely applied to a heterogeneous array of infections involving the sublingual and submylohyoid (submaxillary) spaces, this diagnosis should be restricted to the following classical description:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The infection begins in the floor of the mouth. It is characteristically an aggressive, rapidly spreading \"woody\" or brawny cellulitis involving the submandibular space.",
"     </li>",
"     <li>",
"      The infection is a rapidly spreading cellulitis without lymphatic involvement and generally without abscess formation.",
"     </li>",
"     <li>",
"      Both the submylohyoid and sublingual spaces are involved.",
"     </li>",
"     <li>",
"      The infection is bilateral.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H975545753\">",
"    <span class=\"h1\">",
"     ANATOMIC CONSIDERATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The submandibular space lies within the submental and submandibular triangles between the mucosa of the floor of the mouth and the superficial layer of the deep cervical fascia. It is subdivided by the mylohyoid muscle into the sublingual space (which contains the sublingual gland, hypoglossal nerve, part of the submandibular gland, and loose connective tissue) and the submylohyoid space (which contains the submandibular salivary gland and lymph nodes) (",
"    <a class=\"graphic graphic_figure graphicRef81946 \" href=\"mobipreview.htm?4/57/5012\">",
"     figure 1",
"    </a>",
"    ). The two divisions communicate posteriorly around the mylohyoid muscle. This accounts for the bilateral involvement by contiguous spread of infection within the submandibular space in Ludwig&rsquo;s angina.",
"   </p>",
"   <p>",
"    An overview of the anatomy of the deep neck spaces and anatomical considerations for other deep neck space infections are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/45/36569?source=see_link&amp;anchor=H2#H2\">",
"     \"Deep neck space infections\", section on 'Anatomic considerations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H975545745\">",
"    <span class=\"h1\">",
"     MECHANISMS OF SPREAD",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the submandibular space is divided by the mylohyoid muscle into the sublingual space above and the submylohyoid space below, it can be considered as a single unit due to a direct communication around the posterior aspect of the mylohyoid muscle (",
"    <a class=\"graphic graphic_figure graphicRef81946 \" href=\"mobipreview.htm?4/57/5012\">",
"     figure 1",
"    </a>",
"    ). Over two-thirds of patients with Ludwig&rsquo;s angina have a dental source of infection, usually involving the second or third mandibular molar teeth [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35622/abstract/1\">",
"     1",
"    </a>",
"    ]. The submylohyoid space is initially involved, since the roots of these teeth are located below the attachments of the mylohyoid muscle to the mandible (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/30/16873?source=see_link\">",
"     \"Epidemiology, pathogenesis, and clinical manifestations of odontogenic infections\"",
"    </a>",
"    ). Other sources of infection include contiguous spread from peritonsillar abscess or suppurative parotitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35622/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Medial spread of infection is facilitated because the lingual aspects of periodontal bone around these teeth are thin.",
"    <strong>",
"    </strong>",
"    Infection extends contiguously to involve the sublingual and thus the entire submandibular space in a symmetrical manner. If infection were instead spread via the lymphatics, involvement would be unilateral instead of bilateral as is observed. An identical process, initially involving the sublingual space, can arise less commonly from infection of the premolars and other teeth or from trauma to the floor of the mouth.",
"   </p>",
"   <p>",
"    Once established, infection evolves rapidly. The tongue may enlarge to two or three times its normal size and distend posteriorly into the hypopharynx, superiorly against the palate, and anteriorly protruding out of the mouth. Immediate posterior extension of the process will directly involve the epiglottis. There exists a little known dangerous connection between the submandibular and parapharyngeal spaces known as the buccopharyngeal gap. This is created by the styloglossus muscle as it leaves the tongue and passes between the middle and superior constrictor muscles to attach on the styloid process. Thus, cellulitis of the submandibular space may spread directly along the styloglossus muscle into the parapharyngeal space and from there to the retropharyngeal space and the superior mediastinum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35622/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/45/36569?source=see_link\">",
"     \"Deep neck space infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H975545737\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ludwig's angina is typically a polymicrobial infection involving the flora of the oral cavity (",
"    <a class=\"graphic graphic_table graphicRef81076 \" href=\"mobipreview.htm?26/38/27244\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35622/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/30/16873?source=see_link\">",
"     \"Epidemiology, pathogenesis, and clinical manifestations of odontogenic infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The most common organism isolated from deep neck space infections is Streptococcus viridans. Most abscesses originating from the teeth also harbor oral anaerobes, including Peptostreptococcus species, Fusobacterium nucleatum, pigmented Bacteroides (eg, Prevotella melaninogenica [formerly Bacteroides melaninogenicus] and Porphyromonas spp), and Actinomyces species.",
"   </p>",
"   <p>",
"    In immunocompromised patients, gram-negative aerobes may also be present. Furthermore, Staphylococcus aureus, including methicillin-resistant S. aureus, may contribute to deep neck space infections in immunocompromised patients and others with specific risk factors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35622/abstract/1,4\">",
"     1,4",
"    </a>",
"    ]. This is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/45/36569?source=see_link&amp;anchor=H10#H10\">",
"     \"Deep neck space infections\", section on 'Microbiology'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H975545729\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients typically present with fever, chills, and malaise, as well as mouth pain, stiff neck, drooling, and dysphagia, and may lean forward to maximize the airway diameter [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35622/abstract/5\">",
"     5",
"    </a>",
"    ]. They may have a muffled voice or be unable to speak at all. Trismus is usually absent unless there is spread into the parapharyngeal space. As the illness progresses, breathing may become difficult; stridor and cyanosis are considered ominous signs. (See",
"    <a class=\"local\" href=\"#H975545699\">",
"     'Airway management'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    On physical examination, patients have tender, symmetric, and \"woody\" induration, sometimes with palpable crepitus, in the submandibular area [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35622/abstract/5\">",
"     5",
"    </a>",
"    ]. The mouth is held open by lingual swelling. There is typically no lymphadenopathy. The floor of the oropharynx is usually elevated and erythematous, and is tender to palpation. Occasionally, the inflammation extends to the epiglottis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H975545722\">",
"    <span class=\"h1\">",
"     IMAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Computed tomography (CT) is the imaging modality of choice for the diagnosis of Ludwig's angina and other deep neck space infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35622/abstract/6\">",
"     6",
"    </a>",
"    ]. This is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/45/36569?source=see_link&amp;anchor=H988692187#H988692187\">",
"     \"Deep neck space infections\", section on 'Imaging'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H975545714\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of Ludwig's angina is established based on the presence of suggestive clinical findings, usually with the support of imaging studies. When needle aspiration or incision and drainage is indicated, samples should be obtained for Gram stain and culture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35622/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H975545663\">",
"     'Surgery'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Since Ludwig's angina does not usually involve abscess formation, a microbiologic diagnosis from the site of infection is often not possible. Needle aspiration of the submandibular space may be attempted and specimens should be transported for culture of both facultative and anaerobic organisms. Blood cultures should be obtained from patients with Ludwig's angina. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/14/11494?source=see_link\">",
"     \"Blood cultures for the detection of bacteremia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H975545706\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of Ludwig's angina involves timely assessment and management of the airway, and empiric broad-spectrum antibiotics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35622/abstract/5,8\">",
"     5,8",
"    </a>",
"    ]. Surgery is not usually necessary since it is uncommon to have a drainable collection in the early stages of infection. Surgical drainage is important once abscesses are identified by CT or MRI.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H975545699\">",
"    <span class=\"h2\">",
"     Airway management",
"    </span>",
"    &nbsp;&mdash;&nbsp;While maintenance of an adequate airway is the primary concern and may necessitate urgent tracheostomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35622/abstract/9,10\">",
"     9,10",
"    </a>",
"    ], most cases can be managed initially by close observation and intravenous antibiotics. If cellulitis and swelling continue to advance or if dyspnea occurs, artificial airway control should be gained immediately, before the onset of stridor, cyanosis, and asphyxia. Tracheostomy under emergency conditions may be required in more severe cases.",
"   </p>",
"   <p>",
"    If airway compromise is suspected, a recommended approach is to perform fiberoptic intubation via the nasal route. Fibroscopic laryngoscopy is carried out to assess the airway and to aid in nasal intubation of an endotracheal tube under direct observation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35622/abstract/11\">",
"     11",
"    </a>",
"    ]. Blind oral or nasotracheal intubation is both traumatic and unsafe in advanced Ludwig's angina because of the potential for inducing severe laryngospasm.",
"   </p>",
"   <p>",
"    If intubation is not possible, tracheostomy is the most widely recommended means of surgical airway control, although cricothyroidotomy is advocated by some experts because of a lower complication rate. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/50/4905?source=see_link\">",
"     \"Emergent surgical cricothyrotomy (cricothyroidotomy)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H975545692\">",
"    <span class=\"h2\">",
"     Antibiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of Ludwig's angina has not been evaluated in clinical trials. Empiric antimicrobial regimens are based on the expected microbiology, and should be tailored if microbiologic data become available. (See",
"    <a class=\"local\" href=\"#H975545737\">",
"     'Microbiology'",
"    </a>",
"    above.) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H975545685\">",
"    <span class=\"h3\">",
"     Immunocompetent hosts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Empiric antibiotic treatment of immunocompetent patients requires broad-spectrum antibiotics with activity against beta-lactamase-producing aerobes and anaerobes, and Staphylococcus aureus, including in some cases, methicillin-resistant S. aureus (MRSA) (",
"    <a class=\"graphic graphic_table graphicRef77338 \" href=\"mobipreview.htm?42/20/43342\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    For immunocompetent hosts, we suggest one of the following regimens:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?1/8/1160?source=see_link\">",
"       Ampicillin-sulbactam",
"      </a>",
"      (3 g IV every six hours)",
"      <strong>",
"       or",
"      </strong>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?21/42/22183?source=see_link\">",
"       Penicillin G",
"      </a>",
"      (2 to 4 MU IV every four to six hours)",
"      <strong>",
"       plus",
"      </strong>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/38/20065?source=see_link\">",
"       metronidazole",
"      </a>",
"      (500 mg IV every six to eight hours)",
"      <strong>",
"       or",
"      </strong>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/21/33104?source=see_link\">",
"       Clindamycin",
"      </a>",
"      (600 mg IV every six to eight hours)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/21/33104?source=see_link\">",
"     Clindamycin",
"    </a>",
"    is the drug of choice in penicillin-allergic patients (",
"    <a class=\"graphic graphic_table graphicRef77338 \" href=\"mobipreview.htm?42/20/43342\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In addition, patients who are at increased risk of MRSA carriage or infection, who are septic or at risk of rapid deterioration, should be treated empirically for MRSA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35622/abstract/5\">",
"     5",
"    </a>",
"    ]. For MRSA coverage, in addition to one of the above regimens, we suggest",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    (15 to 20",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    IV every 12 hours) or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?14/3/14393?source=see_link\">",
"     linezolid",
"    </a>",
"    (600 mg orally or IV every 12 hours). Risk factors for MRSA include a history of intravenous drug use, comorbid disease (eg, diabetes mellitus), or residing in a community or hospital where there is a substantial incidence of MRSA.",
"   </p>",
"   <p>",
"    If MRSA is not present on deep cultures, coverage for this organism can be discontinued. Dosing and monitoring of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/47/15096?source=see_link&amp;anchor=H9#H9\">",
"     \"Vancomycin dosing and serum concentration monitoring in adults\", section on 'Routine administration'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H975545678\">",
"    <span class=\"h3\">",
"     Immunocompromised hosts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Empiric antibiotic treatment of immunocompromised patients requires broad-spectrum antibiotics with activity against facultative gram-negative rods, and beta-lactamase-producing aerobes and anaerobes.",
"    <strong>",
"    </strong>",
"    A cephalosporin with activity against Pseudomonas aeruginosa, in combination with an agent with activity against oral anaerobes, are frequently given. Alternatively, a carbapenem (eg,",
"    <strong>",
"    </strong>",
"    imipenem or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/38/32359?source=see_link\">",
"     meropenem",
"    </a>",
"    ) or an extended-spectrum",
"    <strong>",
"    </strong>",
"    beta-lactamase-inhibitor combination (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/41/24216?source=see_link\">",
"     piperacillin-tazobactam",
"    </a>",
"    ) may be used, particularly in the immunocompromised host with severe infection (",
"    <a class=\"graphic graphic_table graphicRef77338 \" href=\"mobipreview.htm?42/20/43342\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Treatment for immunocompromised patients may include one of the following regimens:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?16/33/16919?source=see_link\">",
"       Cefepime",
"      </a>",
"      (2 g IV every 12 hours)",
"      <strong>",
"       plus",
"      </strong>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/38/20065?source=see_link\">",
"       metronidazole",
"      </a>",
"      (500 mg IV every six to eight hours)",
"      <strong>",
"       or",
"      </strong>",
"     </li>",
"     <li>",
"      Imipenem (500 mg IV every six hours)",
"      <strong>",
"       or",
"      </strong>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/38/32359?source=see_link\">",
"       Meropenem",
"      </a>",
"      (1 g IV every eight hours)",
"      <strong>",
"       or",
"      </strong>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/41/24216?source=see_link\">",
"       Piperacillin-tazobactam",
"      </a>",
"      (4.5 g IV every six hours)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, patients with risk factors for MRSA infection should be treated empirically with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    (15 to 20",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    IV every 12 hours) or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?14/3/14393?source=see_link\">",
"     linezolid",
"    </a>",
"    (600 mg orally or IV every 12 hours). Risk factors for MRSA include a history of intravenous drug use, comorbid disease (eg, diabetes mellitus), or residing in a community or hospital where there is a substantial incidence of MRSA.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H975545670\">",
"    <span class=\"h3\">",
"     Duration",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general, antimicrobial therapy should be continued for two to three weeks until clear evidence of clinical improvement is present, and fever and leucocytosis have subsided.",
"    <strong>",
"    </strong>",
"    Longer courses are required when complications are present. We favor intravenous antibiotics for the entire duration of treatment.",
"    <strong>",
"     &nbsp;",
"    </strong>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H975545663\">",
"    <span class=\"h2\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early surgical decompression is unlikely to locate pus and, at best, may only moderately improve the airway. Abscesses develop relatively late (not usually in the first 24 to 36 hours) and are sometimes difficult to detect clinically.",
"   </p>",
"   <p>",
"    If the patient is not responding adequately to antibiotics alone after this initial period, or if fluctuance is detectable or a collection is observed on imaging, needle aspiration or a more formal incision and drainage procedure under general anesthesia should be performed. This should be done with a cuffed tracheostomy in place. Additionally, when a tooth is implicated as the source of infection, it should be extracted. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/53/20313?source=see_link\">",
"     \"Complications, diagnosis, and treatment of odontogenic infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When needle aspiration or incision and drainage is indicated, samples should be obtained for Gram stain and cultured for both aerobic and anaerobic microorganisms. (See",
"    <a class=\"local\" href=\"#H975545714\">",
"     'Diagnosis'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H975545656\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, airway compromise is a potential complication of Ludwig's angina, and requires careful monitoring and rapid intervention for prevention of asphyxia or aspiration pneumonia. (See",
"    <a class=\"local\" href=\"#H975545699\">",
"     'Airway management'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Mediastinitis is a rare complication resulting from spread into the parapharyngeal space and from there to the retropharyngeal space and the superior mediastinum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35622/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H975545745\">",
"     'Mechanisms of spread'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H975545649\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;With the combined use of systemic antibiotics and aggressive surgical intervention in selected patients, the mortality rate for Ludwig's angina has declined dramatically from over 50 percent in the preantibiotic era to 0 to 4 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35622/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H975545641\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ludwig's angina is a bilateral infection of the submandibular space that begins in the floor of the mouth, most commonly related to the second or third mandibular molar teeth. It is an aggressive, rapidly spreading \"woody\" or brawny cellulitis without lymphadenopathy. Airway compromise is a potential complication, and requires careful monitoring and rapid intervention for prevention of asphyxia and aspiration pneumonia. (See",
"      <a class=\"local\" href=\"#H975545600\">",
"       'Definition'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H975545745\">",
"       'Mechanisms of spread'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H975545656\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The submandibular space lies within the submental and submandibular triangles between the mucosa of the floor of the mouth and the superficial layer of the deep cervical fascia. Although the submandibular space is further divided by the mylohyoid muscle into the sublingual space above and the submylohyoid space below, it can be considered as a single unit due to a direct communication around the posterior aspect of the mylohyoid muscle (",
"      <a class=\"graphic graphic_figure graphicRef81946 \" href=\"mobipreview.htm?4/57/5012\">",
"       figure 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H975545753\">",
"       'Anatomic considerations'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H975545745\">",
"       'Mechanisms of spread'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Ludwig's angina is typically a polymicrobial infection. The most common organisms implicated in deep neck space infections of odontogenic origin are Streptococcus viridans and oral anaerobes. Gram-negative aerobes may also play a role in immunocompromised patients. Staphylococcus aureus, including methicillin-resistant",
"      <strong>",
"      </strong>",
"      S. aureus, may also be involved in immunocompromised patients and others with specific risk factors. (See",
"      <a class=\"local\" href=\"#H975545737\">",
"       'Microbiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients typically present with fever, chills, and malaise, as well as mouth pain, stiff neck, drooling, and dysphagia, and may lean forward to maximize the airway diameter. They may have a muffled voice or be unable to speak at all. As the illness progresses, breathing may become difficult; stridor and cyanosis are considered ominous signs. (See",
"      <a class=\"local\" href=\"#H975545729\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      On physical examination, patients have tender, symmetric, and \"woody\" induration, sometimes with palpable crepitus, in the submandibular area. The mouth is held open by lingual swelling. The floor of the oropharynx is usually elevated and erythematous, and is tender to palpation. (See",
"      <a class=\"local\" href=\"#H975545729\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Computed tomography (CT) is the imaging modality of choice for the diagnosis of Ludwig's angina (see",
"      <a class=\"local\" href=\"#H975545722\">",
"       'Imaging'",
"      </a>",
"      above). Magnetic resonance imaging (MRI) is useful for delineating soft tissue involvement particularly if septic jugular thrombophlebitis is suspected.",
"     </li>",
"     <li>",
"      The diagnosis of Ludwig's angina is established based on the presence of suggestive clinical findings, usually with the support of imaging studies. When needle aspiration or incision and drainage are indicated, samples should be obtained for Gram stain and both aerobic and anaerobic",
"      <strong>",
"      </strong>",
"      culture. Blood cultures should be obtained in patients with Ludwig's angina. (See",
"      <a class=\"local\" href=\"#H975545714\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      While maintenance of an adequate airway is the primary concern and may necessitate urgent tracheostomy, most cases can be managed initially by close observation and intravenous antibiotics. (See",
"      <a class=\"local\" href=\"#H975545699\">",
"       'Airway management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with Ludwig's angina should be treated empirically with broad-spectrum aerobic and anaerobic coverage, including in some cases, coverage for methicillin-resistant S. aureus (MRSA). The appropriate regimen depends on the immune status of the patient and risk factors for MRSA. Risk factors for MRSA include a history of intravenous drug use, comorbid disease (eg, diabetes mellitus), or residing in a community or hospital where there is a substantial incidence of MRSA.",
"     </li>",
"     <li>",
"      <strong>",
"       Immunocompetent",
"      </strong>",
"      <strong>",
"       hosts",
"      </strong>",
"      may receive one of the following regimens:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?1/8/1160?source=see_link\">",
"       Ampicillin-sulbactam",
"      </a>",
"      (3 g IV every six hours)",
"      <strong>",
"       or",
"      </strong>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?21/42/22183?source=see_link\">",
"       Penicillin G",
"      </a>",
"      (2 to 4 MU IV every four to six hours)",
"      <strong>",
"       plus",
"      </strong>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/38/20065?source=see_link\">",
"       metronidazole",
"      </a>",
"      (500 mg IV every six to eight hours)",
"      <strong>",
"       or",
"      </strong>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/21/33104?source=see_link\">",
"       Clindamycin",
"      </a>",
"      (600 mg IV every six to eight hours)",
"      <br/>",
"      <br/>",
"      In addition to one of the above regimens, we suggest that immunocompetent patients who are at increased risk for MRSA infection be treated empirically with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?41/41/42649?source=see_link\">",
"       vancomycin",
"      </a>",
"      (15 to 20",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      IV every 12 hours) or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?14/3/14393?source=see_link\">",
"       linezolid",
"      </a>",
"      (600 mg orally or IV every 12 hours). (See",
"      <a class=\"local\" href=\"#H975545685\">",
"       'Immunocompetent hosts'",
"      </a>",
"      above.)",
"      <br/>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Immunocompromised hosts",
"      </strong>",
"      may receive one of the following regimens:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?16/33/16919?source=see_link\">",
"       Cefepime",
"      </a>",
"      (2 g IV every 12 hours) plus",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/38/20065?source=see_link\">",
"       metronidazole",
"      </a>",
"      (500 mg IV every six to eight hours) or",
"     </li>",
"     <li>",
"      Imipenem (500 mg IV every six hours) or",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/38/32359?source=see_link\">",
"       Meropenem",
"      </a>",
"      (1 g IV every eight hours) or",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/41/24216?source=see_link\">",
"       Piperacillin-tazobactam",
"      </a>",
"      (4.5 g IV every six hours)",
"      <br/>",
"      <br/>",
"      In addition to one of the above regimens, we suggest that immunocompromised patients who are at increased risk for MRSA infection be treated empirically with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?41/41/42649?source=see_link\">",
"       vancomycin",
"      </a>",
"      (15 to 20",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      IV every 12 hours) or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?14/3/14393?source=see_link\">",
"       linezolid",
"      </a>",
"      (600 mg orally or IV every 12 hours). (See",
"      <a class=\"local\" href=\"#H975545678\">",
"       'Immunocompromised hosts'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In general, antimicrobial therapy should be continued for two to three weeks until clear evidence of clinical improvement is present, and fever and leucocytosis have subsided. Longer courses are required when complications are present. (See",
"      <a class=\"local\" href=\"#H975545670\">",
"       'Duration'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If the patient is not responding adequately to antibiotics alone after this initial period, or if fluctuance is detectable or a collection is observed on imaging, needle aspiration or a more formal incision and drainage procedure under general anesthesia should be performed. (See",
"      <a class=\"local\" href=\"#H975545663\">",
"       'Surgery'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35622/abstract/1\">",
"      Boscolo-Rizzo P, Da Mosto MC. Submandibular space infection: a potentially lethal infection. Int J Infect Dis 2009; 13:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35622/abstract/2\">",
"      Furst IM, Ersil P, Caminiti M. A rare complication of tooth abscess--Ludwig's angina and mediastinitis. J Can Dent Assoc 2001; 67:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35622/abstract/3\">",
"      Brook I. Microbiology and principles of antimicrobial therapy for head and neck infections. Infect Dis Clin North Am 2007; 21:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35622/abstract/4\">",
"      Patel M, Chettiar TP, Wadee AA. Isolation of Staphylococcus aureus and black-pigmented bacteroides indicate a high risk for the development of Ludwig's angina. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 108:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35622/abstract/5\">",
"      Reynolds SC, Chow AW. Life-threatening infections of the peripharyngeal and deep fascial spaces of the head and neck. Infect Dis Clin North Am 2007; 21:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35622/abstract/6\">",
"      Hurley MC, Heran MK. Imaging studies for head and neck infections. Infect Dis Clin North Am 2007; 21:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35622/abstract/7\">",
"      Roscoe DL, Hoang L. Microbiologic investigations for head and neck infections. Infect Dis Clin North Am 2007; 21:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35622/abstract/8\">",
"      Barakate MS, Jensen MJ, Hemli JM, Graham AR. Ludwig's angina: report of a case and review of management issues. Ann Otol Rhinol Laryngol 2001; 110:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35622/abstract/9\">",
"      Vieira F, Allen SM, Stocks RM, Thompson JW. Deep neck infection. Otolaryngol Clin North Am 2008; 41:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35622/abstract/10\">",
"      Ovassapian A, Tuncbilek M, Weitzel EK, Joshi CW. Airway management in adult patients with deep neck infections: a case series and review of the literature. Anesth Analg 2005; 100:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35622/abstract/11\">",
"      Barton ED, Bair AE. Ludwig's angina. J Emerg Med 2008; 34:163.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13964 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-190.111.122.2-6B4A64F196-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_50_35622=[""].join("\n");
var outline_f34_50_35622=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H975545641\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H975545592\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H975545600\">",
"      DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H975545753\">",
"      ANATOMIC CONSIDERATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H975545745\">",
"      MECHANISMS OF SPREAD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H975545737\">",
"      MICROBIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H975545729\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H975545722\">",
"      IMAGING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H975545714\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H975545706\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H975545699\">",
"      Airway management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H975545692\">",
"      Antibiotics",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H975545685\">",
"      - Immunocompetent hosts",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H975545678\">",
"      - Immunocompromised hosts",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H975545670\">",
"      - Duration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H975545663\">",
"      Surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H975545656\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H975545649\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H975545641\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/13964\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/13964|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?4/57/5012\" title=\"figure 1\">",
"      Submandibular space anatomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/13964|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?26/38/27244\" title=\"table 1\">",
"      Cultivable flora oral cavity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?42/20/43342\" title=\"table 2\">",
"      Treatment of deep neck space infections",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/14/11494?source=related_link\">",
"      Blood cultures for the detection of bacteremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/53/20313?source=related_link\">",
"      Complications, diagnosis, and treatment of odontogenic infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/45/36569?source=related_link\">",
"      Deep neck space infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/50/4905?source=related_link\">",
"      Emergent surgical cricothyrotomy (cricothyroidotomy)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/30/16873?source=related_link\">",
"      Epidemiology, pathogenesis, and clinical manifestations of odontogenic infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/47/15096?source=related_link\">",
"      Vancomycin dosing and serum concentration monitoring in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_50_35623="Ultrasound of the tibialis anterior after polio";
var content_f34_50_35623=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F55106&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F55106&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 515px\">",
"   <div class=\"ttl\">",
"    Ultrasound of the tibialis anterior after polio",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 495px; height: 434px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This is an image of the right and left tibialis anterior in a patient with remote polio. The image on the left shows the more severely affected muscle, with greater atrophy; note the distance from the surface to the interosseus membrane (IM), slightly greater hyperechogenicity, loss of bone edge delineation on the tibia (T), and greater loss of heterogeneity. The overall appearance of the muscle tissue, however, is similar to that seen in many myopathic disorders.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Francis O Walker, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_50_35623=[""].join("\n");
var outline_f34_50_35623=null;
var title_f34_50_35624="Thin basement membrane EM";
var content_f34_50_35624=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F55486&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F55486&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Thin basement membrane disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 243px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Electron micrograph comparing the thickness of the normal glomerular basement membrane (GBM) (left panel) to the much thinner GBM in thin basement membrane disease (right panel).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Electron micrograph of a normal glomerulus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 377px; height: 266px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Electron micrograph of a normal glomerular capillary loop showing the fenestrated endothelial cell (Endo), the glomerular basement membrane (GBM), and the epithelial cells with its interdigitating foot processes (arrow). The GBM is thin, and no electron dense deposits are present. Two normal platelets are seen in the capillary lumen.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_50_35624=[""].join("\n");
var outline_f34_50_35624=null;
var title_f34_50_35625="Acute rejection vascular I";
var content_f34_50_35625=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F63730%7EPULM%2F75560&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F63730%7EPULM%2F75560&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Vascular pattern of acute lung transplant rejection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 235px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADrAWgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD3Mn7uT+tcb4pW60TWY9csrc3EMoaO6ZnyIcKNh2Y5UkHLZ+XPTFdTqNqb3T5bX7Rc2pmQqJrWTZLGT/EjY4NSQxOLZYrmX7USpV3dAvmZ9QOOnB4r5ulPkd9z6Dm5ZXIdK1Sz1S382yuIZgvDiN87T/nvXI/E9dMuI7G2uLGG51KWUQwTIoae3JwwC4+Zc9eoHGak1rwZcLrI1fwxewafelBHJBNEzQSADHCowK5HBxnIA70vhHwZdWHiTU/EWu3dtcatfFSRaKwihwu3K7yT04x0FdVP2NP94parZa3v67W/PsVHljJTT0/H0Op0LVLfUbKJop1lmWNfNXOWVsY5HuQawfE3w90XX7qe6YXFndXKBJ5rSVomlAxjdjjt2GfXNW/CVhd6LE2mzxNJCGeRbkEYck559z/SukHNYSk6U26Tt2JbdOT5Wcn4f+HfhbQjG9ppMc1yjBxc3bmeXcOhyxIB+grrcjI9ccU0HHbNGcdc4rKc5Td5tt+ZF2x+R2oPT0po6/8A16GJUcKWOQMD/P41NhCnPp7UpO3OcY9TTeOgpc5z2FACnofSkx1oPTjIPsKCeOaAQjAkgg0ki7l2tnB9DTiR26mmkjaT6dTQM4zx34KtvFD2kszJthfM6OcLNH6NjrtPzV59pnhSeHS5dJlvIddF5J5plW53R7TjAVl5wAAQo747Zq94j+L/ANk8S39hY26y2NirfapWXdnttA75JA/SuJ8I6gml634avoLzTYtNt1a4uhJ5irHEznDRp94sQSM84PBwK9vC0a8abu/Rb9301O+jzqN302Oh+I2r3bahYaXoFxd2thp1j8zq28s6nONmeDjofQ+1bvgbx1o1rYahZWklw2rGNZlF0QqzuVHyx8fwjqT6E9KoR+F7Lx34jn8XaLqr20d3aOFsLtAkkbBSm4FSRsPUkZwSas+HdHuNDbToNV0E3dzbxCe51VZVMcCE7RCjgfNkHI6nkD6aVHRdJUpbrps79dXvr/wC17KVLld79jK8SeJfFujajCxluV0+aBbh76ZJHSEsCwVccYHAOc9eemK9C8LX2gfErQINQZIr26sWa2a6WAxPDMUG5os8gHOR2PpVmz8XaLq8V5Y36JBp3mGzMlyQttI/Qx7jjDegPXjBNcDe6RL8O76WTQ7b+0dEuLhUKRuHe2zy3mYwV6YDLj7oyc9eeS9suSUeSa2fR/Pv8zF/vGoL3ZLX1L9t43ufAusavpPilZJdOghF1ZOmwOqZww5I3biQR6HcPaul1Xx9pk3h9rrRdSgt5p4/3N1exMIISf4n9SOQF9faqVtH4a8c2sJ8Q28keqaa8kCfb3EE4Q/xjnDKQRyR1B+px9XvNA8PWcuneCoIb7Uggt7lhIZBbwnOWyfl356cHpmo9nGpJKUHz9Xpy+vX+u41ThVk1Z83b9fJEtlF8R9Rk02e41147KZlSRbWwhUFQM+ZnqqN9c+wzWwviPVPDXiyTTNXtbq702REktr4gASucbo0GeoJGQT2OO2eCI8faklve2EtzNFpLiOFIJF3zpjqztxk9zg4B5HFdGfE/irS76XStSgs9c1B44njs1ZY2KvgsA38RUHqMg9cVpUpcz5bwej0WlvO/l3eg3QtdWVl0W/4jNMnt9Dvj/wi+r6XeJ5jzXFvdQFr4FuSN3bHT8fXmr/xO0OG3ltNZ0y3K6ilx5irCwj3k8kk8ZPHc4/GtfXPC1jqmnyXWl6fa22qy7XlHTzR3RyOvTtirn9raRrawafqqNDeHrC6lQGUckN0A74NYKr70alO91vtf8LXX9XH7T3lU1fch8R+HLLx3odq9zNNZysqyMbZwWRivKn6biPoaw/AHg2/0HxPfSXKgac0Bh+8CkxwFXC8kDaDnPeobbTdW0HXIX8O+I7XUYW3vdWM+DJMucjZjgso46g13vhzV4tb0mG9hTyy2VeMnJRgeh/Q/jU1JVKVNxhK8H010+T9N9vmQ5yjBxWsfyPO/H/hS40bwrv0ZpLu3tWPmLPmSVrZmy0Gf4hkgg9Rt70lzJHq3gQ6fuyNOkV8TfMXtSSm4dyBu5PtXqN3bi7tpIGLKJF27k4ZT6ivK4Wij8eQXli+Gvbg2vlSN5SXLKCsmFJOCVPTgfKMAdKqhVlVjaWrWt/8/wAdTWhUury3jr/Xqdp8OteOveHMzoYryxlazuIz6pwrA9wy4OR7+lZ/xN8TWWn6Pc6YZoPttxGQySuFCJjJyTxkgcD3ya53w79v8AalqVnf20lxpkCFrS5Vh+/gyCC+DwynIJxjketcfdaRL4y8eJd3lvPdaDqrzSabc4+SNlHzI3odyBfT61rDD0pVXVb9zdeu9vXy8rGcKSjPn6br+vIz4vGch/soGexZN2y7gRThnkyVVMckBduW9Seta+iXms6rNPpWpWEK2kdqLoyF94ADgE7ScHAbgH0yM1g6VFb2upCM6LJDcRXTQF5gA8a4AR2TA4YHHHTsa+iYLDStStLnyYrWZLlFjuHtj7DgMORjtiu3G1o0Ipxjo/66ep0VK3skk+p5FHaeFNB0fU7y9itrq8vHjgCTwfJDwdgAA5IBJ4GSevc1R17R9eWfT5WuYrWZ0dk/dNidiMKQozuOCODzxmvVdH8C6Tp6ESma9YTCeI3Jz5OOQAOn1ro75rj7HP8AYQhu9jCDcu5RIRhcj0zjPtXA8wUJXp6+vpYzliYpvl1v8jhZ7ex0vUDr+vK0U1tawlYpZV+Vvus4z90nHIz25rG+Is41vVrC50e/uFjs96SiDYVulZQwHJxgZwSfUnHFQXNhqXiHRQdbmhuL3y/LnJXBnKk5Kqvy7Q3GR61iatoyQ6ffWmow3lnbRgSS7AYmdMnMYHUZHXHUfWtacIqSlKV5L7rbaXNIU9VKT1XQ2b66vrPQ9K0TwxHH5Vpg3TGItljh/wByckZAzjnn0ri1vvFdxe3AsWtdSvN6mS4u7VbdrRiT8jjG189OMnjtXo/giPWrf4Y6ZPbWEUN/czpsjQFtsB+RHHUqduOfxJ61xmp+HE03xHDMdPv7XylF80oYyQeaZGCuxGRvBGfpg9jW1KrCM5Qdr3eujbfn69LfPTQzg1JWitfX7/6/UzNX8Y6dJ4Wa5gRLfU0iMU1tk7GlRl3sRjDdcjGOOue1z4W+GhrGq6drZkszp1lK80sdvCA6SlTgOxJIAzkKOnFauheElv8AVNOl1ObS77Tbe6klnDvmWZiC6hccMdzZYZxgDI7V0/ia+i03w7d2Phi2ttMYN5nyIqITn5j0xn360Vayt7Gkrc3XtfTtf/LuFS7fsou/n/T/ADPI/G2gpaaYkUeq3l/cRyzeRFLIGeRXIUqoznjGT6iitN5L3XPE2k3AsEuJdNkje7vZYNsEq4yCpBwMkY57j6iiuyOMlQiotKT8/wCvmTXpKbWn5I+k7eQSwwyDgOob6VMMZ6fnWR4fmeSya0coJ7Nvs5deQwAG1se4I/GtUsyyrn/Vn5ffPavluWzaOOsrSsh/4+5pcZOMYzQOvtThyegx2pmQxCzbl2NGFbAzj5vcYP1688HjpTyM/wA/rS9iR9OaUClYY3POMcdaXGfTn3o4z7H0prhyoCFQc9xnApWAXAI96XqR2H+e9IAQB3+v9ad1PA5NAwHbIzRgZznp6GjGOufpSnqSRzQIaQSOGIo+vanc9ugpMDPanYBvHrWX4mmng0W5ktv9YEOOa1QDk5xg9OK4v4q3t3Y+Gw1hKElZ8YZchh71pRg5zUTSmuaSR8wpbXFv4mvbzUILtkEpaRI5Nu8Mefc/5Ne22Hhnw/8AFHw3pGrWMF1pc1kWgVZFXPDZww5BWuB8JJfX3iF7OZQ97cpkkdFXPX1r1XxPeXfg3Q9D0rSmtYW1GWS2kMituPy/w46HBbn1Fe1ipS54wpu0ujv0tqepWTXLCLs7/K77/ocddWc/h6/YSI89pPOtvYyBgXeLy/mlbBG0M2QAB0GMHgl19qt1eX3hufW4IbXQtLBkS2kl8pppi2ASpJD9sfjwOlcd4k0EWkUFhqd88emJGzWET7vtBlCgktwTt7DHXjFekeD/AAZHq1lpb+IozrD6cyFQwKKCcOQQcFtpOOeDg8VtU5acFOTv5/hp0v0ZMmuXmnq1+f8AW36Hbazo+kXFnaWOry29nezAAQkCRX7BWjPDdhnrkcGvKtL1GaGz1LUNPtptMkllkhuJNQhk2O6DO7y8jJwvT1HOa9S8UrpVprL6m8yrrJRYYmk+ZBz90IDySRXH/GP+1rvQtC1J7R5pSZbbyUkKgGQfK7HooIBBPvXDgm7qMtpd/v26r1MqTvyqT0f5+XU47wHpdk/h/VtSlnlfUJ5GaF3QhQRz90ZZssT6/wA66jwb4V1HXdWvG8SWjQWdnHG8UMbGLz5sZCuy43J6jNeheC/C+neHdBtII2N2I181bi4Cu6AjO0MB90c4rRn8R6ND5S3Op20LStsjWaTaSckAYPqQcetFfHTqSl7JPXr1Xp2FPE3hyQWh41NceNjqFlPq1utjp9nc41CKe4EGm+UeACM/Nx2Geg6kmruv211c+HU8TtYQWlxo94vkteMRHNApCwsvqCGAJ7gAivQvG+ueGrLVdG0LxQkc0+ozZt4ZbcSxqRwGfPABzjPP5VlS+OfDmuaprHhvVYEe1hlNrcLdjCMBn5j/ALO4AAjBHB4pwrVZqM409tdO19bfiZwrXfNCPr/Xmg+H3xAbxFeXGna7awabqahXt1SUPHdqRyY27kHPSp/iVoJm0u41LSdPnutXUp8lsRvkxwGIJw20Z47574rx/TrMXmm6Xf8Ah6OLSbmxeWWxD5dUlDqQAWB3Ajdjd7V1kvijxrfXulS295YrHHErXtskQy56FyME4Ixxx7dsXUwfLV9pRaj3Tv09Oj9dzT2E4S5qe39aFzw/p+peJfD8kFzFq2meJNMV2sbi8g8gXII+RZiB8208evIINaHwa8TS6jPrGlatF9m1mK4JmtkQ7UdRh+eQM4B68knHSl8IT6zZ61JJ5rzpfSK720kpfavZkBPoex7YNeliCGG4nmWKKOV/9bJtClsf3j3x71z4qqo80Gk1La3R9flfoTXbg3F7MlHYjPTvXhXxU8L3Om2d7dQOWhF99vspgn723kJ3MoYHlc5PYjHHrXuYKgoCwGemO/0/CvG9Su/FF9r98b2TSo7SKYh4bjzCLWLOGHmY27tm08YJJ71ngOaNTmi7W/r+v+CThvid9V1Lun+MJr7whYrr1g+qXT4El3av5eVJxuAHzA44OOvORXUQ6voNrpGnNpd5Fa6ZbneER8KfqRnPOcjv3IrzqGxNyLW80xjeaev76zvrSRiispKsrx8lW65X7pB6c5rBWNb+PUYvDNrA2q3jFJokTbAsiknIRwArbepHHOPWu6WFp1W7aa3fS3qun6bWOl0YSXufD6ndeJNW0S58QX93caY66c1pvk1iGfMjkJxtixg4yByea4HwzFNZQR6PK0/9oWlwl+Hmd4o7jcCUwUPXaQec9DW/qWkXdtZW+ianPa/aH09zKizCJ3kKZ8uM42nPQ9hmt7XLOx1DR9HtPFiywSWKiWFLWQJcW0YwNjBeOmMYzke9XTlGilGGqfZvpezS/PZdhK0bLdW2f9f10E1f4t2uiX4+0/6dbOGVjCy5SRRlhxjnB6V2t5OPFHg6aTR7y5svt1oJElRcSxb03D8cHHBryK30G38PeLri91rT7bUtB1WYRJLFuMUiOSAT2R1PXpg5rsfBN/beFLi/069uZY7K6uQbNJCNtu7ZDRD0UkAjHvx68+Iw9PkTor3lr691bujGpSXxQX9f1uHhGzmn0y0gSSV7eO3WOKdpD5jgEA7h0xgbvXP0rz/Uk1fTtUutQ1c3940s8lrM9vM0yOS4AYp90NjgDI4HSo7bUPEWl6hrH9h20+n6DFPKnk3ClonfJI8t8cNweewx1rG8Razrlrew6nc39wlu6qXeGMgyuDkFFJ57fOccflXdQoPncm1Z/f6M6lG15WVl/X9eh9EeOLu403w7KLR1t1ePyfPJC+SMYyM8A4yB71xnh7X7rRorbzraZ7BIz5oyCSCcllUcAD0AxSaMNH1PwndHxpfl7KbYZre9uNjZBDKTtIIOR04zWP4ouNNmW4HhrVFtGtk2tblflt125BUngoR3Ga8+lRUb0pq+urtp9/8AXTqZUYR/hSXzNT40XV9YaJpOr6Xplnqlhbzec7S2+WhDYKMpGCo7ZHtmsXwfay+KPDw0/UsvcXsRvI2WEQoiFseXkcAjB+oNYXg/x7f/ANlX1rq99pkmlkCKOV4RKkcm4chDjIIJ49Rkd6970W3SDToEj8sx7AQUAA2kcYx29qdZSwVL2TS30a+/sZScqOv3f5niptpvCukp/wAJTpsOlr5xjjFo5lMsQIwwwTzluh578UV7qY0ICsitsIZdyg4I6Ee9FYrHp61Iu/lK36P8zOWJqO1mcz4OR01dwhUQKjYCrgFc4X+tdTp+p2OpPeRWU6TSWkxguEAOY3HY5+lchYs3h6HR7RcyXGpTRQNJsLC2XqAxHTK8DjqTnArYtIo28fX72k7hUtx9pgR8I0hxyV6Egd+vNZVIqTcvLT8jTF+/Nvtf8GdOPYGnD8+Kbn6flTgeegrmOAdzjn86ZNIkMLSSsEjRSzuf4VHU07qMY7Yrzn4265qGj+HLeLTZBDHeu8M8g+9t2/dHpnJyeta0KLrVFTXU2w9F16kacd2dJovjXw/rE8kNpqUSzIcbJ/3ZcZ6rnhgfauiK4OccjqK+MWcq68nORg55r6w8C6wuueE9NvQ6vIYhHMEH3ZFGCMdvX8RXZjcFGiuanex6OZZasGlODunob+Pb2oxx8uM4oyeOlKM9jmvNseQNUHGXPPsKWlGMCkPT37UBcX+dBBxyCKReV6nP9aU8iiwCY68V5Z8ekZtH0iQ3DQQpdfMAeJOM7PfIBAz3r1PkA8k4rF8V6Pput6LcWetRpJadTu42kdx6GtcPUVKrGb6GtKXJJM+frq8uPD+up4h0WLfp15Ev2bzxtKMxBMbY6Y556e9bcut6r478VaDZ3NnJYkXRaLEZf5Y1yZQegHPJqxp2o6d4X1MWMSPqGkTHYyXGJVC57Zr2fQ5rC606G70tUEEq8Ntww9j349K9OtX9mlLkvpZM9CtW5LTtr0Z57418Fz38tmUt5mvWkVft1mSjKoPOST8vHU16A9vDpOmXcsCpEywlnkHG5gv3if61pdAfpWf4htheaJeW56SIQeAcjv1rz3WlU5Yz2RxOs6nLGWx88Q3moW+kau/iNLMW0Mgu7e3E4uLhlOcfNu4Ukg8jr0FXrXxHq2pCa38WW23T8RwW1gGDOS2SN4yMMdoUZxjkYzUOpaHceF9W1DUGudPm0QW/kSXUcAEnmY+TcoGAVOAOmQOTSXvhrxO1pM08sd4upiPM+0JDaKuGjkVAuQcHtnlu5wa+icqcvebWvXbte3Z/jsd2miXy/rc3tG8WeItOsZPD97pcAe0dox5ZOyaMnj96zYz1zgAYGBg1xWtG21i+eaztLm/mjvAZIHZwYCSdoAYcp2z7CsXwn4j1W1u204XLXccsrWsd08B3pNtOxRuzyTxXW2hmlv5vCviWG+vNQ+zM8k5tzGZEI3Dnrlcbs8fd9jk5I0JOWl3rp+Lt/wAH8Bw5bXS3/P8AH9SSSC10+WG8nv7RNGEe2K3bloZhnO1j94/e6dfQd9TwxaJrlvFd3WkLaapJHJHDDdSlftCngBG43bj0zxnIrJh8IzXsM8Go6h9oswA8V1N8ptRGu5n34yGOOQPXmuotTYX+lLdPGlyEBkt5kf7r989mAwRj1J6VjWmmvdd/P+rfP0NG3a1/kSHRI7eSS3+2pJb2aGBXtz9nRuASF5OSDxz3FSQNBAHIS3jcgEggDdngAkcmmlzFbQvddJHyxBC5GefofwqLVbORrJ4raaZY48yFgpZlUDcSB3JA4HX86wUeb4mNdmyzPGXmEdpI2zeVjV5fLkRiMZ3KcA8kflmqvhfWrnw9ZXFhYHUtStI5ZFdrmMs8TAAkbSBujY5+YA/jWTHdardWmmX9tpV7p1vNJIGtrwKszxjGJMNjCnPoeQQOMGtC81GGEQDUJowDgAxPgqxPAC9f0/Gn7JuNt0/mKMVWSa1RvXXj/WZbmzGhaFDLauoeaW9lKlScfJGifN05Bb17V53f+ILaHxJq9zHql4mltcpLJpMLiZYJXOHyCMFCck8cE4PNdMlyHdUjGY3cqWWQDPfr3P0NRjQ9KfUnuRYwxzjO2REVW5BBOBgHj1zTpQp0rvl/rz/rQmNGEHeP9foZi+KPFGjeTpWixWsySJ54FlZLaLDydrMRwwPp7e9aSeNxp0zTeLPC9o0l5cq1zfWzkLCAqgMxfpxjhSBweMnFZXiGe8tEuwW+yWgg8xbtNrOJQc7CnZSM4OMA9Kt2ekabr3gm1uNYmH22YBpbIyFrd4wdyyjJG1tvUhuTkd8VcoU3BTlFWbtpv96t2/zM6lOC0V031/rp/WhHdzWevXN5d2LtLahDcw3k0gAlhU5Y+YxzuGDkYGAmD2p/jCZpLKKz1Wwubq28tFVI8OdhAKurL25BBBqhL4m0ewKwWenrO8qSWcen3cLIsm7KOYRjIBzjjPOfSspF1PVLT/hHdPu3hXTQimWyl3eWgPALbV34GBxwcDmrhB3Ta91d/wCvQ2jJuy00X4/13LpSy0bQJ7PVra5/sae5SKV0uizxtt+SVCBgHjDBhz0+l/xNpFhr/wBjsBdwvNbGJmillYHYoCkgDvx1/wD11zfhw6iqXoigWy2XomuEkAK3UX8W7OcbuR8oA9q6bxJpMtn9h1DSrT7fEZGWzuwCdkLcujMpwGQZwTwRzyaqVoTT5tX1v1sv69PQctXqtyLxN4kun1hfCOmWU6QSH7ROZ1yJht/9B7Fuv5UfC7TNe8Q2EsCf2fp9vplwYXjukme4CN8w2nPQdAM/h0p+n3mpaLamTU72zvxHcGOBxIojkBORyfut3I4HrU2reKfEOna7bCzuIYNNG4TM3ykSc4HPDeg6jOfrUOMnD2dK2vXzXXVdtPIzlTny3h/Wx0HiDwPDHYT6jrdxaTNYr9oaFNxVj03srHGfqMdetYV5FZ674TtpvD9v9okDAsEDkK4yC0m4knAyeeM4rVttY1rXHaa38T2ls0IKXOnahEiR3cXIYoSO3PYgk8034X+GdSa2m1C4C6da3Lny7BCfLRAT09M9T+FcicqcG6s9Va2/3Wsr+qI9pKN+d7Hkln4d1G1kuIRHb6hamJpVmLgh5Ac8j29MfjXtXg3xDe6b4KuLvU4bicwQiWC1CElRkL5at/Fyc+2af41sIdKubWGBvsGlCzcEpbB0eQPuALdUOeR681N8KNKvNM8PyX+u6lLdLcsVtxdKo2xbuMfU9vYUsRiVXoc0u69Xq/x9ArVFOirrT+v+D+p3lnK9xZW80sLQSSxK7QucmMkA7T7jOKKqXOsWkdvLJDILp0jkkENuwZ32DJAGevYe9FeVGlOTdlb8PzOKFGdT4Vc4n4f6/qFrbXsXiKG6YwSFbGa7iImkfB3oCedoOPmOAMkZxWhpeizyeKY72/ubhGS4MxeJzEJmZQQenKDlfesG2ecaayR3F/Fc20RQXEyvLJbogzk7xgjHY9f1qCTxWjjT7OYBXmlxJJPIyySuAOFG47FxycfSvTjQlJycOu/3f1+eh6eIpyU3KCtf7vkehSeNdNl85bGQysu9MkBfnHopwSPpUfw+8Yr4tiu2it3QWsph84rhZSOrL7V5F4f1Sw1/WJdJkto4dVjkkgQSogMiYwdkhHG7PT0717Xpb6b4d0G1Vi9rAx8pEm+ViyjG1Qfp2pYnDwox9mo+8/6+Z51SlCK93Vs6DoMcgYrzr48WjXHgUTDGLa6Rz/wIFf5kVtXHj3R7WRFnFyu9tiFU3ZP4ZA/Ota8t9N8TaLPZT4mtLhAGXOGXurY9QcGuanGeHnGpOLt/VyaEnh6sakls0fJkzR+XGBgYUZ+tfR/wStXtvAFqzqFNzLJP9RnaD/47XkGu/DDxHYX7wWtjJfQE5hmgG9SM8Z/un61694A1aa1jtfD9/HbjyYFjhljbgso+aP39j3r0cfP2tJezaa3PezavGvQSpNPr8jvCcjHSnY/A4600cDjke9I7BFG5sAkAZ9T2rxLHzA8/hSHjqf1ozxzj6460HqR1JpDF/pSY+lHFIfcUgDn7wxzWbr+ntqulS2gmaLzPlZlPIHcVpHvXJePfFB0CzRLdkF5LzvYZEa/Q8Z+taUacqk1GG5rRhKpNRgtTzm6+C90tvfTXXiq6WO1ZprMwxZdU+8yuOMnjAx9fauh+A/iOTUtDn0y/vJ7u7gYzQSyxbFlgzt/d8DhW6g9CfTFZ2jePtTt4xBJb6jrb30rRQCzjDuh7P83RevXjHPFa32a/0LxxG+laaL23MwE5eUq1tBLguy9mAOeOegHPb1KsanLKlXd3unp0/wAzrrU5Jyp1N1qj009QaOhyRkZ70pBBI4o6eo9q8exwHMw+DNJEd5Hd+ffw3MxlaO5kyqgnOwAY+XPY1tz2dvPZ/ZJYY2ttoTyiBt2joP0FWRz6UEZxjrVyqTk7tlube7M5rewtpItlnCJDKCDHACQ54Dk4/wDHjXAeNI7S21We5trmdp443aVIydynptyeuckAD3FSeOvGuv2t4lp4R0r7Ttl8qe4dcrknACE4BPckZxxXFf2je6ZObWWW7meW8NvbXLZZnbG75s/dCk9T3OOxNelhcLNe+3v0v+Z10IST5pGR/wAJLPeeH2mfw3qty97vjFusw8oQ7cqzJt3LuP3efm2HHSuy0eKaLRrSO5jit7lIuYUHCH6jg4Jxx7ms63ubaG2W7e8ie6llWJrhWLlyD8iD+EkdBxn0rWe6jWUWVzKFllXvnEhwSQD0zz9a7Kjd+VRt9/6nRFNbsz49Inlu7CW6W5u47cs5bftyzDb8xHXr0rH8f6fZTajZaTdSQG7lu0lktp53T91ggsnOCewHX0HWumttTj0xnaRXitbWIsAAojA56ADt1PHOfxqhe6PpniCB7UyyzWd9MjxzRv5ZAYjLISDtDdx04zirhUlGXNLby/qw227qwsGn2trqN1cTXmyTUpA3lzXYGSvePefvHOcZ9K5RtAnub67gmaCXVJVed4Yw5by1YbVVRkkuOcjOMepxXb6gtpJc2p/ssTTW7lLecN+6tUVdpxu+ZyQoAPXvUUUSXGpzSxqjXMgWFpgPmIGFCjvjAA/CpjUcdfL/AIb5f1sb0ak6bvHQ8+0Aa+0vkXNi+n2yJNgyo6pExXhsYMjMCBjg8jpgmus0a3mm0xSt/PqqefmC4eN4539trFjkMDwex9Kj1TXEtNeTRIUb7bIocdcpnOMDHJwKsalp+oFLaSxuAJllHnNIApkXGDyM47HA/MVvKbla9lf+rhKXPre7RZuI7q+tXns5I4L2LMTPsyBnPOM8/SsnTLfbYQ6fZXdvO9m2yQzQlUJ/iUgcKcnIx7Z6mtfTbq3liu1sZ0JgYpId4zFJ6MD1HH69aran9rtPLvLS6u7mLID21raoy5bqwJGQByTzWKbu4/1+RLlZnJeK9WluJ4R/Z2oJdwh7fHm+QFVicrI6kkE/3eAQfeuj+CGrSXt5IJNLijZ4fskLiTMZRf4MD0x/nrVXTPBunWcUlzPcPeGRx5tzdHCsQSd4HQ7QeeTVDwRruoT+KbvVPC9qbnSdPYQKrARQlSDvl+uQW9eR2zWtR050pU4dvT9e5lOzWr1aenpr2v8A8E674sQWel+HUXUZZPKWddrWpwUzyScA5HAH5VieBfGVtoeq3OnRQeZp8caieJi2TAzZMoB4ON+dvpxXaW3ibwvNf/2Lqzw+ZqhHlRzfvkZycdVAGM4x7968v8R2KaTJ5GinUdMsbW+ljkW5hUy3G1sZD4BaPk4U5Azzk9efC+/B0Kqev3MVLmqP2LV3/Xn8/l1ueh+OPCCzT6edC0dzbXURV4otixwnHD8nGSD1rMh0C48N2tldePxYX0KSpbafApd3M3LKZH6E4B46V2EGrXdt4Ntb8KdQnt7IsMLtWV0BA6dCcVm614jste8E6d/wk+gZTU7Z7hoy4/0c8qpVjyGIOQeMZrkhOskobxTt59dr+V+xl7SrJRg1ffuV77xrNPe6ZP8A8IzbR2cDOJJryNDLGcZAhGcZPI4NdJo/iuy1Z4ZngMg5aCfaE5weMHoeDXlnjWyuLP4caRCtpLPZR6k0tzdxuz/ZYlRVHmY5yRnngA/WsrxNqutQWt+/kPpem2zRtbXUCAiVGA2fKepxkn8e/XZYSlVSUbLVr+vvKdKm00r3V+vr/XY961nX9PsdO865KMJV3QxyADzmKkhVzwW4PArxwfEbSb5tQudUgvpZbooEsJhtgQrgK+QcjkYCgZ680eP9XW58PW2i66xvwkSbL7TU8z7LdKud3OMqwOCp6fhWfdx2UaWlzBD5moNbSPGQu1JJQmPMk/u9cDsCfxow2FhSi5TV79uy1/T1HRo8qvK/9f10Nuy8WrovjPTpNQsLMadLE7C4X/XK+3JIHYDpggDrRWD4E8BeJ9ciN/qcQs7UMQtvMxX7QjH5uxOOhyeCTRWeJhhJSSnLVK2n/BJnCjKTbl+h6Z8LfHNx4qv9T0TXHS7uLdWPmJamNJYwdjoylmOQfzB9q8u1+8tNUu7y/tNJOoSxan9htFdGja3RGBBBB5wOM8deeleg+JfDFj4W1i5uNJYaPpF1o9zbs8JP7u4kfk5J4+U8HPB6YqCTw2bj4OSS6o0k89ji8inQGGWRUGOSexHPv1rahKlCXtIaKTSXlp/na/8AkZxSjaeydvvv89vmYGsw2Nt/ZXiCcS/YIZSjIqFwzL2OzJBJxkdOO1SyrqF1NB4l8U3TfbrtS1vFMGHkqxO1UUjC4Xbnjkk+9W/h54usNQ8C3NrA91btBqMLyytcmDY0oJjAdT83zIFIPHPIpvjSz8Vzad4b/tPRtR1i5HmyXF1CrOUdnwF+UYGAPTnPtXRGfJPlm7WbV7621en6/I3hWVSsk7WWiZXutS1ex8n7OkVrJcOU8+4lQnA6yKDkN9MH3FbPgrxPcSKHkKxanbyiC4JXYjjOSvKnGQe2OcdBXL+JNFupPCUOqzfZZbGGdZLVGhaS5XYpMqMjHbngcdKbf6n4V8TabHb6sZ7e7nEd0YlYwtuIGACARnGAcit5QhVhZRv3t/X9MqTjNtW12Po60n86JXU/NxnHrXnvjHSo7HWVawLQvOpuVYj5Y5FPJUk9O5Gf51kSeObqx0C18h3eNNx+Qb5p1AwIx3467sZOKpS69Fq0s+oX975ggU5t2YuUHBMaqOvUdvqRXm0MHVpS53sc1KjOnNt7Hq3hPUp9T0aGS/aA6hH+6uvJ4XzB1wOwIwfx71s8H8K8es/HB0vw+506ymRS/m3V5eJ5TbSODHH1JAAHf15rX8C+PzqOp3Wn6uyRJEoaCVzulZf70pACLkYwOtc9XAVEpTS0X9f1+JzToTTbS0PSweOT+NA6H+QqvZ3MN9b+daypPFkjKdiOoPp+NSxuJFLIwZcn5lII9K89q2jMNh3U9Pwpoxxjv+tLkdc9Kbn8xUjRm3tzJDclTJsQjcp7Zrzb4jWLpq8epTGSWMoGKt90rjB4Hp/+uvWyAx5wceoqvfWVtexiO8hWRBkgHg+4zXXhsSqM1Kx14bEKhNSseK/CW9W48Zx2oRl2ea4wOgCng113xhsWWyXVLPUp7G+jtpLUrE5+ZGIYPsz8xUqfwJ9K7HS9C0vR3luLG1SByhDyFifl68kmuN+JV3p2s2Npa2c9vdm4hdkeKXcjAnao3Ieu7P0rq+sKviY1IJpL/gm9evHE4hSgtDpPh5rY1zwjZTtdJdXNuPstzMmQJJEABfnB+YYb8a6MjJxjnrXIfCrRYND8HwxRZM87tNcNt2gydMKD/CAMD6V1/wCVcFdJVJcu1ziqqKm1DYMdTQvDDnB60cA9KRuwrKxmeC+I4bO28eB7mKaRIYzZRwzBj5GckkDptYHANRQvcW2sQaXYW4Nl5Z23EkvmbVH3QFByD7kcdK6T4w+INc0bUYxZarb2tiI1laF0BMy4OULEHGSCOfX8DzFhevf29q0NgdMu75tghaQM2CfugjnGOeAMDNfQ0rypRnLa3f8AH5fM9Sm+aK0sSW8clzbDVBClto1jG7WysAjmdm2KwQgB8hiQwOBk5wRV+S+iWxtJ9IszfpuKkW5yIyuVZixHTPHp6E1y/jXUILfxZHZDTNTtgZYrVA7/ACTIp+eSFOAA2QAQTwO1ULDW4Hhj0vS5BbC1v0htJBhYpWxx5gJyQxOTjPvW0cO5pT/4a3yf9ajjO65r/wBf1c77ULQR/vL6KBJCg+7IHwG/hJHUc45rIsddsJGubGzYB7NxAYhGSqnJHG3ORwee2KoXNzqGg6dO9yvnarC5ka2Llo/l+8UwT90dPz5rasYDqnhm+u9Oj/s6S/tnfzQFBLONu7I7/wAvSs2lCN5aruac7t5kGmwSP4puJJrtlhjjIlijfptGTuHtjgj1/CmTXOqtDPqWjSstrBJGU2hcyFTlweN3Q4AHWo4rNLW50y3kmaXWH04Ce5C7flVuQccE4AXceT17Vk+PNXjzbRSzSSRsGmmWAln8ocYAyB82T+C1cU5zVtfl2/zK0e5vXEV34v0+W60fUHslvZc280MX7xlVcvCuSDkjnaDyFINN0a81S80lLmaxeO8jiAljYlY48EgbhjCkgAntzjisPTXnnl0W10pYFuEmiksLKObJVCwIkPPD4LEn069K9/0trqRrs6hbQR3HmsnmxD5Zk6g8/XnqK5MXU+rKySa7dV0+d/0OepP2Tuz56uGnMN7aaZpluqXEcv8AaVwqNLjI4KnOAec7eg4Peug+Avgy984+INTkY6e9v9nggYn/AEjB4dlPQKOB6/z9msb+xuS0NlNauU3CSKORSVI4O5B/WrjyBVUtxkhQBj9K56uY1HB01G1/6/ryOerX51a2p4t+0fJqTaKYLKMJCLckKGAygb5yoHtt49CTXI/CzWbCz8OXGj219Pcm522sokgVQvmjazIoG4qP7zdwOlfSN7bWt3CVv4beWGPLt5yhlXA5PPTiubsNK8JXxa80OPSoZYldTcWaxr8uMnOOCuOc/rUUMXGFF05wuhRqxupdlby79/v32POtM8LWKjUJdJtLnWNZ0N0kt/tCCOCUhzhlwcnGM9QPY1i3thNJbtqniHT3k1GbUG1GS3S/VvLYj5iqKSNhwPlPPocVp6UbieI3KeNLHVbYHY9ra28qoF3nGGYAkHByO3XpTNL0i31nxhfzC3W3V41hW5DljvxwAM8DAAJA7V6MJODlKT28mmttNbb76I7oyVSSqz19f6+a/wCGOn+EaXer+FPEsU05+yXV0wtWbGY3aIb+B0AbbgfX1rjZNPt/EPit9J1fRNQa90zTltppQxVH2YBI9jjIb07V7L4I8PQeF9EFhbytKzSNNIxP8RA6fgBWhqsFrtS8uoBK9uytG2DuU9Bz6c9K814y1acoLR7dOlrnKqyjOSWqbueZ3HiWDTbTSNNhup7GaaRoPtlun7ovtCYxn7oXaBnnI3Vx1tp2raVqN9b6fbTXaXkr/bZL2XlJGYESqTycYzxnqeelep20tzeagYdPs7JLd3V5AIdxJHBY7h8vH0ro4tFtYRCAZGSHiMNg7fx6/n2q/rKofZ33/r+u+hpKpCn01/E8e07wJqVp5drpN1cy205828lAwzk84yccHp3/ABr0HRvB6RPE+opCIYyGW2j5BI6Bif4Qew7109yZomto7UReXv8A3qHqVx2/HvUyxIkjuM72Azz19OOlctbG1aq1f+ZnUxc5RUVoiK7tvtRjM0kmFbcyg4D+x9qKn57D68UVxqfLpc5NWeQ2XxnWW0S61nRrQQiVitsHPnAK2FZMghiTx0HI61Qu/iWLq81PS7yO5tEuX+1OmrZaOBO4Plpu2nsmDk8d6k8SfDJvDk0GsaXFd6lDGpWeNLopNCjKQxj46YJPByPpWLLoem6V4ftY9Tke2t9Zmkjhf7UzyyRpjynLj5Vb5mHHGMda+npU8JJKVNXv/wAPt5L7z0JwpO3Jb+v19D1D4Q6HpcHgc2sCw3ym7d5HntsRPMp+VlVhkqPlweDx2rgl0n4qah4mu4r251C0gnLo80chESq3dSOgA9DWaNWk8O6TZaXousXem2s0kmVgfzJGkAA+d8EDZgHaMHnkE10Pg/4k6xpGuppPi64m1CN5orU3EqrG0DN0JAHJ55yegB65znKhXhz1YWd7vXffp0J9jUjKU4pNefl/X5eh6Bqt7onhLQdMg8Yam0zyoloJpQWaVlXBbjtnkk+vJNc9Z+F9Gk1W4ZL6J578eXHI8C7tvBwSe/QY4rotf8P3Gv8AiER6npsE9jaMJLaSXaQSeGAHXPTqMV5lqmjfYPG0qaLe6h9nS9g+1L5YkSK3cncUZuMgEbhyfcCscMouLUZtStd7NeXp/mZUHZaS1fY9MsPAtkl6k8o3PEzbEdR6FcgZ5BBPNZvij4YaNd3CarZwjT7q2gaIkSGKJ0I+ZyRyGwcbj+PQGsVfh1bbLu9fxdFNqc0zGzv95YQJ0I4bkgdOgBrqNJ8G3Vmktxa+Jr67muoxHPLcgSpOoGMlSSOncY/qYnUcHzKs/ua/r8/IiU23dz/BnjusQ6PoVtYW9+ZJ9JdHhSazuRKgAw67WzjLHqWGcD6V2Wj+BdV0rxHp9rpFuIdIu1a5u9QkXzxKCuQjbiHRhxjnv35rr9N+G+lRxTJrITU45ZlmEJj8qFSPujavXGO/vXY6ldfYrG5uvL80wxlwgOMkDpntV18wvaFHXdO+z7P5eZVTEPSMDyrxXF/Y3imy0Swivro3sBnmkJCRhMlVj4++SwyfQYq34D8O+Ioby2TXpY7jT7OWSWGQo8bK5YHIVsDb2HGRRpFzqfjLxVo1zqmjwJpsUEjm5tZ3khyCdoDkAMQ3XHr7V6kOFA9BgVjXxMqcPZdba/iKrOUYqM9/67dQPXPGaO3TIFY3iTxTo3ht7OLWL1IJrtttvEOWkPAOPbnqa4LXfGuoPe2kUJlgdHkaL7GgcyqDgM6ufu49ARnPIOK5KWFqVdUtDGlSlU+E9VUE4CjJqlc6pp9sqtdahZwK8nlKZZ1QM/8AdGSMt7V5Vf32uP4jE2p3s/8AZhDLGrSYWKVf4/LwACQehPGegGK5bRPCnifXPB8A0q0EWo6ddTyNFq0GGediDvUvwxwu3kYHB78dMMDBJSqTSX/Dmrw9o8zZ2Pxe8b6FJpJ0SO9uWme5Ec8luWQRbRnaz4Iw2fQ9DxxW78ItL0xfBOnXtta2jtIzuk8cZXgMQCAwBHIPYZ696880Xw1f6nqq6P4jitrea9mWac6ZcKZEYfM5fqAAVB3L/ex717R4u8R2fhnQbjVr/c8UYGyOLlpD2C+vFaYhRhCOHo3beu+/9foVV/dxVOHXXz/4Y2eSff1NGe/v3ryfUfixdvDYXHh3Q1v4pXPmiafy/k4xg9jnd2PTpXR33jqHTr7w9Dc2zyW2r3b232oDAg4/dhgOpJIBI4ABNcjwlVW0/pGM6M4ayR2p5HPf1pORn0xSE4zu4x1oJBIPtn/CudGRwfxj8PHXPD1s0H2WK5t7mPE8w+4pPQHt823qK4LWrGC08R3Wp2+nNf3lyoslTz2hdozwSJOikn+IivRfi7o+oa54InttIt5Li8injuFgify3k2k5Cn15yPWvKvGUdzc6Hp2ptFc2d2jq7RsuyaMHJKqoHLZHT2ycAGvYwL5oxi31at6/id+GacLMz77RP+Eb0y+sbdJjKYWvdPvpomka1ts7ZNzqduT820AdRk7d2Kq+G7e31CSGaLTy9uFMtoXtAiNMDy6yhiwYDqpJHTI4GOz8TaYdG04WVp4it7/SrqytnOjXd4u63SMh3nijyC5YB8gY6nO7AAxvCNvoX2G3uNGRmj3CNJTAUI5zlRk5znr14ArtjXbpOT1f9fd/w7W5VCXN/l6bG9G8dvq8VxdXsVvdybvsy4AZt+CqFu33WYDqeewNXtVmjtdKuJJCZYLdM4hBY7l6KyjkduOOvWqekzQa5dgR4zbOBczCLcYiB1xj7yg4JHOCa4e41P8Asrxfc6dBNPOJ7/fI0qmNTK+fmUZzyuBg5GBnk4NYQpOrPle6Nup1+tw/2lMCfJS2mt1swIgVPlyD5nz1z279eveseR9BOsWen6d5Uk9rG1son27GOfmhyx3MfmI28/e61tf2u/8Aaemabp88LxOs/wBqYfMVRUPyZ7Nk5xxjAH15/X/LS3g1PRLWw1K/tZ2kUxybm3OuGJIwSw24wecn2qqfMnyvb/h1r/XUE2np/wAOVtN0638RfEyBLNbrThp7xM88MP7sRqwwqqOFByFHOMc17J4m8SXH9ow6ToCJJdz7vNuhINtuBn7v95uDzjC4J7VzPiHx9aw+HoNK06CyTVZoIzqVpG5QWYkjy5Q4wzrn3x35rM+GVh4d0PSbO6inlu9S1q3uDYpKrZdLZSXBz64x9Mgd65q6dSKqVI25dEt76bvy0v20OaTUv3s1bokRWVk+nJFqdhcSWM0U7CGGMr5d5yP3pJAJDHeA3oPQ12Xi3xjqGmG1tNL0ePUr9lX7QiSnZDIQCEGOT6knoK870mz1zUJLRxAl1FFMZLzbDmRlABURjuMnHbAGMdc6ul+DbzXNV1IzWup2thqE/n3d1eMYyWXO3yozySSc5Ix+lFWFNyvVadv68n5nTOEHO9S1l/Xz8hPHniG51CxOitFL4gv54Xee309/LtISOsZYfeIAJJYms+OBYrSJ7qyttE0632h5FiaQyKI8tsxhig5GQMHHfmvStI0208AeDJXaW1nvYI2Mt6YUha5lLEopx7sqgZ5AFcn4Sh8S6/chL3VoJYVRmu5Hm8yWKbOUURn+DH05z6YM06sVGXJpFdddfNLb8O3UwhUik5LRf12/4JjadZ2rxRXOlako8OSqWeJ7EICB1+diTj34rEvtYay17+1fCtnc3dybYTJMuWt2CttLEfxbQOmQM9c4OfW7T4d6bBpd1ZTX+qTpdZ80+cFHPYLjGOe4NZviHwf4Y0HStKlvb06RpOm5SKQuS7OzbjjH3i2Dng8dhThjKbnbV9Nt/W272XmWsVFtpvfcktvGt7etpUWm2hee7j2yCWE4DgZLBQQQpz/Fir0Oka5rjrNrN+1nZknFrArIzAeoOdvTvk1uaD/ZKxztovlMJD+9kRw7SMOxYnJxnp2rGmTxXH4zN9falptp4PhVj5Y2qz8cF2YZHPvj2rhc1zNU0o+u/ovPojn9ol/DVvXc6i0toLK3WG1iWKIDoOp+p7n3p880cEEk00ixxRqXd24CqBkkntgc1ymo/ELRNP1Szsrj7ftumKJcxwb4twyccHceATkKRjHNTad4w0vW9RvNN0uQyT22FkEsRCsGHBUngjnoawlh6rXM0zLlk3qmS23iPSdT1TToNNu0u5ru2e5h8oMVWEHDSE44yRtGSOcit1CSqkgjIzg9qr6fp9pp1vHDY2sVvGieWqxIFCrknAHYZJOPWrB6HB5xWdTlb9zbz/rsQIcDPXiikY5BwSc+9FZ3sOxheFnfxN4O0W81q1MF4U3vGHyUcEqc/UDOD64rO+J/gtvFWi2/kTsl1p8hni4yWTGSgx34+X8q4D4eapdaL8T7k6leM+mawWjEsspVYpQSyKwb8VUg4O7HWvfF4Ix1zn8a9Orz4OsnF+a+fT9Davz0pr+up852XiWHTvD2/wAu/WG3VPOJjAI3EhSMBQzbgTxjHJyTVBV0t73SEvtXn1C11CaIiLbsL5fhnc4wR6kbux6V6l8T/B15cRwan4amlt/Jl8y8trfALx9WeJdp+fjkdDk++fHpdJudQ1S71LSJ9OmjVibGeZE8uaFh8ocDIEsWcc+nsK9nDVKdWHNF2v8An/WunQ6IYjmd4rf5/wBdNT0/VvF2t6rfasHRLLw5AXMLQfNNcRpx85B6NyQBjjHXqeXsvC1rK80lndTy2eogTCDJXL9QQyFWQj0APHXNQ6fqevaboEVzNprXktvIuCt3581y2DhmVeCnJDAZ429TyZNK8SW+qyromu2cEUlw7zvdaRciNI2x8yOjZaPoOCQ2fWlGEqcWqasvK3T9fncSUUlBR/rzN6HRZLV5pb29e4MpBMEcaRwrjoQuM7v+BcnqKsabf6tpPiFJkn1O3LpulsryHEN5FnPmRnswB5wQRwCKz4NWhX/RpILuzC/KJLiWN0YYJ5IbIPHUZzntWs11rM3hq9jt3sJIEK7FaYzRq5PyndwRnkEjIG78Kyk21aVtdP6/r7i56q0tj0vS/EGk6xd3FrpmoQ3NxbqGmiTO6IHpuGODWk6h42WRcowKkHkEHtXjv2G5ZPtOmanLYahNFF58NndNDLKUORHl1Kvgk4IIyODgcVPPqPiWw1GCe31aeGVY8SWepQeakuecuAVYH0wR09M158sEm/cl9+5x/VZa8rudZFcyeE9QNobDUrjRZNvlTwxqY7Z+cLgHgHgDA+tX7bxfpk13DbSLcW88knlfvEBVX9CwJGOozXnmr6hf3+rDVbuZneOJY44Iy6wwEHJYLkjJJ6nJwMZrOvI9ZuLqKKzutJsLHGZry9dCm/nCbSwPPGcc88VusHGavN62/r+uptLD+7zVN/I1/EunPf8Aii/v72SG9t43YWMMzI/kuB1GM/KWxn/Gueg0q9vk0q+1t4UurIM6xWzLhJW4fc2MlWwrbc8cjpXRJCdPsd92Y76/DDH2RWS3Y57s3zEe2P8AGqlrNqEWpXr6o8Ajkw0bKMZHQZXuMdzW9O8VaL2/rQ3ir2XY5/xjCjJIt3cpp9pNbm4upo2y27cFDrHkbsqNuOO1ei6rc2uufB0m3updSsvIjiln3HcyIQTvwc5wOR3/ABrz3xpZTazeWMOl2L37PH5csNucyeRKuNwB4I4DDtxwRya6nR/hTfJZXG/XLrSheWaWNzaxETiSJCACxJ2hyARkA43HHuV5U1Cm5ys072/rX9DKvyprm6C3uvXVj4f0+70bRppNIlCtG9tGJknVjgvKwG7g5Hl47cmrXjnQItR+H8EetKN+WNvHGDBHbu2CpYDJ2jB4H5Vt6z450Dwhe2fh+Pa91BEivDbhY0t48ADPQAkZIUfpmuuvLOC+iiF1CJog6zIH6bgcq31rz5VnDlly2V736v8Ar8TJ1GlGUo6P8T5ltxbeH9OmhvJZJrMTK4tJSif6SMZeGQt8ynJO3jr9a6zStXv/AArqQ1C+vLmbw/fszy2NzBumtJGGVKKM7cf5zXpHjnw5odz4RvortdPsIYWa8juLhQIoZuztnjBOAR36YryTS7DxLrdmlrf+IRdw2kSpI9vGYZoQcldjBfmUjAwfqPf0aVeGIheSsut/08/xN3VVdvTQ9Z0zX5J5LM/2gPLmCyAXEOzMRbBJb1GD689ar6J480i/udQ+zRmCytBcM8ki+WCIiNxGT3ycVyl7fX9jp8c2n+Ze3sLx77aRSMqCMM2BkjHHBOMVRi8IaRdPqUl9JNLFqMimS2ibaFUFWHAHHIHvxXMsPSs3P5W/pESoLU3LnxF4h1ST7VaYj0mW1WWa2ScRzRq/CBcHeWYZIAIJ6+lYt5e2Vtpun213ZanaJcDCWNqTJOIt2STI7EJzgEluM0uoWMVrq0Op2yj7TcTupVmJ3HYqRqAf4VRDwOcfri+K9ZS61dtEstJg1G4FuJLiQTBVj5C4xgjvjnpn8a6KVNSaUVpv2t+NvnuWocq00I/FM9s3iBI9MsYl1y5jENvKymWVIwCNoHToeSRjFaVw82lNZaZaeU96I3YJI4AjCrkuzDrzxwOSeKpJd299rkN5prtDNYw7ZJXh/cKqvkAuwC8HnA4OO4ArDmgkl8Wr/aTWtxrCzCGaWFzKNpBJb0LFScADv24rpjC6UdrL5/8ADGy00R0HhwG10vT5LrzVvdQlleYkBQVOc7lxnOB+YrSi0vTr2+llnAZbWB8XUkexYMnkxrzjJ46Zxn1rkWuJvEtpb3Ogb2FhfKiR72wsKjAdlHPU4JHTNXtF2Wb2dhomLhLQzw3bXDEyRhlyFPTzG2lQCPlA6d6yrQlq07P8v62RXNfQr23iXSdC0m//ALKt5Jbi8uFuxDcRqszF165A+VCFyF+nSu88E+AdF1ixtPElzZXdhdahaeXPYSOGQHPLqevzAAjHIz1rlotL03XZ7t/Fmoadp6wosMlwsjeYYixMK7SMBs5478+wr1fw9qsV/qN1ZW1rNb2+jsLVTIPvEDb1x6c8etc2Lm4Q/dXT6vy7efTzRy1ZNfC9VuQab8PfD2l6jYajBHctNYRsiG5uDKpUg/f3ZzgE4HSt3+z9OvHGoJEm42rWqTouwpCW3EL2XkA/hVTxjYNfaI7pcz20lm32tGhbGSgJwfY1w3hyDxH4s0u4v7m/2C8kdGtpS0UdvFj5VQL94EHBP5150YyrRc5z201/r1MYwc4qTlotPTsR2MHi7wzb6k9ulre6Msxlim0xldpQzdCnLA8nODj0q54N17Wr7xlbf2vqsMWnTQSKlh5iPmTedoDjOWwOmcjpxU2n/Dl7GKWS3vlinMYiFvGpSBxnJB9j7jr1rjPFejX+g69pN3emEm2m3W8pZ3PPb5Rj/wCviu6DpVm4XTbvrbXb8/M6404V04Jpy72sa2q+IrrxP4d1KDxVZWVjZJOHEZk2FAkgKnexHJ4GR1yRitvwddaDZasdLmha01W6RrmMjfi5BXLFmHAcDOBnkZx1GfP/AO0vtkV5aXaWUt6WkltQg80uNpZQUIKZBGeME+grufgrp17FoiTazA63Ss7w+bI5eKJsYDBjjJOSB/CPrTr0406Mui7L0/4Gv+dicRTVOG1r/f8A8MemKMIBuJxgDccn8a4/UfAlrqfijUdW1O+ub23uoBFHYT8w27ADDqPqM9up65rsutYHjrV77RfDN5d6PbxXOpAYt0nOI93JLMfQKCcZGcYryaUpqXuOzehwRck/d3OY1tNI8NeKhqlrct/wkNzbxpLZRH5J0UcHb/yz3EZJ5JA4xkmvIb7VdI17x5KurTXmp6hOxiE3lmRFkVuIo1DACPOeR+uc13cU0HiPT9Ys7bUGOugokl9bsTc20uQd4zjCEgr8vQcZ6CpLP4cNa6outweLQIJVjN4scCnzyiBZFXbhQWO7kc/Nnnv69CccP/Eetrdfwsrpf1sdV1T0S172v9xLpN3pd3q8+gNDs1RYkawubg5SZG+9tIPUYI+oOfSo9P8ACmv+HtLkl1Wf7XOHaQXFufnXB+UFQBgkAcjI5p0WheDvBHmXkWmyS3jxyNF5U7TzxB/vL0wq4OAcFuT161TtfGmla81jJLfeXqa7o20+Qlop48bSHU4IbBxkY6ZxxSXPJ81JPl63XXy1fz8/I0jKd79H/Wh6JY+L9Iexhae8ImCBZPkLEOByDjvntWzYX9tqNrHdWM0c8Eg4dD09iOx9jXhviK4jtbWc6TfWegQTyBZHncsUI/uZH3yOCeuBXovwy0zUtN0u6l1jJmvJUaNiuHkRUAEjqOhbr7d65MRhYQg6idvL+v8AMxrUowWm/wAjtM/59KKxdd8TaLoUgTWNRitnKq+1lLbVLbQzYBwM9z6H0ormp4erUXNGEmvJXOSUlD4nY8m1bTbTWPKkliNzayW+YXjIdXZeU2ADdvJBXjtwRxXv9pJ5trDLsdN6K2xwQy5GcH3ryTwVo9nqGm2HiHTb620zw3GzObZYtwmQYyHDcK24dvw6g16B4T8X6P4qs/tGlTOVDsvlzIUfI9B6V14tuok46qOnp5euh3Y2anZR1tudDnBz39a5PWfhx4Q1i8a7vdDgS6LbzLbO0DFv73yEAn3I5rqx2pwP4Y9K5KdSdPWDa9DzzjrT4c6Lb6hJN5+pyWzxqgsWuiIEIOQ6hQCD2PODk5BrdtfDeg2in7PomloWI3MLVCWx0ySK1h196Q9c05Vqkt5Mt1JvRsy9Q8O6JqMAg1DR9OuIRL5/lvbrt8zGN2MdccVw3jTwjIL2/uNOEcdnqEal4vPECx3CECMoWO1WJIKkY54x6+mYHvSOiOu11R14+VlBHHIPPvV0cROk7phCbg7o4nw34XuTo8UesQxpc7RuVtrMvygHLY5JIySOMmsXW7aTw9KkM1vc3QvJ2ZJzIq+SAoURouB164JbJzyOtemXdxDaWstzdyLHBCheR2/hA6/5714musSeN/iv4eS6kWC3sybqztSTvwuWMrKAQCegz/dFdNCdSo5VH8K1Z00ZSqNyk9Ed3H4W1csxj1OGxiI4jHmyMAeqsA4UkDjvV8eCdL2IJDK7Kc5OBn6DHFdODTCJPNU71EQUgoV5LZGDnPAAzxg5yORjB5ZYiq+pj7ep0ZkN4Y0kv5jWpEmMbhIw/TOM0SeF9HktGt5LJCrdZDnef+Bfpitodck0h4B7VHtZ92T7Wf8AMzH03wzpOnatLqlta41CSIQm4dyzBAANoz0GAOKb4u8SWfhXQn1K+O/DrFDEOGnlY4VBgH8+wFbR6+1cN8X/ALT/AMIpm1uLKBlmXD3jqkYfOBktxgc8dTx1rSivbVYxqO9xx9+S5meda0ND0BZdQbTNuo6pcuRA482WaZyzcE9gXOMeveuv8J+T4B8CSeJfE5vLWe4ij8+ykkLMshOFGCeHbgn0HHY1w3guC2vPGnhyTVLZ9W+zQsf7ThmJjSZCxzsIwwAC46dOnp2Hxbvm1m2sYraKC602CbzLjzujMvOcd8DO0dcnoeK9WtFynGg9nu/0/rU7J87/AHMdI/oRePfGZ1zwlaRW+jv9gu5MalDfL86RBhgRgH5iTghh0x09LWjITYRRwmNoniV1jC7Q6g5+YZ46DjPUVh+EZ01azkvbWWZ7GebNvHMu5rdF4CcZGd2fmHLZ5qxLdafqdhdHSbpIoTmASohV1cHBVhwcD0zzmj2cYr2UVaz/AKv6foXCEYq0CDxnf3tmlumnGOL7UNkMwOAtwMkK+cgq2SBkcGr1zf3VtPDE8DMn8TD+Dp0x15yP/wBdYl1rcNvq7aTcISLREeZ3jwEPAVumMnOfx+tWdQ0+K61K31SyuLiK6UbW2PmOQDsV9eOv19q39mlGKkvn+Rqo213NxVa5WRLOMyyzDMcxlKsgXGSAPunPJ5zjjtWDoei6PYWlxcaNJIbq7VVllVuGZTljnPGPXHOatwpNgmM4DDnIzz6D8OaF122EX9hxtZybXEMohAieFhyxfaByeMtz0POay5ZRvGOw5Kz0KWqaBqOqpZx3uL1IAPNYsYo41JJG5em0KVHcnr61z0t1ZaXq1/qV7p7QsvBnhUsqyOMApzgnjqOPSs7VNQ07VLGeaGzdtJlvkjv5rczLPJcbSEEZLECPCt94E/MeAQK3dRshaQfZjZXEnh6CychFUyOzxuCAG65IPTPTJrqinT0ns+m3m+v4ERnffYSHTU1DWdPuLF5Y5zLGbnSkZWOW/jABGCQdxO3gEnNQxQanY3r6tNp4u9MncpNqMrYSOMhl+Vz2BzjkjOBxkVY8LLNJFJqMd211rM9tIsrQQDzIYTHtMTY5BUHA7jA9OI9FmltfAuoeFNdsLvF06TWUSowVAGBLszY68HC8HBPHeZOSdlrsreXW22wNyXwodHHHoNjNPD4cn1KytfLCI9wssTheA6x4LIRuzvb2A7mvb9K1qyunsrb5ob2e2ScW8q/OoKhsH3GR+IrxnwPrEsOkw6Va6dPeylmtVmu441dOeHRTnAUkKBz0r2Dw1pT6JoqLdYuruCFi07D97IeTyTkjPpmvOzCy0nv013OatFcqb36I17+0j1CxntbgSeTMhjcxsVbB9COhryex1LXvAV9JpN1aSXWjtOBDcCAFYYsZMmVO6RiAflPIIIGa6240/W7+fw3rUGsm1giHm6pbxxEpOg3EBR2PJX1PHpW5pGp6T4o0dbvTZ4NQ065yhJXIOOqsDyCPQ1xwl7GLTXNF7rs/8/0M4z5Pclqv1OG134kS3CWcXhURCSVXla4vbZyrJGpZ1RAQQ2B39e3WtP4deOT4qtil9FaRzOf3ZiY7ZuM/cYkq3XjJ6HmuX8VTW+mCfS/CPh43OlQmb7elparLL5rjaWTPO0YAyMZwRyKqSaKfDN1qKaTqVva6vHpouILZXHnNJkgs6kbEAJ49vxrsVGjKlZKze3f52+Xl+nQ6NFwttK2n3/h6HsYsbPz/ADhZWomHSTyV3/8AfWM1YAC9BjJycDHNeaeCPEeuT3RfU/tN/DLBGQsA37XwN5Ax0BOMY54PtXotlcRXcG+Bi5U7WB4ZW9COxrzq9CVJ2lqclWnKD94n5xiuf8caTZax4buYtTOIof34zkruUHGQOoz2+laCazp0lnf3UF/aSQWLOly/nKqQun3ldjwuPevMvG3i7XtXOnw+ErMx6YxFzNdySon2tRysaE9FJ59SMdO7w9GpKouXS3Xa3UKSblePQ5++1mKXTtfHhaxgufE7rFbyjyyGDk9W3H5mA3YGcE9R2rf8H6NresQk+KLiNrhAfLMEQjSM7fu7VAGc5yRn61zEmsTadq+nRTR3EJd1N8IoQFQkAJLuA3Mob5dx6Y59D6V4W8QKLN7O1hW5uLY75h543sD1fHr1/KvTrKUIXgt+vbpv0/4J21IuLco7nAeM9G1XR/FmmNFHfS6GJFFy1vOBJIWUAsFOA2Dk4ycY5xwaz9Z8I63pUlzrMi6bMu5rm41SDEaz2ijoRjKueAQB1AJJ5NdwlofiTE/2+xvtHWCQ+WwkCzLg+gPKn146cV6HJaRS2klncxxT2bx+U0LpkOuMHcPf0rKeLnRUYuzkt/T1/r8jGVVxabf/AADw/SvFazWdxbtpJkto1N1BNMgZGwMAqcZ6kOOnJqbU9U1zVfDE+r6b4iuLG1cReZM7+UqbSBg91OQQT/EfXNdx4t8KtB4as7Pwpp9mv2VtqwyM2RGWyVU5yeSetc7p/gHULtJrPxDp8K6a42NFa3Aw4BBViezA57VccRQl7601622Xl3enzNlUpyhzPfz/AK0KfiiC/uLG/wDGFxpazag8MNqsNtllkhP3z3BQg9cY60V2N/qejaVY3fhdo7m3it7JVXYDIpV8qEVs5JHvjiiuvASpyjL2kVbpdtafK/r8xU25rdr0X+ZxnhrUrrT7STwr8QYbOCFfltJvKKhgfu7lUfd9H6jHOe3Q/C7SNO8NSvpt2p+3Wb7RIGOw7l3Bh3YMD972qz8U9R0jV/Ctwls+/VY4ZDBOmEezx98sx+6ODwD2rlvCut3E9x4StbVpr5DpoUyNDtkiCllDPnnk7QPbn0rnipVqMnblTvdea6r1/rzc3eNrNN739enW3c94GOM/rQPUdfSmICqKOMgdqd+P514p5Y8H0PFB7cUADAx+VBGBn16UAAPqKRRlgFBJ9B3pM5Hp9Kw/FGjTaxazRvf3MdosL/6JA/krM+0j97IPmKf7IKjrnPa4pN2bsCVyC9kOteHdQt9SfT7W4V+UE4lEW1wUMm0kjJxkVi3es2/hyLFhbaXdXpjZbjUDIvzTDOUKr8/3hjHA/KvOLvSz4bsPD95G3hvTri2dJJBBsUXEYb7/AJygtnGBkP1BqS/0n+wxPOdS05ra/uJLm1uILpWkCO5cBs9W+Yr3zivVp4aL91vR9DvpUdeWb0d/S/3/ANWPWfAXid/E9jctc2yW95auElSMkoQRlWXPPY8dse9dOc9iPyrwjw1d65b6nrN14Kjlv7wWiIbCWIJAr7gu4tu+Yj5iBx15OBivbtOF0unWgvyjXwhQXBjxtaTaN2O2M5rixdGNOfubPp1Rjiqap1Go6LsWc5pMj8KU/wCeaTuOMn6VynONkyFypUEDq3QDvXkXxsutH1K+03SddsdQe2jdmiuoGdUWYjoVxtdcYyevJweuer+J+rS2mipp9vpMuqf2k/2SeOKXyzDGw5bPX+nrXk1/pWpQa61w1z9kgmj+xwXrO0zQqSEijEYP71wBwemfm/hr1cBh1f2snbe39f8AA+86KNO/vSWhFqMehabZaYLzUdT0yxmjVIrSWMedNAjl3jGxgEJbpKffitDw/BPqF3bSW19dXHh0L51vBfRx3G11IOfNX5XKnOCfmBAyKk1qz0q4utP0y+u73+2CrfY3CtvmZQAQ0nGwnBJP5ipvDuseZp1vNpWmwWkMc3k3lhEFUxgrjecAAOcAnIya9BycoXX47fL17nTye+9TS0bT5tNhu/tN8b26lmMvneWsYA6KoVeFCr0A4GTUVzpn2iG403T5jZNdONzWsYLEMQWPOMMcCp9MefUrmSC1m8qdiI42bDHJxjjp9B1pPAur6X4gutTtbDUrhodJTLysmC8jMRuVunVenfsBjNYubjeXX+rGknGn7r/r/M3VCWvl+H47a1i09dttO92nmSMgU8MwI4BJI9OOcVz72iW1rLaYS4gB2IuOGTPHH0q/c6lcyaXcpbxQG6Cs0cz8/ORjdIxJ471zfh+fUple31O333YIDPEoIdyQAFI+Vgc9vTtVQg4xcvv833LgraGhbww6VFPFIL25iitZJo4LQhpIiANrcnB5bIB64HXFcBa6frGrSafpvhGJrO9uv9JN2/7qR2XO4TZyQOcgDjnv1rR8UWcuk6tezadpwmtZy1xeXSOWkJ3kbSSSAvbgdzzxUsfiK886yMek2jx28KTfaFtSPsKhPlLPjLKTzzk4wOa6IQmoucXe5E25RfnoMuLS2tdQmuLTXbOGTTbIG4sIkdI5G+UOwJGHJJBwdueMYA4ltr1vFuu6G/h3VNRtpTH5E1rHIIpNw+9gBuQASPM4+70GKv8AwZ0i28US3Fxf6Wgm5e9uSxKXCl+ECdFJwc47ZPpXsWl+DNA0rXZNYsbER37IYlbezLGp6hATxn156mufFYuOHk4Su5JeX9W69zGpWjHTf1K/hbwRo+gWWnR29szXFlJJMszSEs8j53M5438HAyPSpbrwbol1dx3V/aC6uELHzJHK4DfTA47HtXSDjqOD7UhAIIIGOmOxrwnXqOXNzO5yqpJapnnGkfC6Gwvrtf7RI0aWaWRNPigAwrY2q0hJJ2kt9c16FbQpb20UMZOyJQi5OTgDHWpeO1Zt9rVjphf+1biKzQttiaZx++4ySoHNFStUrP3ncblOem5Dqmh/bNS027h1LUtPFluBt7OQJHOrdnXv04I/Cq3h7w3BoGqXUmjtHb6bdkzz2wXJec8eYGzwMY4A5P4Vcm1yyh0l9QlfMUSh5ktyJ3iXONxCE8DqSO1S2+rWU+jJqonEWntF54lnHlhU5+Zs9B3/ACpXqKNum36/8ETUrbabHkuoXFxpsly0OuweHRLfC5ubqZRukGSBEG7csT0PA9uc/wAI3Oj3evm/jvrrU4klG64uYBBJcQjgbl/iXccZOM46Zrp/F9n4R8VSXc8N9Y3V1YtD58bswhJdS0Z6bWJAJyMjAOe9ZFt4S1HVbrTbqxV9OtI35RlRw8QGQqqh2lGJyOg5z1FetSqQ5HzvlfXp0+96HapRled7XVn6nca34Ysr+4S50uWKzdWLXUsNwYwF2n7wU8eueMde1cX4cQ6T4g0//hC9bt9cS4uNl5H50kylP4m8xs42g5Byf155nxH4pjufEOo+HPB8Caf/AGjLv1K4nbes6JksFGPlRue/O7HGa9A+HNnaeF/Dmo6te+RDHM4RWSIK21eNgAHTPQe1ZuE6NFym97WT6377/LXoRaSi+bXp53f37f5HLfEfxNomoanD4I8KtcQedeM+oyadCqxMzZyknGGz/F1HY5xgOOi6vr141hcWt3a6bblZLQ2MoUOAo3KxGcKCFwBzVG01W11/VZbrw/oq6f5sn725DLChPYED77fTnvW5pfiK+XWZ7LTp7CZbaASeZHN5sil2wWY42564Xt361cYypQUYLVau/fua+wlSVnv/AF/X/AMm8WV/E0UsNxPZfZZo1vori3BNygOQqHGSPvdOBnP1jsNF0zRLfW/E2matf3Ooy3AsmiWMExSOwxnByQoO7HoK6Dw5pes3l3eTXpa4lncSJNJ95MMeM9NpXHbPX2rVltNE8AeGmsYrlmm1G9IaVmBkMrjBKnoGVenfPvU1K/JaCd3orLrtf5CqS95RW9/U4G+/tqx1+w8Pf2rcyiOGS5FxDti+0SAnavmr/qxjGeSeR612mheN9WitoT4ghtsmDLqjASh+dpUkhWBx0PzZOQSOK8p1CxfR9QuLq10qPT4pY1J1eWR5RCpYBsISctkgbff0rqIzc6zoutImm2NxZWt4okGvgW8LdRGY3yueeuCM7hnqM71qcJQXNb121v5eq08uiCpGOqn/AJf1t6ep7Vpt4uoafb3KKyCVA21hjrXnHinU7j/hZcS6BfGa9sbN1vIWmAjhyAyYj6MeSCe3FQ6v4t8RaVFpdpqXhwadDERL9os/NuLZlTp/q2DBT/dOevNaXhHw69/4qvfFV1E1vHeWhh8thh5y75LscDGAqgDHI5+vnwpKi3VltZ26+Vvz9OpzRjyLmexS1WTWtb1Kz0S/jUW+4Tm8VkDxHaVOYwM7efvdMjFFejRadZx6jJfRWyC+kiWF5xncyDoCaKzVeTVqcfuuP61OOkHZFfRfCPh3S7C5ttH06K2gutwnMbNvbPX5icjnsMCrdv4dsYZopAshZHEhy/8ArGAwGf8AvYHrXAad4k1XTtb0kLf2s3hksY7syxhplLcK+9RzhsDp0656j1YfgR7d6VVVaT953v8A195GIjOm7N6dB+O560o69qbk9O/vTh2rnOYUcnPeuN8R65a+ENetZbgateDWp1jZBJugtAMDeAegOegPQGuvkjDkEs3HQdqz/EujQa/pgsbqe5hi81ZS1vJsY7exPoea0pSipe/sy4NJ67F+6mgtLeW4uZo4reJC8krnCqo7k+leX+JviXoWs6fq+iaS+om6a3IWcRbE56ZJO4A/Toa77xLYw3mgXOnzPEkMsJjHnS7QRjAySefrnrXgstrFY7pEZJ/LyZluIDC0Z/uHn7ox14Jz0rswVCNT3uqOzBUYVHeW6I7LRrXWdO83xJamzsraYFIhLua6A6YweF/DucHipbSxv73ULtNaNndx3ch+ywRoGRkCk7NvYAAADsR61taPHL4keG0s4LeC+T95H5A/concE89T82CfWvTvCfhKDQws9xL9s1HBHnFcLGCMbUHYe9dtbE+xT5t+iOutVjSbct+wz4baXd6R4ZSDUIoopGcvHGqgOkZHyrI3Vm6nJ55rpyBuz6dKXrxn9agvry2sbWS5vriC2t0GWlmcIoH1NeLOTqScu55E5OcnJ9SfOO4A65rB8Ua9HpUAijKm5foufug9M+57CuX8deNpJ9C8rwRfp9uuGULfGLKRrySEDDlzjA4OMn61yui22uXloNSP2i7jDJO17dc7sACSTb0BAHAwTXbQwbtz1HZdup00cO/jqKyNXXotKGtvG+oQX89ixe6thfOhtxjgnPysQeq5x2461zuuvocN5fxXd2dS0soklzFkN9lOcojGPB3Z+YY7cHjNYfjOyb53WK3K3k6M8KII5rskgqBIx5fJJwPr2rrLeziGgx2FhCtlKUWOV0kIZHx8uG6EDDYJ5OPSvTUVTjFtt/1+HlbyOq0muVvb+v66lrTpVvjPdzqHgYNCgQMmF45O4ZyfpwKmlsbOAyT6fDAk14d13JuJNxhSFI5wD0z+PXNZFhDJbaBqFtpuqSNeRSFvMmYTbJBj903oDjBzW5ocF3fRW0V3Db2t3cRtvg27UVhguBjPHzDp1xWU/cbd9AbV79hng/TInvZL03MsEVsxERX5SHGCcNyDgfzqG+u1vtQuVS1js7RZN0caDaJHYkmRgozvOOT+HFZ1hFrUWuXf26SK1swqRRWEXIjZDkuR0y3XJySD7CneKL1NKS3vZZ7eJLhjEs9y7bYxgMTtVSWA64HPPvTUb1N7t7Gj1k5yZPqeo6faz21tPNFE1w2URs7nbIBYYHTnvzVLXNQuYoLq00y5jgnVQ8FxA/msTu+YKoGQwHQ/U9s1hXcs2l3Uc19cw6xqVxf/AGSz823YJChjBYGRWBTHmJgjOMH3qp4mgsPCTLeSXER1O4Zp106CYgIWOHOepj4bj649RrCnHmS3/V/11fmR7RddipbXMz6vdxXZurDTIIlghBjeNkY4Vdz4PGepyTzx3qHWZdTTS7NdSW6tNTfMKCONMzR5BZnz975WC7RwcZ710um+alxpQ0KzRNKvIFeVp53Bg24G1VYtuxt27QCX4+tbvw48PXt/44+3a/bRXkNhGGgngfdbW8wAAUZY7nIIJHGCBx0xrPExp+9Jbff/AF3JlLli2zvPhdoEmg+GAl15/wBsupWmlE/DRrn5EA/hAHOPVjXXgMR3rzjxT47u9A8RRaXHFHfTja9wMYZw5+VYwP4wuMnuccVoeNYYvFXhnVNM0ZGu5cxSNGjBSHDA7WyeOBznjP0r52pz1Ze0l1OaVCbkpT0UtbnblcE8YxSNjP8A9fpXM+B9K13TLMf2/qhuMoEjtOHEAHA/edW44x/OofGsvjRL3Tk8GxaM1u5IupdRY4jxyCcc7SOPlyeay5Fz8qa9ehjKKi2k7mr4t1C50rwzqN/p8SzX0UX+jxv0aQnAz64znHfGK8mkh1E64uoXd29+zW5jkEp2SI3U7cZVQ42hgACNowcV1XjfxJYS6K8plLS2AMsyhGWF32EYR2A3fMcA471y9gks+jaRq0ADw38UrtIrAqsitgRAD0ALZPPOOMGvRwtNwhzNb6fht+p24anGK97dh460XWNJuY9T0yK6TTkaB7O7gcC4tg6nd5nBDqM4K4wwOCe9V9N8d6vBrlxYXWqadr2mJF/punXNots0CAc+WQCuPY5Xtxwa6rw/4kv9IltLSTT5LvTppD5sxuFDWinqVQj51yc4ByBmvQLvT7O7Eq3dpbymVfLctEpZhjGM4z0pVK/s1yVYJro/61X3ozqSs1Gor+Z5z8QNc8J3fhFIzZW19HMokis4rlLNm42sNw9Bx0PA4rmtJm8L6R4f1C98OxXlld3enrY7Jb1JbeKPcSxDA8Hrknr26k16dbaN4UvLfUvDsOmWcsEGEu7doidu4Ej5jznqQQeO1cz8RfBfg6z8I2091od0llpRXYukgiRUZhuyDneM8ktz7ipo1qStSalq/wAH5Xt/W5HPTT+F6bXZy2j+HLrWtDL2FlAJFUiRbKVWdsg7WHOTxjBPHHHHFU9etrjRdJ07wNEi6nCQYpUSTfLHLIxYnAHyhBjJOOvFdP4r0jw7a6QdPh8Q6tZxXPlxtbWa/MMqGXzFGCoK4GGwBnHauX1S7/4QPz7yGwmha8HkrPcXIcwhQMIRjAZgV+8TjnB6kdcarqy766J6a+vz6f5HbB+1d29lpf8AHfsinYaUNKEukazHBDGWWJEW5+R1A6LzkEkZPfJPANbXgzwhpEeq3MWkXUSXTbo0nac5lRSN6qOM4yCePT6VUt49H8J2djf+MrW+EmoynydKif8A48yx5dyDlj90qOwPc9Ol1nRrTU/E2lyaFFZq9hFKIHlvGScyvjKlSCNu0ZB+tVVrT2TdnfXpdfP5f5iqVYSsoff0X9f13PStPsxY2ywqxztxu9/YVw3xG0CbxHpENtc6b++trhJt9uwjW5m2knbnnbgcsSOeK5WDVfGXhzS7q415Z11YndEb6djFCg+8wK53Dn7o9M10CfFfwtrelanGZb6L7IikzJbZSV8jBjJJ/i7OBxXnrD1qc1Uh72u61/I5XB05r7V/6/4c5rxC10ljE2iW0GsXD3UNtLDbnzUBbnb6Z+UksflXFL4v0mLR/F9rZ6vrD3EVzeCext/IBSCBBnLsQepB6DnGcDitf4fXH9v69dXMdtPFJaTljLNAY4Z5WBJZQO+GJx34PetnxprWjabqkY1FbfUr2T92FY7Ai7uFIB5OeOa3lVlTqxhbX8dbW/Ly3N25TqcsdV/VzI0j4q6bpdqsWrG4luJpZ5ttkpkFrCGwnmZOQzHsM9ulQ3PxltZDqa2mj3wWK2eW3nZd+WUfedB0Udev8639W1XRrDT7cT+FjM16RElotqCWOQO/VfQj0rtLWBbeC2SG3jtFjQKsUaqBGv8AcGOMfSuSpKivedN636/5fcYS5Ie81q+//APG/DGoeP8AV9AuNUin1S/uo+BBcRpZibOGHljHzLg9feivXZtWs0aUXE5TysBvMU/L+GMgZPWitI1pVG3Ckrf16GLc2kkrei/zTPL5zp1hq01hJdpLqYRVXa3yXcTDcCAOMgHcOe5/Hvvhl4jXX9Iu4P8Al60q6ewnKkFX2/dcHPQj+RrkvDGkWl14itIHsoYJrODynMaq67MltqN3G7I5yccVnz2cvw61i6ttFsZ7q2vNRW+uJzJibygMiNcDDHLFcEHg/iOqrGNePs18Wj/z/wCAjsxac+WHXV/jb/NntgxjjilyOeegye3HrXJ+D/Hmk+J3t4IBPaalLB9oayuFxJGu4jntjjI9sGty+08XFwZBKqyNA0SZyMEjg/TPUV5bpuEuWeh5vK1uaQPOKDjGTyvTAryzwlF8RLq08u6kg0o2t7tmikQEyxZ5MZIIxg5x+WM1vQTXvg64SPVbgXml3MhAmB+eJv75HYHuBnHX2raWGcW4qSb8jX2N3aLuzmPFPw98ReINR1DUI720t7qS9xH9okLq9qM7RgA46jj27d+t0TwHp1pZ3VvrMs2vrPIJB/aRMoiH9xAScLnJ6114IYKykMCAQR3HqKB688+1KWKqSio3sl2JlXnJJN7DIoYoU2wxJGoAGFULwOg4px9aUjB96Q9+cVzt3Mxfx4rivirYPqfhYQWmorpt4lyjQTnBJboQM9Dg9a7Tp0/KvHfifd2upeNtGsWmljjs5Q7zTSLHaqzY6lhlm44QfpzXVgqbnVVumprQjzTRx2t2ms+ImWbQ762ki0sR+fqjOscUU0fySyHOAoOM55zyRnNW/EPjvVLm7kbRL+xufC1jBBDHHFFtluZThX3Z+Zdx3njjGB1zVJ2a6N14a8OWWn2OkNP50stveG7eaJWbaynlSWY8+m0VoefpPhnw26m3SWG2i81zwxkOOpPqTtBPYds8V7jUNOZXtstNvPz9DvhBytOXT+rl3WizyQfZRaPM+FklunCiOI5LkZPXHuOMntVvRbi3vI0ls5jPZysRbj5gjEcbxkA9/TGMVh6ZqB8RwxT6vPHZ2tvOrQRQyiOKclAWVcnLB8nrzjA45Fbel2hsrlnvNaa7u5yFjt5AAYgTkKvfbnp9OMVlNqMLNmvvXJ9A0Z9PguDcjzbt2kaVoyP3p3lgfXOPy6Vbh1EXMKPpd3plxYwPItwyPuuRKRiKNAPugnOSeMKepqTzJluAsgR4mba5DbSp7Y96sJY21rPFMLeKGS5IPmbQvmlSQCT7c9axqSu7y3Zm49Cg1hdLdXeqzXUpllgMbW+5Qqc/eC+p6D0zXJ3Oo2VlDe3l7dTQXLaeGk0523vGVO1GYdA3IYZ7ZPNbEcepXi6tdWLKbuKZlhjuRhdnTcB/Ec4xn8KqR6NcW76hdJpWm3t29qRbTywL5k8wAy0hI+bnLZ5AyB06VSno2/Tp0/r1NJrlfKZWk+IJbBrq71BtRSPMNjLGJWMbjdlXRQCc5APvuOetGrwDWEe8msfsDWrFX1CTEnmRdRIAoyMf3RuxinG+udT06DSI9Hv7zWLhBNqUWlAtJb8jhkGAdxx/EMVvR/DzWRq+nLaeGobK0S3G64k1QZiZlyyMqckZ4Iw3f5q39pTpvnk+V+q6fNb/ADMnUhGWrt/X9fqczpmnapq15Jp+geIP7Se4izbAI3lxITklmYAg8Ecj9cV7db+G28N+BpNG8JiRbhUPluZVDmRjl33EYz6ZA6CvKdPsbrwX4mJ0rxFp0EzToLizI2GRFAzGRJlhuHUKWAIyD2HZXXxD1b/iYuNDMdtbgvDJG+9psdUA/Pnjp0rkxqqVnFU7OO/b79iK0JyastEd7pNgII4bi7jhk1ExqslyYlEzADgMwzkjocHHpU3kxWUY+x2SgFuVhVUx6n/PNYfgfxUviPTbeW4iW1u3jDtEXBPXBHsR3FdOevXj0rx6sZQk4z3OOacXaQ1h1xXBeP5Xa92Ocwwqh2ckYbqe/OePxrr9T1nTtMYLqF5BDKV3iMks7L67FyxH4V5r8UZ5tVtND1TwfelkkuGguNQtoxMsSjkB1bGBnPXHtWuFg3UV/v6GuHupKVtCFr8WcUssekaZCkSGVpbppJ2Cgc4ViFPH6VkzQebrJu7kuzxc2sa/JBagjEmxFwoVgFOCMhlJyc8atvBqZOmxGMSWc7CFLmJMjAwGLDkJ6Y7D1rA8Q+JdM0XxNf6ZctdI+m3XkQeZEZWus+g9cke3T1r0qV3K0Vrr/l/X/Dnc/Z3vLpruWvENsb3S7uyE9zbyTLujmRuVPXK85zjt9a7/AEiO88T/AA3sraPWLq21ExJDJfx58xnjIDE4IJ3Y55715HfHTLx5bW6vTd2+iyxyx35n3iSQ5+R2HzNtJAJwCenbmaPXtWh0mDQNXvbjw9NqF7G1pf2UavA0eNpSTB3Kp+U56nv61VbDupBcr1TT/rv3aIrWcVNbr+tj3SaOGwszGL23g1B7dU+2TopeUooHmOON3r+NU77xNZaToEepX90JcqATaxsTK5/uJ1/w71wPjO1/tHQzZaHAuqX5tVht4hPjzog/zMpBwBkA4zztxXL/ABBWax8O+HbC3uHshaRHzwlwE8mTYm9TJjJwX2YHdua5KeEjUaTlq3+H5+XqcyoqTtfU6XX/ABbHrk9xcaNp4vb6wUGSKMkSZbIKKy5YnbnJIHToMVz8muI2jXGp6n4anuIvMWOS21X5UXkfOWIxwcdqyvCsCXdxrslhNJPpjeWWuLeQBkfbtYKSD6A55H41u6jZ6zf6XLpsmqf8S+WJWj8+FJJM7l3FgRtJIAwecE13KlCm+VLt1d/PY6lBcvu7ar+v6sbH2Hw+dKk1bUZRZJqspuEmvrlG8wDkNGoPKnPAx6Ctbw0YdAjkuJD9oWSLzopfs+JZEJ4YN1C/gPpXmHjFNKgvtFstTsp76C3Xy4rxYmDLkDC7B8vB525A64FamjeJWu9buNE1e4upmijbzb024EcoHCoAPugg4U88noKU6EpQuno7/d5f18hNSatUejt/w39XPSvC3ii38VyajY6dZvbXFiqyJdvHviDN3Vs8nnpxWVb6J4X1LxNdeHI7PV47u2j+1y3Cny48kg7cjHJyD0xUUni+40q0t7Dwto9nZ2FuyjbdOTheS2CDy2c8n1/CqHij4gSf6Jm8ltrZpCga1jIVveR+gUZ9Qa5I0ainemrJ7a9e7/yM/Y1E3y6J+f5npj6jp2lRx2j3itNGNqQAh5m54UKOSelcJqeieC/EepXdxLNcwaoq4dDJh4CcglVGcMD2Ocelc3oslu1vJeW8pnW4LzS3bESMR3HmY5C4I5zgcZ4ocWFpaNcG5s47cFVEm1YVwepZ16k9j+ppxwns23zO/kXChye8pWN3wzO3hG9bSLO+u9S0RI3JjvF/feexz8rn7qBQDgZ5JPesnUvGUmieHItH8HmythaJ5UfmXSStbrnJaRm9M9ACeccYrH1DQItT1T/Tdcu5rZ41ePSYDsDAd5MHOC2Pf9K0tE+GWh3WpLHqNtqZsniCxRQbVQtnJZioLfnjr2rX2dBe/Vd+r03tffa+7/zM5wpw97l/r02/rYx9J8Ia94iuLYWsRj02eVX1PVZrthPcdDlQ3zBTk42qMgjJ70V7jp13pUDNpVjeWpksIo1eBHDNEmMLux6iiuSpjq1/c0X9f0uljnlUlJ3X5X/My/BXgtdBMM735um2YUKm1cH8TxVvxn4X0vV5rTV72ORL+wBVLiDd5hjPVMA4IyeMg4ycda1PDOtQa/olpqNuhi8wYkgdgzQSDqjY7j/OK1gSOcnJ6Vh7er7Ryk9dn+qFXqTc1KW6PnSzv9N0H4qR3Xhm+vLySZJIpYJlZ0EgyNrNjds9MZwR6V2dv8YmtGtm8S6A1mjzfZ5RbymSS3fJHKEfMuBnII/E11Hja1v7O2nvNA0yC4upY2SRUCRuwPVg5HXH5145rXg3UE8HWlxc3kslndagr6gbxvLmt4zgqDyeBjJxnoOMV7MVQxaU6i8t9dE+34XWpsnGpG7V3+r/AKf+R9LJIJEjaNt6OAUYcgg8ivMPG3iewm8Tw6YomluA3kRRoA25mOCAOwJAGSTnAPAqpY67qvhm91mG41Jb1UiR1guLjItQ33DGABhdpAx06HPrS8FeCr3UNV/tC9izYFd3nykCSWTOG6chdvH+TXHSw8aN6k3otvO5WHoxpXqVXp09Tq/htq9zcI1rE4vdPSRoxIpz5BXqmfTPY/hXfY56fjWb4f0LS/D2ntZaHYxWVo0jSmOMnBdupJJJPb8AAK0h06jmuOvONSo5RVkcdWftJc1rB2/kaTJJOKXOfekySawIM7xDdz2Oh3t1ZrEZ4Yi6+bnbgdSfwya8Qto9K12C33tFdwbjcw5LBk3Lhn9cnn6V7N4umxoN9Gv3mTYf+BD/APXXkEM82k+H52fTxAYiy28dvtaUxDAVmwOmSTtHQe+a9fAK1N23bO/Bq6atuZjeHUlstY0rTrqO1uwqrAtszZt4QwZY8dFZtuWbOT7ZNVtYwdV8RWkmoTzXBtVAMbPFsQFfNKuFOMjnoRhiCetb/h4TWtzJHeKBdCBbqSTZt3PKM4YdiFCiny2TWB1H7XeyLbxiSZEVcs5KA+XnJODzyeBxXc6jjKz1/pf5HU4JN3ZS0XQ9DU2p0YRzaffTG/hd3IdW24AC9irAqQOOhFUTNplxr9rqLw3ljcW77Y1uF8tLjtkhhke2M5xzisbUrzT9X0K11XTzBa6jo8kduj3AMSSxncdpI46kZzjHJ4zioLGz17+yb271MfaI5pQVsLolkdO8sMhJO0dMA853Diq5bP8AeN9tf67enyJi7e7/AF6nQy+JtSS5Bgt7K6YlFgsLYGS4lRiMykjhdoz8x5JwCMZIu61e6ldaTeahps8d28ZUWn2VBKevzNg8Fh0yOnPU1jvfeHIL6zvGtJBLaoPMU/LMhC/djCNtxliOc8da6awVj4etpFtDbWvkskVqId0gXOSMZyTgDGfXiud1ocycF95pySjrIzLbU7rxBpF7bW1leWyqip9tuCVkZ+N6rnIwAG5+ldxp3hTUrbxtYM0q3WiRQbLhQSBGyr8q+mT8u4Dr3rg4tX1PxNLpuk+H7Izf2rHJbTzu4lNjDkAk8/KQp3Ak8545Jr3Hwjox8PeGdP0h7uS8a1i8szy8FzkngdhzgD0FYYurKirKybvpv87/ACOOvW5fdiaP+jWkSZaG3iUCJBkRoMnhQOBU+KxfGFrYzeHrubUbB9QjtENykMfDllGQV9DXM+AfF+oeKJ31F1gstCWBd0Vx/rY5DgLhuhU4J555+leZGi5Qc103OVQbjzLodrqmmWGq24h1OytbuNTlRPCsm09iNwOD71h32meFfDOnXN9d21nY2RBSVipZSX+XpySTkjj3ravtW06wsxd3t7BFaFPN80NuBTIBYYzkZIHHrXiPj7xVZ+ITp9/cX0F1o+mzGO/0hH8pJpCx8sl5BtDYHrkcjA5rbDUqlV8qbUev9bDpxk9r26le/wBTTQ7O9i8FaTeNYWku2wnmmaV5Wwd0gVvmVA2wAd8H3r3XRPt50exOreUdSMS/aPL4Xf3xXi/gTwvHbeNW8S6prE/2ecGeK3P7wSAD5VMgJ3BQR0HYdq9gPiHR/tEcA1CB3kYIChLKCeQCw4X8a2x/K7QgrvdvV/15mlWL0gk9DyyB9O8WfE/UJNcSbT5NPubiygMU6o042Kq7gRlhgMwA6dTnmrHhW2tbbXvEX/E9RtHksJrWS9llG2Fkl2gktw33hkn0A71Q8YT+HPFnim+TTopIrywmRZtUgCSMswHVYXHzYxjcMZx3rxdruHw7qdxpP9sWmpaT9p3vCsRUXEYYNtcsuVyQD3x2rrp0XUioptaJWNlFqPZNeW/3/wDB8j6l8D/a7M6n4e1OSzlNmUeAxfemhcZ3sOmN3pnr7Va8T+BtA8TX1ve6vYl763x5dzDK0Ug+pHX8elcF4E1PUre80WXWraIWqqsNveWSMITG6ZCMf7v93POc+tdb4P8AFNtfare6dLdwPKAJkUPnYD/CffnNcFalVp1HOD1XYirTkm5r1N7Q/Dmj6Bph0/SdNt7e1zvaPbu3t1yxOSx6da8yl0/+0/Hd3Zya3dqlpOYbyMWgBnkdQV2Ochdu4YOOfSvZSOOK8o+JmmxDxfaai8cSlbctG6x7Dv8Auncw++SvHI4GKjB1JSqPmerW++vzJw93JxT3KlqrfDrxFdR+JL+SPw80ZFlcwQu0jA/xP5a4BDccDGSDWP8AEHw/Dc2GhaboN/Z6jCtz5xhadHlWFgCsrqTuYlsjpyeteteHGtbNbeFgiarfW6T3KrLuDbECqTzj7uAMDnHtUsHhjRbbWJ9VTT4P7Snx5ly4LMfz6fhWscXyVFN7r0s7eX363+QlWaleW/5njl2mpWt3rBeCz+z2gMUMNrMyTTylQ2HYgAAgrkAYwfxp2mXUN5HFBPIg1dIklnsxIDsZucKR0+n9K9O8WaFJNc2c9npJun8xjK3mCNU3Y+Yg/ePAH0rl9f8Ahgt7Pf3cEGmyXhQeSJ1OyVgCAGPUAdO4+nWuilioNJydjphiI6O5z0+paWFt22eIJ5TnzFihjCxEEjADOGYj27Guk07S/D10n+l+JY9sZ+eITIR+bKP6/WvP9aXxlaWFvZjTJ7HUbZ1WSc+W4ZcA/uiflKk8EegAPeuu1Gy1S60N7rRZLG8vI5FP2Rh5bGLGG5PyqQeeTjH5VrUjorTsm97p/oW5t/aaRoW1vaeGvD2oanqq6drd2bhzaLaMZC0WcxqfRvXgD1rmdftfEXjTTbW/ksre3sIZPlikjVxCB1Gztzxk8mtCbS9U0670eeR4hYXkTyyEBXO7b/q9wHIBycjrx71Nba1q2kfDUPcWpk1O5v8AyJI0YZigZj82QeSEB/QnvWSvB+0i1KV0l5dNvluJe7aS95vr5FK6tvK0sW1zG4tHjMLxwS+Sdh4K5BHGM5HpnrV3SdK8Gw2tsdStIUmtiI7e7dvLMShgypktzg9zk+hrT/4RyfSINS8SeIdQjayt7IPawGzDCznYf6zIDMWGQAAD1Ncnpuk2+pz2Ota3ZTahplnpAkunurgBRMucyshUMfXkg9gOKlVFJN82i3a766ev+ZE6sKl9NuozxPoOkeHL271DQNM1DU9UF0ZnuDe4UB+WjVRwQAc5PT3xXRa7rF0+gxDS9Zt7WK4J+0zs4KQhl+aM8cse2MexrkG36dqFvqT3SXBntkuGtnuwqRiUExgKMKWK8jcxqroFrq+seInu9cgexkuJksZrd03W1wv95R2IHzbh0PIPNaujzRXO727/AHWt29PyNacYwtK11v6+f/Du2hL4NsJm8ZWNro9zfXmmgeZcSqrRwxkZ5Y/xD0HfNFerTa7DpmnPHounGSC32ri5kKB16Fg3O4gc+p+vFFcdapUrtcqsl3av+JFV1a83UUfyOH+GGtS6d44g0+50ybT5NV80yRJGWSRgcrIx7Hrk9MGvZ4tVsZdYn0uO5V9QgjEs0Kqx8pTjG442gnIwM5xzjFeT6LqfjC1uG0q60C4/te3h8tNQQBIJOS2CFBHQBQcj1OKTS/EGv+BLqzHi+e7vZtdLypaXF75/2d06gOBtXgjgZHIxjFbYig603ONr22Tvfz9Ld/8AgEYqHtZJ6a7dL/p+XloezHBHTIPUGs7W7DSp9GuIdVhiOn43yKRgcfTmuHTxpqXibw/ex6Ko0bVwwWFv+PkScj7uBx6E9uKlbXprrwzcaVqc5l1+0jVrnbHsDH1APb3Hf0rCOFqRau7O/Tdefb8Tmjh6idnoad1Z6JqejavqukaBDeajNACIJoijXBQARDHp8owPYVq+A5teuPD0M3ie2SzvnJxbjGY16c44HrjtXltjf32g6Drc1lNcSi7uDJIzSb1iRhhmjcHg98duK2vhDJqGlyW2muZbjTLiNnRpJxIYO6D1AI9f1ror4WSpyd7pPS+9rGssNNQltZHrJIwMYo/GjPT3rk/Enja10TxBb6R9ma6vJoPtG1ZlTC5IAAPc4PpXnU6cqj5YK7OOEHN8sdzrDjsOO+aYXUOFZ1DsCQpYZP0HeuSj8ZSurE6HOhXu1whA+uBXPeIjYeI/EOh6jdzanYLp8qyOsTHa5GSFIHUHP1x061tHCzbtLT8fyNVh59UaXxc1S90/TNOi06CWaaeZ2bylDFURMsRnqSDgCuO8QQ6pbeDPtmhmeJkhAm8tj50EfBY7hyevOO2e2a3fikumeKdHtjb3k7mKR45Y7eURvtbGcg88kAZ9Ca5Xwj4luZ7S0sTpx02KW1mh8t8t5WBt2tnnlPmGfQ16OHg1RjZapu52Ya9NJta+Zo6fLJB4asJp3WZ9oM8qsZCwwSTnuenXnrWRrGpagzS2stg0FlPCZLPUI2BjuATtaL/Zk5IHOQQOMHNa+LuTw4IdP+y208bKFaQF4GGec7RnGP8A9VcQljqmn2WpW00l59gmkM91YErcR3BLDDRAENGyH5g3Xp1xg9VOF227Xv8A1/X5bmk7p6a6nXWXhm8svCpiKJrGl+Quy4YBTdBj8qEEna+cDvjb1rJn8LWMOhIJfKsr+2Zyy3ieatsGOWVudjgHjkECui8M+Kn0e3nUIHth+9nimjKArg5bJGOx55HFdhL4S0TxLpcNzpl9cLp13G2xYSrRsjDkDI3DkepwR2rlqV50ZNVNE3v39V/wNfQiclTdqm3c8gXSLO5v1bTtVS3vYLcym6MSOs5ZuXUZGPqBgY5wevRafDa6h4iMV1qd+hjhms5dPjUH7bIse4GNgfkI3Ak8Zxj60/GGleHtK02XRPC+i/briyvEe5/tCWVd+QSPKcEKW4Hy+w4Jqr8P7PRdx8QS3OoaBcSu8UySp5kfn5GyUt1VcnnjqeoFb6OnzK6XTT7u79NPQbm6ivr/AF6HqHww8AxeDRqNxJLHLe34jVvLBARFH3Dz8xz3xmtDxz40sPCU1jHewSzTXIZo9rBVGCB8x7flUvg7U7y4WW01SWKSVJGWKVJA/mYGWGf4sAgg+n0qh8RfAFn43utEnvLiSD+zpW3Kh/1sbYLKT68DH1NeNJ89e9d/1Y49I1b1dV1sa9v4osm1uy0S5SaDWLqMym1IEnlKAT87KccgZB+nrWV8RdH1W9tdLbQrk2kNtM7XCwwrIw3AYkVOMspB44611ttZwWpVo4l8xYliErKPMKL0BbGTVgZBHUH1HY1lGooSUoIzjU5JKUUeTeE/BTajp0d1Hrgt7owzR3VrarugkkJ+WcoTuXjblfu8nGM1QvvhTrL6bY2Ed7YT280rNqUzo2XyeGHcuB0PsPxyfHVnPp3xdknsoxBrN1sfR7tj5cUQMZMgfBBfLBwB0JbBz0rqI9A1vW9TsvE+m61e2d/NEEnjjP8AozhCq8KcbMkOSDu56V6cqlWnaopKz1269v8Ag+R1qc7ay0ffXp9/9eoupfDm90vSdCsfDl0buGF2gvUvpGUyxucmQFSNpUZHHOMY5znmFvLPSbjU/DEGqzanfQyGK5vJ4kXaCuESIE8sozlnySR+fuWo3lrptlNd3twlvaxAb5pTgLkgDP1JH514pqng9PD3je9vb+5gvF1hhNavIApyM7kA7kAjkdjWeGryq3VV/wDBf/AJw9SUmubb+vyOTn0loNHll0fXbU6nZgSvfSxh3kZOQjdQCCVUE/Q4rO07WtCntZbrXtCjGqTxef8AapkUxlgxbMi/3SMnIGSeMV6x4a8HeHrnUxs0+5itxFLCbdWUw7HGMtn5g/Qg88jPtXM6f8EdW03xC7trttc+HoldlF0pLkejJjacDOTnsCPbu+tUlJqb/T8vyOh1oKXLO/T+v8+/5V/DGr3Ws69LceI9Qz4eureL7LZTJ5JkQch0VeRggAjphuvGa6q1i834n6XcCxhs7COIBkjgC+ZMyFSJG6uRwM8jAH1rK1PztQaS10/UIoL9k8iLUIYVSaJMcKrEgoGC+xx3ru/AehQWdtHcXDvc3GEVJpBjdhRyOeSTnJ79a5a04xXPtpa3qTKXs02+qf4/kdmw9etYni7R7bV9GnW4i3yxRu8JBI2nH/1h/StzoPem4HQ968eMnFpo8+MnF3R8za/c6al9YagsjQ6tvewls7glWlgDHlMHBBwyqDj5h9K72x8Tp4cEsV1qGoPa3caxWouQxSNscYBG5GwccnA2/jV3xn8O47u/i1O3gS9WHBS3f5WjYNu4I6jPauZ8LW1xPe6vbx29+8kLedJc3aFQZC2MRg8ADGB64r3OalXp33S3+89FyjUjra36lTWdWvdH1S70+wg8QLdaTC1wslrcsxcGTaIXJyrjGOeepxmvQ7HW/Et4NOtY7SESXMMdw00yEMkbjILgcAjocd/Ssj4c6bGfFWs3Vwyzw30BKwlGCoSRvDckMSOMkDgfLxmvT0RY41jQbUUBVUcAAdBXJiasI2ja77/15nLVnyys0eQ65qHiseKrfR/F66WdL1GdYLE2kHmYOeZMk5Xg4Oa9M0HQrXS0kiQb/OOJN3OR6e9aRVWcFkUlemRkinRgKyZyQDySc1zVK/NTUIq3e3UxlVbjyo+Y5rzXH8Xma5mH9maesiz7Jm8v592DhumABjHpx6V6N4egm1fxNZx30xXTYoIbm1hRB+8k2/OGI5ByQcHt0rk7TQ7oeLNct/EEUDzxXAezgfDGOEsSCmP4WJXn88V6v4S8P3FnO97qqIt2fljjBBKjpkkcZxgYBPTmvTxNWEaata9vz7f1od9ScYxbT1f9aeRzPxEbT38Y6PPG1w+qr5lmY8yeVgjzCWAwCcdMZz6HAx3ljp9v/YcVnLAHt5YdssUgyHVhyD+B6Vmx6HdT6zeT61dwTWa6lHf6UiA+ZGVjIKvn0JOMdvrgdEzKilmYKByS3AHvmvKqTXs4wT2/XX9TilUulFdDwDxNos7/ABA1MJqFta2liYQ9t5G8NESGjUKeFChfvdeeK7/wXpNxe3sOq3UXlWkKkW6k58wkYDD/AGRk89zius1bw9o+syxzanpttdSqFxI64JVTkAkEFlzzg5HPStB0DgKcgDGAOK1qYxypKmlqlb+vX8DaWJTjaK1e/wCWhwHirwfY2mmxXdnBq93cWdws9vBbMXZX9cBlwBk89s9DRXoLEfeHT1FFYxxc4qzdyFU5viimeV/FT4gIgGm+G7+V7q0uPLu/IIBjkHRckYOOc4+nrW18OvFA8RpJpXiFrO71SMu65jUhwvD4BHUZHT19K8k0qDTfEa69daZaKkz3iTzZ3bsFyWYZJHRm4GP5Vl+LLjUrDV7XUPCk8Np5U7RxtGQrxyIQHUnGecjOeueM17f1GDg6UdJLr1vv/XkejOjB4ZQteW+iv93VnqXxljtIbux0/Q7FbPWZEedb2zKxup2kbW24PIwQx6Z715touqKPD9oINfVJokJuI03u5V5NpDOe2cDGepz0213ev6faa/4vjl1PUhANds0tYIo0VCJ8AMM9eHGcnqMCuw0D4X6ToPh+ewtJWklnJee6nxkk8kcYwOAfwpxxFKhRhCb10f8Anr5bephGsqHJftr16/keTpaX1t4m3xxyxwTQm2trIy4W7fGPkUcEdMj/ABr2r4aaNqWnaMra3bQw3uAiBDlgn+0Ox9hxR4Z0Hwnb39tqeny2d5qaq9vFcmfewx98RrnA9yozg9cGuy7ggVx43He2XJFWRhicU5xdNLS/zGnI46V474907Urnx1De6THCbx5vsscfLOyJHuYgds9QM9K9jJ5HrXBeJLl5PiFZ6bY2UlrqMli00Gr5DAEZBi2sMDIwN4IOcDkCsMHN05tpdGYYefLO/kzhdBtNcvdYvIvE2paTHZttgWcScySk5KBeD0yu3A/HnPqdp4btLV7Q2aqY0UK7b8YUDjA9/T0rx+4v/DVxr4t76y1rSvF1xdIjTX6LI9khxyqdFVhnGOecjI67cnjLxRL4evL7w3Yww2mnTkOjuJJZYA33zvX72Co46ZPXt6GIpVajXJp+C/p9PyNpc04pxf8AX9MxPjRaa3oOp3M0FpBeaHc4ntyiHzYGAw447g/Nn0PPeq/gXVv7Z0y8hjijt79YAA92SyzMMnc3fODg+grtfhp40u/Eep6tpfiEb50b7XZboNpjgKk4m42rjK4HufQVzBS00rxveTabfXd5Gl7Jpi6dCFCNcPl3d2P3VXqcA9AM9a0jOSj7GpG0or5M1p15KLpTd7f5mw2jyx6HHpN2PIkkXzJRE21JQSdzI/p6H2wai8Q6OmqeILHWvDF9b6fIHt4dVS/ZYztUbEfceu4ccck4roZIoI4zAHhlgLgxWojLssjdSmPmGe4HWuZ14aYLLUrV9dg06e6UW2LqDap+bmFxgkZYAgj5gRnntnGo279fTTXf+vLdmiSk1rYz75tQuPFs2ka7H5OiypN9rke78zzIMEJLBgeoHBHBypxXc+APF3grS/B2n29hrSw2cDtAPtqGKTzM5Py88EnPBI565zXAaPper+GbCW2aaxurORpWN75geXT5HUAJHyR2BOQCcqcDGazNS0O+1m0h0ifUrSOfz2+xujl5LtMfMzlukmOeOMngAYrSrQp1lyylaPlt11tr+fr3M50/aL3r6eh6V4itLbT76W9nvll0K7lAd4p02rIw+UOxyEU/3qw9f8T6ZoGmzyaVpey5kKxW08E/2mSViMgliSCg4wecHBGKq+HvCtx4StNQls0ilnaxT7XDdSKWlUAMFWInByMY7547mneFfHZ8U6wltdWNr9kW3SS1nuFUGJ1Y7gAeDlVIwP7tZRpfaXvRjv0/AqLdtdfn+h1XgWCPXNQ07WZLrdNYlwscqlJldkw4cdGJBGc88Zr0rp+FeEaffa3rHjPW4vC96bS5EaRspjAVGY53hsHjAYBq634ieI/FPhi20mPTYvt0ghXzplt/M8+UYBGB0z6DB5rjxWGlKpFJq72XbqZVacqtRRTW33Gt4cstVtfib4pmure+XSrmKF7W4mug8TEABlRB93knr6e9dr1wB1I4FcPYeIPEUmvaTpt9o62he3W6vLl1Zo0BG541IOAVBxznkVk+KvH+qxapFaeEbWyvJmODJcvhI0IG1wON2TznOMdjnjF0KlWSSS2XXtoc6pTntqcP8aPENprfjCDTtNeKT7Di1lmEWHSXzDvUN1IHHbqDjqc+s/D3X4dV8I2suI0kgiIZYh8rbRncB7+nrmvIfAvg/TdR8dXNteX0l5qHmm+u5IUliEYJB2q4bIO7o27OcVt6k3iqyvL/AMK+HrG7i1B5JZo9UaIpFKhO7PmYwhweuep7Zr0K1GnKEaEHqtbvTTqdtVxnRjSejiu/m/8AgDvEPxHl1iwgt9R8Lu3h+6mWO4aeVonGGyuD03HbkAZJweKLm2n8b+LbVbeyMGnaNElrGsZO+CJ1+do36b1wowefToSbGu+Cr2y8J6XbXlrcaldSt5l39lZ5Ps04GUeM8tnkjdn9K9U0FJ00i3a+t47a9dQ1ysYUBpD1Y47nrWdSrSoxUqK79fx/QylOMIJw26f52/Uz/Cnha28OQuI7m5vLqRgZbiduZCOAxA4BxxkelT+LpvJ8LavLkxlbdwGx3PAI/OtrFZXiKzm1DSL6zVYTHPAyMJCTuJ4249PevMc3OpzTZzRk5TTk+x4G9+zJ4Un+0RWumPcJetd3cwK2xVirL6HHPrXoMXxTt38RLYS6az2Ij8+S8jZituoGSWJGCAMHIx1xXnuj+A4dLURatDGzE/vIC+9Ix94HH94Z7djzzXceFvDY1+W4muL+0vNDuIT5cSAeYZA21lIwVaPAyD94E4PTn2cUqEleWqV/x/M760IRV56+n9I9WVlZFeNlZGAZWHRgeQR7Gkz2zzXE+HtM1Lwz4nntrnV57zRLtSbeGb7tqFUYwTwuMEED5TuU4B69VeXUyXVvDaCOR5Tk78hQoGSQw6nFeLOHK7Rd7nnuNmRzaxYRakdO+0B71UEskMfzNFGejv8A3V96kiubTUYX2SpKitzyOCO//wBeq+raFp+q2epW19CHj1KHyLgjCu6dhkc8dqXQNH0/RdJt9O06P/RIF2L5jb2wBjknr9KPctdN3FpY5fwbprWXjDX7uyNlcaNdxoYpbeQNL5qnBEgPIOOB247dK7kcgZGO+D1rn7vw6F1H7dpzRRTPw/mAkY9BjpzXPxp4vi1a9stVu9Ph09l/0KeIzMX5wN6gggjvzjPrW8o+21UtUvy/M0koyd+Y78gjOfXg0HGOxrjfDui+MILlDrmuWbQoxwLRpHZh23eYMf4V2ZPP+NYzgoOyd/Qykkno7nmfxUlbT9W0y68h5IbsC0maMYIUk4YnPQEqCPRiecV6FYFTY24Xaw8tQCp3AjHr3+tYvis3l/8AZNN06wWZ55cyXNzE3kW0Y/jyCNzdQEHJPUY5qtdT6L4A8KRWNq8UKxRyfY7R58PcScsVUsSeWbqeBkdK0k+alGPW+n9f18jaUueMY9TL8ffEPSvDepW+nG4WPUWmjilna2Mq2qOM89MsQOBnHc+lU9V8X2cEltDrOpParM6rCJI2CStkfeYZUdecnHFYdnfyalpvmq0M0kjApPMolO4EBjJ1UEMcYyfu8VpW3kWEIfUHsN1t882AFTzAQVYqW2gdOD7kYOK6lQhTSUlqt/8Agaf1+J0qkop2PUemP6dPqPakPHPp+lIrblRscOoPUHGRn/J9qXvg15bOAacc5/n2oqO8uIbS2lublxHDGu53IJwv4f0orSEZv4I3+V/0LjCUtUmc8mjaJomlapqvhvSob6RYJZHt7eXeJ3VSSmBkZI449a8hnaC7isrtJE0m4sUN9d22pODPDE/PoN5wBhcBsFT6mtO8lk0/TpbKwdrW1cNI0cJ2DcF4PFcV4osYL9jqV6rz311ofmzTSSMWkdMqrHnqAi/lX0GEoScnzSu31/ryv/wT1nQq4de1jK+/5M9C8C2lpPqOkajqVgx0iSaXVLK8lJVbeUEBQ2einORk9RXrvibSV8QeHNS0lpzAt/bvB5qdV3Dg/TOM+2a5zQ7G21jw3La6nClxbSWaq0TcKQFJHA4GMDGPSuk8MSPLoNi0js7FMEsck4JH8gK8zEVXKSqLdP8A4K/4P39TzMX785OR863Wp674VNnef2CLTUtNZbVReqcsAMeZCgAUqemcnqMd8dDP458Z/Zrq4S7hLQKRtiUBkY8HKd9uc8+ma95ns7e/jSK8hjnjQ71V1yAw5zXF65p9onjnS7NIES1uoJnmiXhXIU4JA7jArsp4ujW+KmrpPz0WptDGRk/3sbv+v69TjtD8aeJPDHh6zu/FUs+oiVgskrxsRH82MsQuUzkc8jP1Fbdl420HXtUiS7W50zVYWEcF5CgkjdTnKK/IHcHIBGfrXa+F1A00xYHlhygU8jb0x9K8Pu44oJpZ4YYUne5aJpRGu8qHyOcZ7detFKnRryklHlflt16FUoQrTcbWt1R6f8Q/7Hn0i/W407/hJbzEV3Bo0MoFxw+0SJt/ebBkk9R1963vB1vaw6BZSW1vcW6tEFeC4kLyQn+KMk9wePyrx/4yWFsfh/ZeIhHs1v7O1t9rRirmMlQV4OOjMPXk1h/su67qlx4ol0qe+nk05NOeRbdmyoYSDDD35NZ1MNJ4bnjLRP8ALT+n16nE7Rbp9f8AI2fiP4b8SWVrf2kDRvpEipE7iRleaJW3D5c4cjABUYI6k4p+mTza34hgv9ItP7O0iGFrhvPwks7AKivgcMzbWz7H0xXvhOEfHrg+4ry3xZZwWXinUPsqGNfkwgY7F3IC2FzgZ9hV4fF+2XI1qk/0T079jroVud2e/c6Ow1WHSoVhgsfPkdi6yJhC4Y9emR6VjHxToHi6AWev+HxPbxzFmSdRIUkX5Q23AbODj8e9ZWkXU82mxNLKzMr4Uk9BnHFXbi1hjHlom1WKIQCRkHkg1l7KEW+a9+6ZUqEG2pIp6/Z6Nd6hcRaJHpDR3FusNxp8l15ZvYADnEbYYSJg7Wyehrj7qPQbLxdY3ltawPBbwRsLye5QtEEGFDof4xjAbGcd/Tb+L2k2FjFJJaWsUUtt5LwyKPnQtu3YbrgnnHTPNc3ruj2F9ZWN3dWyvcXVvHJO4JXzG2A5IBAzXoYVKUE7uzX6evb/AC2sdFKjGVNTet7r/hzX124uPEEeiNHrVlfu92ZwL4iVtuMMIm2gpypwPbhuKteM30u38OMLtbewuktg8LRAq0bp/EoHU8gkjufrXCafHHc+FxqckUaX1lHJBbywoIiihsDhcAt8zfMfm5zmuz8ZaZaaOPCEOnRGFI9GMi/OzHdIXZySSScn1/Cm6ag4JPS78ttTNPlqKMdG9TO8NSeI/CfiG6t5IzfavdtDcteRAbJPMC7k5BxjvgDkHp1r3PxJqc+n6VJJHeCznSIyyBYxIxUYBCAnBOWA59a8z8U2sWjeBvCiaYHt/tNuLiZldi8kheNixYnOcse9df4yJn8NaDqMvN6qiQSjghjGGJ49wDXBirVZwlbq1620OdpTVNvrdFPU/Gt5BKbK+0WO40uSIx3M63JEi8YKlAvJP+yaqTv4Mn0ixSMx6PFa4jidhjCk9NxySM+v6VwmrW6X9j43W6LuIo0mQCRl2vszngjvXHGaVPFdhpfmyPp93p9q00ErF1dmgVmPzZwSeciuyngION4u1u3pfrfubzpQpzUFdPT8Ue63fhu80/SCbC9hntZFaaW5acRBAFGJCehG0H6eprQ+Gvi298URXbSWtpHpsYUWr21wZWGOCspIHzHhhgcA4PIritFHnbNBnJm0eNS62sp3oD5ee/UZOcdK9V8JWlvZeG9Mhs4I4IjCshSNQoLNyxOO5NediUoQcZ6t7PbT79/Lp3OfEJxj7+pr88Yzk0YwOPzzSZ+97dKc/B49q85K5xjcHv0pMevPpT2AA4ph6j6/0pWGjzn4reHLO60O+kgvjZ6vcoTZxi4WMzTLhuCxGeAcj0rlbHxmNNgh0HS9Kmv5NJgiW4VR5MczsOQh+9tBz8oHuelYvxEuJZPip4pEreYLO3tjbCQBhCTGSSuehyT0rSl/drqMqcSTTqXPruVQ30z7V7VKi3SjGo7rf77foz0sPBSUZS1/qx2/iO4g8WeHLCGeCazS6B85PN+dGA5jDL1xwxzxgYIznHP+E/Esmi+KvFWkvP8AaLSCOGTS7bZsjhjIIwHzwjEJ0yM+nQ5Hw+upm0HxgrSEqVsrnH/TRwwZvqQq59cVtfCqKLxR4Jlu9ehhvLg3I+d41B+VgV6AdCT+dZypRpRnGXwq342f/AFVpqF4y2TL/jTxbHFomnT6laz6dC9yqy3QZljU4PCSAdc8ZIA4NS+FtWj0a7uYXurmbTppN6tcHcyk9T65HfqCB2PWTwBYWmpeH7y31C3iure7u7qWaKZQyu3nOM4PAxsXAHAxxXO2ztLptuZGLEMDk9c7sUo0oPmpW2ev9fIKKjUg420PYnkVYfNyGjCl9ynIIxnNcxYa3LfrfX12wg0yGPZ9nC5kcsAQ2c8c9BjvXO3Go3cPwt8XPDcSRvaWczQOpw0R2g5U9RyTXn/w91S9fwRpAe5kfcTMd/zZcSOM8+wFYU8I3Gbvs0vvMIU1zun1/Q7uXxUPBlpp7eINUvry+1G1lWFb10WPzoydodhgLnKrux7nvXQeB/GcHiPRbC4lNol/MCJIraTeiupIIB6kAfxDK5zgmn+JdH0/UNHs5r2zhnlguVeNnXJUkc4/w6V474DgjuPjB4hmlUmSytz9mIJAi5AwAOMYJ4961p0adeEns1d/8BL5/gS4qSv8v6+4+hrqeG0tZri6kWKCFDJJIxwFUDJJ9sZr51v9Eb4geJ9R12S8aXTJLtliJVgWtUACrFn7ozkFscnp0Net/Ewmbw7p1vL80N1dRJMh6SKFLYPtlRx371xeg6jdL4UvCkgU28/lRbUUbU3AY4HoTSwcXTi60fi2Xltr/XQ0o09OYyp7vT9P8Myaho9vC8unRxyRRR7lIhMgDLgZOCFJ3Nn5ue1a/hHRtF/tC+kcRzQ67breLDcAfP8AMGGUPTo3HrjqKd8Grh9V8T+Lvt4ilGIUx5aqNoLqFwABjHGOlWvEek2Meq2l3HbqlxHaXOxlJG3YTt4BxxgV0zlabpNu71vvur26dTe95ODPVtoK4UBUwMBeAB2ApscaxoFUHA9Tnvnmq+iSNLo9g8jFmaCMk+vFXV5P414UtG0ee1Z2MnxPpy6p4e1Gxkmmt1miI86FsOhHzAj34orV/wAaK6cNjamGTUOpcZpKzv8AfY//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Photomicrograph of acute vascular rejection demonstrating a perivascular lymphocytic infiltrate within the alveolar wall.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of L Kobzik, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Vascular pattern of acute lung transplant rejection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 238px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Photomicrograph of acute vascular rejection demonstrating a perivascular lymphocytic infiltrate.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of L Kobzik, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_50_35625=[""].join("\n");
var outline_f34_50_35625=null;
var title_f34_50_35626="Management of anticoagulation before and after elective surgery";
var content_f34_50_35626=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Management of anticoagulation before and after elective surgery",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/50/35626/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/50/35626/contributors\">",
"     Gregory YH Lip, MD, FRCPE, FESC, FACC",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/50/35626/contributors\">",
"     James D Douketis, MD, FRCPC, FACP, FCCP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/50/35626/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/50/35626/contributors\">",
"     Lawrence LK Leung, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/50/35626/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/50/35626/contributors\">",
"     Stephen A Landaw, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?34/50/35626/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 4, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role for anticoagulants in many cardiovascular disorders is well established and their use as prophylaxis against stroke or thromboembolism is increasing. As a result, many patients undergoing elective surgery or an invasive procedure may be taking one of these agents. The management of anticoagulation in such patients both before and after such procedures will be reviewed here [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Rapid, temporary reversal of excess",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      anticoagulation, and the possible use of medications affecting hemostasis in the perioperative period are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/8/30857?source=see_link&amp;anchor=H18#H18\">",
"       \"Correcting excess anticoagulation after warfarin\", section on 'Surgery/invasive procedure'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/45/40666?source=see_link&amp;anchor=H25#H25\">",
"       \"Perioperative medication management\", section on 'Medications affecting hemostasis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Issues concerning the risks of continuing",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      or antiplatelet agents during eye surgery are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?2/19/2362?source=see_link&amp;anchor=H17#H17\">",
"       \"Cataract in adults\", section on 'Antithrombotic agents'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/44/7881?source=see_link&amp;anchor=H15#H15\">",
"       \"Anticoagulant, antiplatelet, and fibrinolytic (thrombolytic) therapy in patients at high risk for ocular hemorrhage\", section on 'Ophthalmic surgery'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Issues concerning the risks of continuing",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      and other antiplatelet agents prior to general surgery are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/45/40666?source=see_link&amp;anchor=H25#H25\">",
"       \"Perioperative medication management\", section on 'Medications affecting hemostasis'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PROBLEM OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although continuation of anticoagulation increases the risk of bleeding following invasive procedures, interruption of such therapy may increase the risk of thromboembolism in patients taking anticoagulants to prevent thrombosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. Accordingly, individual circumstances should be carefully reviewed before an informed decision on modifying anticoagulation therapy is made in the patient undergoing surgery or an invasive procedure.",
"   </p>",
"   <p>",
"    There is also concern about the following issues in anticoagulated patients:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      There is a requirement of several days for the anticoagulant effect to resolve after",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      therapy is discontinued, potentially delaying more urgent surgery.",
"     </li>",
"     <li>",
"      Rebound hypercoagulability may occur following the abrupt cessation of anticoagulation.",
"     </li>",
"     <li>",
"      Several days may be required after",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      therapy is resumed to reestablish a therapeutic and adequate level of anticoagulation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The importance of these issues varies in part with the indication for anticoagulation (eg, prophylaxis for thromboembolism versus treatment for an acute thrombotic episode). Accordingly, there is no general consensus regarding management strategy in patients undergoing elective surgery who are currently taking long-term anticoagulation. The type of procedure may also be important. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Type of surgery or procedure'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     THROMBOTIC RISK IF ANTICOAGULATION IS STOPPED",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients may be taking oral anticoagulation as prophylaxis against the development of new thrombi or embolism (eg, atrial fibrillation, severe myocardial dysfunction, prosthetic heart valve), or as treatment of acute thrombus-related problems (eg, deep venous thrombosis [DVT] or pulmonary embolism [PE]).",
"   </p>",
"   <p>",
"    Cessation of oral anticoagulation used to treat an acute thrombotic event may exacerbate the condition, which may itself be life threatening. The risk of underanticoagulation varies with the type of thromboembolic event. While recurrent DVT or PE is associated with an approximately 5 percent risk of fatal pulmonary embolism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/6,7\">",
"     6,7",
"    </a>",
"    ], the consequences of arterial thromboembolism from atrial fibrillation or prosthetic heart valves are much more serious, with 20 percent of episodes being fatal and 40 percent causing permanent disability [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/8-11\">",
"     8-11",
"    </a>",
"    ]. The accompanying table has been formulated in order to estimate this risk (",
"    <a class=\"graphic graphic_table graphicRef86930 \" href=\"mobipreview.htm?34/24/35212\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/2,12\">",
"     2,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Appropriate use of alternative strategies, such as intravenous",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    or subcutaneous low molecular weight (LMW) heparin to provide antithrombotic coverage (ie, \"bridging\" anticoagulation) during the period when",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    is withdrawn or reintroduced has been utilized in an attempt to minimize the risks involved. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Overview'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Patients at risk for recurrent venous thromboembolism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Long-term anticoagulation is the recommended treatment for patients at high risk of recurrence of venous thromboembolism. Discontinuation of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    in such patients is associated with a significant risk of thromboembolism as high as 15 percent per year; warfarin probably reduces this risk by approximately 90 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/13-15\">",
"     13-15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    After an acute episode of venous thromboembolism, the recurrence risk is highest within the initial three to four weeks, and diminishes over the following two months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. Without anticoagulation, the early risk of recurrent venous thromboembolism is approximately 50 percent, but treatment with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    for one month reduces this risk to 8 to 10 percent, and to 4 to 5 percent after three months of warfarin therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. Thus, discontinuing oral anticoagulation within the first month after an acute venous thromboembolic episode is associated with a high risk of recurrent venous thromboembolism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/20\">",
"     20",
"    </a>",
"    ]; this risk is reduced if surgery is delayed and there is a longer period of warfarin treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Patients at risk for arterial thromboembolism",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of recurrent arterial embolism from any cardiac source is approximately 0.5 percent per day in the first month after an acute event [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/21\">",
"     21",
"    </a>",
"    ]. The two most common clinical settings in which this is a major concern (ie, chronic atrial fibrillation, prosthetic heart valves) are discussed below. This risk is reduced by two-thirds with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2441257\">",
"    <span class=\"h2\">",
"     Chronic atrial fibrillation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arterial thromboembolism is most commonly associated with atrial fibrillation; embolic stroke is fatal or associated with a severe neurologic deficit in over 60 percent of these patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. Patients with atrial fibrillation not due to valvular heart disease have an overall risk of systemic embolism of 4 to 5 percent per year in the absence of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    therapy; anticoagulation reduces the risk of embolization by approximately two-thirds in this setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/10,22\">",
"     10,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, patients with atrial fibrillation are not a homogeneous group, and the risk of stroke and thromboembolism varies. Management should therefore be tailored to an individual patient's risk of thromboembolism as compared with the risk of bleeding during surgery. It is possible to risk stratify such patients based upon clinical and echocardiographic criteria. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/23/27001?source=see_link\">",
"     \"Risk of embolization in atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The balance of risks in patients with chronic atrial fibrillation (ie, thrombosis if anticoagulation is stopped for an invasive procedure versus bleeding if bridging anticoagulation is employed) was reviewed in a retrospective analysis of results from the randomized RE-LY trial of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    versus",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/39/8825?source=see_link\">",
"     dabigatran",
"    </a>",
"    for atrial fibrillation. While enrolled in this study, 4591 subjects underwent at least one invasive procedure during which anticoagulation with warfarin or dabigatran was temporarily stopped; bridging anticoagulation with intravenous",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    or LMW heparin was employed in 15 to 28 percent of these procedures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/23\">",
"     23",
"    </a>",
"    ]. The incidence of ischemic stroke or systemic embolism for these 4591 subjects was 0.5 percent, while the incidence of major periprocedural bleeding varied from 3.8 to 5.1 percent. Thus, using the interruption approach taken in RE-LY, there were eight times more major bleeding events than strokes in the periprocedural period for both agents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/24\">",
"     24",
"    </a>",
"    ]. These results call into question whether bridging anticoagulation benefits patients with chronic atrial fibrillation, but definitive conclusions await the results of ongoing randomized trials comparing bridging and no bridging perioperative strategies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Prosthetic heart valves",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systemic embolization (predominantly cerebrovascular events) occurs at a frequency of approximately 0.7 to 1.0 percent per patient per year in patients with mechanical valves who are treated with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    , 2.2 percent per patient per year with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    , and 4.0 percent with no anticoagulation. A major advantage of the bioprosthetic valve is freedom from anticoagulation after three months of treatment and low risk for systemic embolism thereafter [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The management of anticoagulation in such patients, both in general and in the perioperative period, is discussed in depth separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/11/18618?source=see_link&amp;anchor=H19#H19\">",
"     \"Antithrombotic therapy in patients with prosthetic heart valves\", section on 'Interruption of warfarin for surgical procedures'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4559669\">",
"    <span class=\"h2\">",
"     Other high risk settings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other causes of thromboembolism include a dilated and poorly contractile left ventricle or a left ventricular aneurysm in which intraventricular thrombi may form and embolize [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/26-28\">",
"     26-28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among patients with left ventricular dysfunction, one report found an 18 percent increase in stroke risk for every 5 percent reduction in left ventricular ejection fraction, although the absolute short-term risk was low [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/27\">",
"       27",
"      </a>",
"      ]. Anticoagulation with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      was associated with an 81 percent reduction in total stroke risk while",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      therapy reduced the risk by 56 percent. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?6/56/7048?source=see_link\">",
"       \"Indications for antithrombotic therapy in heart failure\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Among patients with left ventricular aneurysm, the frequency of left ventricular thrombi in aneurysms reported by postmortem studies can range between 14 and 68 percent, a value consistent with findings at the time of surgical aneurysmectomy (50 to 95 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     BLEEDING RISK IF ANTICOAGULATION IS CONTINUED",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of bleeding occurring with surgery in patients taking anticoagulant therapy is dependent upon patient age, the presence of other disease states (eg, chronic renal disease), the type of surgery or procedure the patient is undergoing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/29\">",
"     29",
"    </a>",
"    ], the anticoagulant regimen, intensity, and duration, the use of other drugs that affect hemostasis (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    , antiplatelet agents), the stability of anticoagulation, and the degree of anticoagulation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/3,30,31\">",
"     3,30,31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The accompanying table has been formulated in order to estimate this risk (",
"    <a class=\"graphic graphic_table graphicRef86929 \" href=\"mobipreview.htm?39/2/39980\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Type of surgery or procedure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prolonged, complex, and major surgery is much more likely to cause significant bleeding problems than short, simple, and minor surgical procedures. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Low bleeding",
"      </strong>",
"      <strong>",
"       risk procedures",
"      </strong>",
"      &mdash; Most patients can undergo low risk surgical procedures (eg, cataract surgery, coronary arteriography, venography, joint aspiration, dental procedures such as tooth extraction and root canal, minor skin procedures, arthrocentesis, bone marrow biopsy) without alteration of their anticoagulation regimen [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/32-34\">",
"       32-34",
"      </a>",
"      ]. In such patients, oral anticoagulation with a",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?3/25/3479?source=see_link\">",
"       vitamin K",
"      </a>",
"      antagonist can be continued at or below the low end of the therapeutic range (eg, INR 1.7 to 2.3). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?2/19/2362?source=see_link&amp;anchor=H17#H17\">",
"       \"Cataract in adults\", section on 'Antithrombotic agents'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/44/7881?source=see_link&amp;anchor=H15#H15\">",
"       \"Anticoagulant, antiplatelet, and fibrinolytic (thrombolytic) therapy in patients at high risk for ocular hemorrhage\", section on 'Ophthalmic surgery'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       High bleeding risk procedures",
"      </strong>",
"      &mdash; More complex or high risk surgical procedures (eg, open-heart surgery, abdominal vascular surgery, intracranial or spinal surgery, major cancer surgery, urologic procedures) require discontinuation of oral anticoagulation, followed by temporary perioperative coverage with unfractionated",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      or LMW heparin in those patients who are at high risk of thromboembolism [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/35\">",
"       35",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Perioperative interruption and resumption of anticoagulation'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7437402\">",
"    <span class=\"h3\">",
"     Gastroenterologic procedures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Management of anticoagulation in patients undergoing gastroenterologic procedures (eg, endoscopy with or without mucosal biopsy), as with any other surgery or procedure, is anchored on the estimated risk for bleeding associated with the procedure and the estimated thromboembolic risk if the patient temporarily stops anticoagulation (",
"    <a class=\"graphic graphic_table graphicRef52596 \" href=\"mobipreview.htm?42/14/43243\">",
"     table 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef50700 \" href=\"mobipreview.htm?43/43/44731\">",
"     table 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef77634 \" href=\"mobipreview.htm?40/0/40971\">",
"     table 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/36\">",
"     36",
"    </a>",
"    ]. This subject is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/33/21014?source=see_link&amp;anchor=H5#H5\">",
"     \"Management of anticoagulants in patients undergoing endoscopic procedures\", section on 'Elective procedures in anticoagulated patients'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Dental or excisional cutaneous procedures",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients undergoing dental extraction,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    anticoagulation is associated with a minimal risk of serious bleeding if the INR is within the therapeutic range just prior to the contemplated surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/37-42\">",
"     37-42",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/58/14248?source=see_link\">",
"     Tranexamic acid",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?29/38/30311?source=see_link\">",
"     aminocaproic acid",
"    </a>",
"    mouthwash, if available (eg, 4.8 to 5 percent aqueous solutions used four times per day for at least two days), can be used in anticoagulated patients to limit gingival bleeding after dental procedures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/12,42-46\">",
"     12,42-46",
"    </a>",
"    ]. The use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    , NSAIDS, or Cox-2 selective inhibitors for analgesia should be avoided.",
"   </p>",
"   <p>",
"    There are documented cases of rare but serious embolic events when",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    has been withdrawn prior to dental procedures. In a literature review of 542 documented cases in 493 patients in whom continuous anticoagulation was withdrawn for a dental procedure (without",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    bridging), there were five serious embolic complications (0.9 percent of cases) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Anticoagulation is generally safe in patients undergoing minor skin procedures (eg, skin cancer removal) if the INR is maintained within the therapeutic range [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/29,47-49\">",
"     29,47-49",
"    </a>",
"    ]. As with dental procedures, cessation of prophylactic anticoagulation (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    or antiplatelet therapy) has been associated with a small risk of thromboembolic events [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/47-49\">",
"     47-49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6637109\">",
"    <span class=\"h3\">",
"     Invasive cardiac procedures",
"    </span>",
"    &nbsp;&mdash;&nbsp;A prospective, observational registry (BNK Online bRiDging REgistRy, BORDER) of patients treated by cardiologists evaluated current practice of perioperative management of oral anticoagulant (OAC) therapy in a large outpatient cohort of patients undergoing 1000 invasive procedures (eg, cardiac catheterization, pacemaker implantation, surgery) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ninety-four percent of these patients received bridging therapy (LMW",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      in all but two cases) during interruption of OAC. Of those receiving this agent, LMW heparin was given in prophylactic, half-therapeutic, or full therapeutic doses in 2, 78, and 20 percent, respectively.",
"     </li>",
"     <li>",
"      Four thromboembolic complications were observed during 30 days of follow-up (0.4 percent).",
"     </li>",
"     <li>",
"      One major (0.1 percent) and 35 clinically relevant bleeding episodes (3.5 percent) occurred. Independent predictors of bleeding included a history of mechanical heart valve replacement and the HAS-BLED bleeding risk score (",
"      <a class=\"graphic graphic_table graphicRef75259 \" href=\"mobipreview.htm?38/14/39148\">",
"       table 6",
"      </a>",
"      ). A HAS-BLED risk score &ge;3 was the most predictive variable for hemorrhage (HR 12).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Use of heparin",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of bleeding after the use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    is variable. A two- or three-day course of intravenous heparin before surgery, with cessation four hours before the procedure, is unlikely to result in pre- or intra-operative bleeding. In the non-perioperative setting, the risk of bleeding associated with intravenous heparin therapy is less than 5 percent in patients with acute venous thromboembolism. However, in patients with deep vein thrombosis who are judged to be at high risk for bleeding, the incidence of",
"    <strong>",
"    </strong>",
"    major bleeding is approximately 11 percent during the first five days of intravenous heparin therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/31,51\">",
"     31,51",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     PERIOPERATIVE INTERRUPTION AND RESUMPTION OF ANTICOAGULATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Interruption of warfarin",
"    </span>",
"    &nbsp;&mdash;&nbsp;After stopping",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    , it usually takes two to three days for the INR to fall to below 2.0, and four to six days for the INR to normalize. One study prospectively evaluated 22 patients with a baseline INR of 2.6 in whom it was deemed safe to discontinue warfarin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/52\">",
"     52",
"    </a>",
"    ]. In these patients the mean INR was 1.6 and 1.2 at 2.7 and 4.7 days after discontinuation of warfarin, respectively. The time required for the INR to normalize after stopping warfarin may be longer in patients receiving higher-intensity anticoagulation (INR: 2.5 to 3.5), and in elderly patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Once the INR is 1.5 or below, surgery can be performed with relative safety in most cases, although a normalized INR is typically required in patients undergoing surgery associated with a high bleeding risk (eg, intracranial, spinal, urologic) or if spinal anesthesia is to be used. Following surgery and after",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    is restarted, it takes approximately five days for the INR to rise above 2.0. It is therefore estimated that if warfarin is withheld for five days before surgery and is restarted as soon as possible afterwards, patients would have a subtherapeutic INR for approximately four days before surgery and four days after surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A slight elevation of the INR to approximately 1.5 around the time of surgery, in theory, should provide partial protection against venous thromboembolism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/54,55\">",
"     54,55",
"    </a>",
"    ]. However, there is no evidence that such low-intensity perioperative anticoagulation, for example that which is used for prevention of postoperative DVT, effectively prevents arterial thromboembolism. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/36/6730?source=see_link&amp;anchor=H13#H13\">",
"     \"Drug-induced thrombosis and vascular disease in patients with malignancy\", section on 'Prophylactic anticoagulation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If the patient has been adequately anticoagulated for some time prior to stopping",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    , it is generally assumed that almost any preexisting thrombus would have either resolved or be endothelialized, thereby minimizing the risk of embolism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/27\">",
"     27",
"    </a>",
"    ]. Among patients with nonvalvular atrial fibrillation, for example, over 85 percent of thrombi resolve after four weeks of warfarin therapy as determined by transesophageal echocardiography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nevertheless, although the INR itself may not be a good guide to a reduced risk of thromboembolism, some patients have a significant reduction in their usual anticoagulant intensity during surgery and a minor increase in the risk of thromboembolism is probably unavoidable [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/52\">",
"     52",
"    </a>",
"    ]. Among patients with atrial fibrillation, chronic low dose",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    is much less effective than adjusted dose warfarin in preventing embolic events (",
"    <a class=\"graphic graphic_figure graphicRef62833 \" href=\"mobipreview.htm?17/40/18062\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef72790 \" href=\"mobipreview.htm?36/37/37469\">",
"     figure 2",
"    </a>",
"    ), demonstrating that such lesser degrees of anticoagulation do not provide optimal protection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/57\">",
"     57",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/32/42506?source=see_link\">",
"     \"Antithrombotic therapy to prevent embolization in atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Reversing the vitamin K antagonists",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reversing the anticoagulant activity of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    and other",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/25/3479?source=see_link\">",
"     vitamin K",
"    </a>",
"    antagonists depends upon the amount of time available before the surgical or invasive procedure, the elimination half-life of the vitamin K antagonist (ie, 36 to 42 hours for warfarin; 8 to 12 hours for",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/63/11256?source=see_link\">",
"     acenocoumarol",
"    </a>",
"    ; and 96 to 140 hours for phenprocoumon), as well as the estimated bleeding and thrombotic risk. The following guidelines are most appropriate (",
"    <a class=\"graphic graphic_algorithm graphicRef86310 \" href=\"mobipreview.htm?0/1/24\">",
"     algorithm 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/12\">",
"     12",
"    </a>",
"    ]:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Fully elective surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with an INR between 2.0 and 3.0 who are undergoing elective surgery that requires",
"    <strong>",
"     temporary",
"    </strong>",
"    cessation of anticoagulation,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    should be withheld for approximately five days to allow the INR to be normal (INR &lt;1.3) or near normal (INR 1.3 to 1.4) before surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/20,52,58\">",
"     20,52,58",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Semi-urgent surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;If more rapid reversal of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    anticoagulation is required (eg, over one to two days), warfarin should be withheld and a small dose of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/25/3479?source=see_link\">",
"     vitamin K",
"    </a>",
"    administered, either intravenously (eg, 1.0 to 2.5 mg) or orally (eg, 2.5 to 5.0 mg). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/8/30857?source=see_link&amp;anchor=H18#H18\">",
"     \"Correcting excess anticoagulation after warfarin\", section on 'Surgery/invasive procedure'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Urgent surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;If urgent reversal of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    anticoagulation is required (eg, less than one day), warfarin should be withheld and a higher dose (eg, 2.5 to 5.0 mg) of intravenous",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/25/3479?source=see_link\">",
"     vitamin K",
"    </a>",
"    administered. If more immediate correction is required (eg, minutes to hours), this can be achieved via the use of those prothrombin complex concentrates that contain adequate amounts of factor VII (eg, 4-factor concentrates) or fresh frozen plasma, in addition to vitamin K [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/59\">",
"     59",
"    </a>",
"    ]. Details concerning how such rapid reversal of the warfarin effect can be accomplished are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/8/30857?source=see_link&amp;anchor=H15#H15\">",
"     \"Correcting excess anticoagulation after warfarin\", section on 'Significant or life-threatening bleeding'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2441410\">",
"    <span class=\"h2\">",
"     Resumption of warfarin",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     Warfarin",
"    </a>",
"    therapy should be restarted 12 to 24 hours after surgery, typically the evening after surgery, provided that surgical hemostasis has been achieved [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/12\">",
"     12",
"    </a>",
"    ]. If warfarin is resumed alone, without",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    bridging, a full anticoagulant effect will take four to six days to occur, thereby allowing a more gradual re-anticoagulation, which may be appealing in patients undergoing surgery associated with substantial expected blood loss.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4559905\">",
"    <span class=\"h2\">",
"     Dabigatran",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/39/8825?source=see_link\">",
"     Dabigatran",
"    </a>",
"    is an oral direct thrombin inhibitor that is currently approved for use as stroke prevention in atrial fibrillation and, in some countries, for DVT prevention after hip and knee replacement surgery. It has a time to peak anticoagulant activity of two to three hours after ingestion and an elimination half-life of 12 to 14 hours in patients with normal renal function and approximately 28 hours in those with severe renal impairment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/60\">",
"     60",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/59/37818?source=see_link&amp;anchor=H14#H14\">",
"     \"Anticoagulants other than heparin and warfarin\", section on 'Dabigatran'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These pharmacokinetic parameters affect the timing of cessation and resumption of treatment with this agent, as follows [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/2,61,62\">",
"     2,61,62",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Cessation prior to invasive or surgical procedures",
"      </strong>",
"      &mdash; For those with a creatinine clearance &ge;50",
"      <span class=\"nowrap\">",
"       mL/minute,",
"      </span>",
"      discontinue",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/39/8825?source=see_link\">",
"       dabigatran",
"      </a>",
"      one to two days before the procedure. For those with a creatinine clearance &lt;50",
"      <span class=\"nowrap\">",
"       mL/minute,",
"      </span>",
"      discontinue this agent three to five days before the procedure. Longer periods than the above should be considered for those undergoing major surgery, spinal puncture, placement of a spinal or epidural catheter or port, in whom complete hemostasis may be required. It has been recommended that a normal or near-normal aPTT or thrombin clotting time be documented to ensure that dabigatran has been adequately cleared from the circulation prior to surgery [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/34,61,63\">",
"       34,61,63",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Resumption following procedure",
"      </strong>",
"      &mdash;",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/39/8825?source=see_link\">",
"       Dabigatran",
"      </a>",
"      should be resumed postoperatively when hemostasis has been achieved. Since dabigatran has a rapid onset of action, with peak effects occurring two to three hours after intake, caution should be used when resuming dabigatran, especially in patients who have had major surgery or other procedures associated with a high bleeding risk. In some respects, resuming dabigatran at its typical treatment dose of 150 mg twice daily is similar to resuming LMW",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      bridging and, in both instances, caution should be exercised after surgery. Thus, in patients having high bleeding risk surgery or procedures, it is sensible to delay resumption of dabigatran for two to three days after such procedures and, if needed, to administer a lower dabigatran dose for the initial two to three postoperative days (eg, 110 mg once daily) or use a low-dose LMW heparin for this period.",
"     </li>",
"     <li>",
"      <strong>",
"       Need for bridging anticoagulation",
"      </strong>",
"      &mdash; In general, the rapid offset and onset of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/39/8825?source=see_link\">",
"       dabigatran",
"      </a>",
"      activity obviates the need for bridging anticoagulation with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      or LMW heparin. In one study of dabigatran-treated patients who required an elective surgery or procedure and who, in most cases, did not receive bridging anticoagulation, the incidence of postoperative bleeding was similar to that in",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      -treated patients who needed surgery and the incidence of thromboembolic events was low (eg, &lt;1 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Resumption following use of",
"      </strong>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      <strong>",
"       or LMW heparin &mdash;",
"      </strong>",
"      If patients are receiving heparin or LMW heparin after surgery and there is an intent to resume",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/39/8825?source=see_link\">",
"       dabigatran",
"      </a>",
"      , it should be done &le;2 hours prior to the time of the next scheduled dose of the LMW heparin or at the time of discontinuation of intravenous heparin.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4559912\">",
"    <span class=\"h2\">",
"     Rivaroxaban and apixaban",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/16/5384?source=see_link\">",
"     Rivaroxaban",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/62/39911?source=see_link\">",
"     apixaban",
"    </a>",
"    are oral direct factor Xa inhibitors. As with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/39/8825?source=see_link\">",
"     dabigatran",
"    </a>",
"    , they have a rapid onset of action (peak activity after two to three hours) and a similar elimination half-life of 9 to 12 hours, but, unlike dabigatran, are less dependent on renal clearance (eg, 25 to 33 percent instead of 80 percent). In countries where these drugs are approved for long-term use and patients may require perioperative management, the same approach should be used as with dabigatran-treated patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4560168\">",
"    <span class=\"h2\">",
"     Risk of rebound hypercoagulability",
"    </span>",
"    &nbsp;&mdash;&nbsp;As mentioned above, rebound hypercoagulability may occur following the abrupt cessation of anticoagulation. Accordingly, alternative preoperative",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    postoperative prophylaxis against thromboembolism with unfractionated",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    (UFH) or LMW heparin should be considered in high risk patients (eg, prosthetic valve in the mitral position, venous thromboembolism within the previous four weeks, or active malignancy) for the period during which the INR is less than 2.0 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/64-66\">",
"     64-66",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical effects of rebound hypercoagulability after stopping",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    are unclear. There is some biochemical evidence for this phenomenon, as well as the recommendation by some investigators that warfarin should be withdrawn gradually [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/67-69\">",
"     67-69",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study of 19 patients, for example, thrombin and fibrin formation increased after abrupt cessation of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      therapy, but no patient had a thromboembolic event [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/69\">",
"       69",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In another report, however, 32 patients were randomly assigned to receive abrupt or gradual withdrawal of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/68\">",
"       68",
"      </a>",
"      ]. Very high levels of thrombin activation were seen in a few patients treated with abrupt withdrawal, two of whom developed a thrombotic event (one recurrent deep vein thrombosis and one thrombosis in a varicose vein).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Surgery itself increases the risk of thromboembolism as documented by changes in hemostatic markers, which are also part of the acute phase response and wound healing process [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/70\">",
"     70",
"    </a>",
"    ]. High levels of hemostatic markers, such as fibrin D-dimer, an index of intravascular thrombogenesis and fibrin turnover, are predictive of postoperative thrombosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/71,72\">",
"     71,72",
"    </a>",
"    ]. Although there is evidence that surgery increases the risk of venous thromboembolism, there is no evidence that surgery itself increases the risk of arterial thromboembolism, apart from risks associated with particular procedures, such as carotid surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2441429\">",
"    <span class=\"h1\">",
"     BRIDGING ANTICOAGULATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bridging anticoagulation can be defined as the administration of a short-acting anticoagulant, typically a LMW",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    , during the perioperative interruption of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    . The intent of bridging is to minimize the time patients are not being anticoagulated, thereby minimizing patients&rsquo; risk for perioperative thromboembolism. The therapeutic benefit of bridging anticoagulation is not fully established, as completed randomized trials comparing bridging and no bridging strategies during warfarin interruption are lacking, although such studies are in progress. Because of the lack of evidence-based information indicating whether bridging anticoagulation is or is not warranted, there is considerable variation in the use of this modality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/74-76\">",
"     74-76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Given this uncertainty, the decision about such bridging anticoagulation should be based upon individual patient and surgery-related factors. In general, such bridging anticoagulation should be considered in the following groups of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Prior stroke or systemic embolic event",
"     </li>",
"     <li>",
"      Active coronary or peripheral vascular disease",
"     </li>",
"     <li>",
"      Previous thromboembolism during interruption of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      therapy",
"     </li>",
"     <li>",
"      Major cardiac or vascular surgery",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Of the available non-randomized studies assessing perioperative anticoagulant management during",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    interruption [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/35,64,77-85\">",
"     35,64,77-85",
"    </a>",
"    ], the following prospective observational cohort studies are instructive concerning the thrombotic and hemorrhagic risks attendant to the use or non-use of bridging anticoagulation in this setting.",
"   </p>",
"   <p>",
"    Two uncontrolled observational studies assessed patients, most of whom did not receive bridging anticoagulation, who had",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    interruption. The first study involved a cohort of 1024 patients, most of whom had atrial fibrillation, whose warfarin therapy was temporarily withheld on 1293 different occasions for an outpatient invasive procedure (colonoscopy; oral, dental, or ophthalmic surgery; epidural injection; prostate or breast biopsy; dermatologic procedure). The following observations were made [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/79\">",
"     79",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The duration of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      therapy interruption was variable, although &gt;80 percent had warfarin therapy withheld for &le;5 days. Bridging therapy with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      or LMW heparin was given in only 8.3 percent of the procedures.",
"     </li>",
"     <li>",
"      Six patients (0.6 percent; 95% CI 0.2-1.3) experienced major bleeding and an additional 17 patients (1.7 percent; 95% CI 1.0-2.6) experienced a clinically significant, nonmajor bleeding episode. Four of the six patients with major bleeding and 10 of the 17 patients with non-major clinically significant bleeding had received periprocedural bridging therapy, for an overall bleeding rate in bridged patients of 13 percent.",
"     </li>",
"     <li>",
"      Postprocedural thromboembolism within 30 days occurred in seven patients (0.7 percent; 95% CI 0.3-1.4). None of the seven patients had received periprocedural bridging therapy; two of these patients would have been considered to be at high risk for thromboembolism (ie, recent venous thromboembolism or active malignancy).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The authors concluded that perioperative anticoagulation may be unnecessary for a significant proportion of low to intermediate risk outpatients who have undergone long-term anticoagulation, whose",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    therapy must be interrupted for a brief period (ie, &le;5 days), and that bridging therapy with unfractionated or LMW",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    may result in significant and potentially avoidable perioperative hemorrhage.",
"   </p>",
"   <p>",
"    Similar conclusions were reached in a second study involving a cohort of 345 individuals with atrial fibrillation undergoing an invasive procedure.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     Warfarin",
"    </a>",
"    therapy was temporarily withheld on 342 different occasions for a mean period of 6.6 days. The decision to use bridging anticoagulation with",
"    <strong>",
"     therapeutic",
"    </strong>",
"    doses of either intravenous unfractionated",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    or LMW heparin was individualized, but was generally given only to those patients deemed to be at high risk for stroke. The following observations were made [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/35\">",
"     35",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The three-month cumulative incidence of thromboembolism was 1.1 percent and did not differ significantly between those who did or did not receive bridging therapy.",
"     </li>",
"     <li>",
"      Of interest, despite not receiving bridging therapy after brief",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      cessation, none of the 43 patients with a prior thromboembolic event, and none of the 51 patients with a CHADS2 score &ge;3 developed postoperative thromboembolism during the three-month follow-up period.",
"     </li>",
"     <li>",
"      The three-month cumulative incidence of major bleeding was 2.7 percent for those receiving bridging therapy. Of the 10 episodes of major bleeding, six occurred in five patients given bridging therapy with LMW",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      .",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The authors indicated that they currently utilize bridging with LMW",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    only for those patients at highest thrombotic risk (eg, prior stroke, CHADS2 score &ge;4) while taking into account the procedure-associated risk of bleeding. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Type of surgery or procedure'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    A meta-analysis that assessed the use of bridging anticoagulation in",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    -treated patients who had elective surgery found that in patients who received therapeutic-dose LMW",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    bridging there was no significant difference in thromboembolism when compared with patients who did not receive bridging (0.9 versus 0.6 percent, odds ratio = 0.80; 95% CI: 0.42-1.54) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/86\">",
"     86",
"    </a>",
"    ]. However, the use of bridging anticoagulation was associated with a significant increase in overall bleeding (odds ratio 5.40; 95% CI 3.00-9.74).",
"   </p>",
"   <p>",
"    These findings from nonrandomized trials (ie, no decrease in thromboembolic events coupled with an increase in bleeding events when bridging anticoagulation is employed) should be interpreted with caution because of the potential for bias among patients who may have preferentially received (or not received) bridging anticoagulation. More definitive conclusions about the therapeutic benefits of bridging will be based on the results of ongoing randomized trials.",
"   </p>",
"   <p>",
"    The following two nonrandomized studies employed",
"    <strong>",
"     sub-therapeutic",
"    </strong>",
"    doses of LMW",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    as bridging therapy.",
"   </p>",
"   <p>",
"    In the first study, subtherapeutic doses of LMW",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    (eg, 3800 international units of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/41/27286?source=see_link\">",
"     nadroparin",
"    </a>",
"    or 4000 international units [40 mg] of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/24/36233?source=see_link\">",
"     enoxaparin",
"    </a>",
"    once daily the night before the procedure for those at low risk of thrombosis, or 3800 or 4000 international units of these agents twice daily for those at high thrombotic risk) were employed in 103 patients undergoing surgery and in 225 non-major invasive procedures. Results included [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/80\">",
"     80",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The overall incidence of a thromboembolic event was 1.8 percent and was not significantly different between those in the low risk (0.54 percent) or high risk (3.4 percent) groups.",
"     </li>",
"     <li>",
"      The overall incidence of major bleeding was 2.1 percent and was not significantly different between those in the low risk (0.5 percent) or high risk (4.1 percent) groups. All of the major bleeding events occurred in those undergoing major surgery.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The second study was a report from a prospective registry of 198 consecutive patients receiving oral anticoagulation with phenprocoumon and a planned surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/87\">",
"     87",
"    </a>",
"    ]. The majority of patients (88 percent) were judged to be at intermediate thromboembolic risk. Phenprocoumon was stopped seven days before surgery. All patients received enoxaparin in a half-therapeutic dose (1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day) starting when the INR was &lt;2.0 and continuing until the day before surgery. Enoxaparin was restarted after the procedure at the same total daily dose (in two divided doses) and phenprocoumon was resumed within the first 14 postoperative days, depending upon the bleeding risk. Only one patient (0.5 percent) developed a postoperative arterial thromboembolic event, and one patient (0.5 percent) required a second surgical intervention due to severe bleeding.",
"   </p>",
"   <p>",
"    Since bridging anticoagulation with subtherapeutic doses of LMW",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    was safe and effective in groups with low, intermediate, and high risk groups, this approach appears to be a reasonable compromise between the risks of bleeding and thrombosis posed by either lower or higher doses of bridging anticoagulation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Anticoagulant drugs and doses used for bridging anticoagulation",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Unfractionated heparin",
"    </span>",
"    &nbsp;&mdash;&nbsp;The biologic half-life of intravenous unfractionated",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    (UFH) is approximately 45 minutes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/12,88\">",
"     12,88",
"    </a>",
"    ]. Thus, most bridging anticoagulation studies have suggested that intravenous UFH should be stopped four to five hours before the planned surgery or procedure, a time interval that is approximately five elimination half-lives of UFH. If UFH is used for bridging, it is administered by an infusion to attain an activated partial thromboplastin time (aPTT) that is 1.5 to 2 times the control aPTT, in a manner similar to that used to treat patients with acute venous thromboembolism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     LMW heparin",
"    </span>",
"    &nbsp;&mdash;&nbsp;The biologic half-life of subcutaneous LMW",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    is approximately three to five hours [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/12,88\">",
"     12,88",
"    </a>",
"    ]. Thus, most bridging anticoagulation guidelines have suggested that the last dose of subcutaneous LMW heparin should be given 24 hours before the planned surgery or procedure, a time interval that is approximately five elimination half-lives of LMW heparin. If LMW heparin is used for bridging, it can be given as a therapeutic-dose regimen, either twice-daily (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/24/36233?source=see_link\">",
"     enoxaparin",
"    </a>",
"    , 1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    twice daily) or once-daily (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/56/32648?source=see_link\">",
"     dalteparin",
"    </a>",
"    , 200 international",
"    <span class=\"nowrap\">",
"     units/kg",
"    </span>",
"    once daily). LMW heparin can also be given at a lower dose, referred to as an intermediate-dose regimen (eg, enoxaparin, 40 mg twice daily), which is higher than the dose typically administered for postoperative prevention of DVT (eg, enoxaparin, 40 mg once daily). There is no established dosing regimen, although therapeutic-dose regimens tend to be used more often in North America.",
"   </p>",
"   <p>",
"    However, because some studies have shown residual anticoagulant effect at 24 hours after stopping",
"    <strong>",
"     therapeutic-dose",
"    </strong>",
"    LMW",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/16,89\">",
"     16,89",
"    </a>",
"    ], the 2012 ACCP Guidelines recommend that on the day before surgery or the procedure, therapeutic-dose LMW heparin should be administered at one-half of the usual total daily dose [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Bridging with LMW",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    is typically commenced three days before a planned surgery or procedure, with the last preoperative dose given on the morning (or at least 24 hours) before surgery. If a twice-daily LMW heparin regimen is given, the evening dose the night before surgery is omitted, whereas if a once-daily regimen is given (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/56/32648?source=see_link\">",
"     dalteparin",
"    </a>",
"    200 international",
"    <span class=\"nowrap\">",
"     units/kg),",
"    </span>",
"    one-half of the total daily dose is given in the morning of the day before surgery. This dosing schedule ensures that no significant residual anticoagulant will be present at the time of surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/89,90\">",
"     89,90",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Postoperative resumption of bridging anticoagulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The onset of anticoagulation after both UFH and LMW",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    is similar, at approximately one hour after administration, with peak anticoagulant activity at approximately three to five hours. Thus, if post-operative or post-procedural anticoagulation is contemplated, these agents should not be employed too early following the operation in order to insure that hemostasis has been secured at the operative or procedural site [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/91\">",
"     91",
"    </a>",
"    ]. This requires both a pre-procedural estimate of the anticipated risk of bleeding as well as a post-procedural determination of the adequacy of hemostasis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, for most minor procedures associated with a low bleeding risk, therapy with LMW",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    or UFH can usually be resumed at 24 hours post-procedure, whereas for those undergoing major surgery or those with a high bleeding risk procedure, such treatment should be delayed for 48 to 72 hours after hemostasis has been secured [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2441949\">",
"    <span class=\"h3\">",
"     Importance of assessing postoperative wound hemostasis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Irrespective of the bridging anticoagulation regimen used, it is important to assess patients for postoperative hemostasis, which consists of a subjective assessment of wound drainage, bleeding into bandages and, where appropriate, hemoglobin levels. Ideally, bridging anticoagulation should be resumed when the wound bed is considered to be dry, that is when there is no ongoing wound bleeding. This determination will vary depending on the surgery type and individual patient considerations, and may be difficult for surgery (eg, cardiac, intracranial) where ongoing bleeding is not readily apparent. Nonetheless, attention to postoperative hemostasis is clinically important since too early resumption of bridging anticoagulation, especially within 24 hours after surgery, is associated with a two- to fourfold increased risk for major bleeding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/74,86,92\">",
"     74,86,92",
"    </a>",
"    ]. If bleeding occurs, this will prolong the interruption of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    , which in turn will place patients at higher risk for thromboembolism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     SPECIFIC SCENARIOS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of clinical situations require special consideration. These are discussed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Venous thromboembolism",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of anticoagulation in patients with previous",
"    <strong>",
"     venous",
"    </strong>",
"    thromboembolic disease depends upon the temporal relationship to surgery or an invasive procedure (",
"    <a class=\"graphic graphic_table graphicRef81389 \" href=\"mobipreview.htm?2/17/2332\">",
"     table 7",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       First month",
"      </strong>",
"      &mdash; Within the first month after an acute episode of venous thromboembolism (VTE), the incidence of recurrence without anticoagulation is approximately 1 percent per day. While postoperative intravenous",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      doubles the rate of bleeding, there is a net reduction in serious morbidity in such patients, since the risk of postoperative recurrent VTE is high. Thus, heparin therapy is recommended both before and after surgery [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Two to three months",
"      </strong>",
"      &mdash; By two to three months after an acute episode of VTE, the risk of recurrence is significantly reduced so that preoperative",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      therapy is probably not justified unless there are other risk factors for thromboembolism (eg, prolonged hospitalization and confinement to bed) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/20\">",
"       20",
"      </a>",
"      ]. However, because of an expected increase in the risk of VTE after surgery, these patients should be treated",
"      <strong>",
"       postoperatively",
"      </strong>",
"      with heparin.",
"     </li>",
"     <li>",
"      <strong>",
"       More than three months",
"      </strong>",
"      &mdash; At more than three months after an episode of VTE, preoperative anticoagulation is not needed and postoperative intravenous",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      is also probably not necessary. In this setting, the bleeding associated with postoperative intravenous heparin offsets any beneficial effect from the prevention of major thromboembolic events [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/20\">",
"       20",
"      </a>",
"      ]. Prophylactic measures that reduce the thrombotic risk, such as subcutaneous LMW heparin or compression stockings, are associated with a lower risk of bleeding than intravenous heparin and are safer alternatives [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/4,93\">",
"       4,93",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/4/43082?source=see_link&amp;anchor=H25#H25\">",
"       \"Treatment of lower extremity deep vein thrombosis\", section on 'Length of treatment'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Arterial thromboembolism including atrial fibrillation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The approach is somewhat different in patients at risk for",
"    <strong>",
"     arterial",
"    </strong>",
"    thromboembolism, because the thromboembolic risk is similar both before and after surgery. Furthermore, the risk of bleeding is much higher in such patients after surgery if",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    is continued or the INR is maintained at around 2.0. Thus, preoperative treatment with intravenous heparin is advised if oral anticoagulation is stopped. Postoperative therapy with intravenous heparin is probably useful for patients undergoing minor surgery where the risk of bleeding is low. In contrast, the net benefit of using intravenous heparin in reducing long-term disability after major surgery is small because of the high risk of serious bleeding.",
"   </p>",
"   <p>",
"    If the risk of acute arterial thromboembolism is low, as in patients with nonvalvular atrial fibrillation receiving",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    for thromboprophylaxis, postoperative intravenous",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    therapy probably increases, rather than decreases, serious morbidity. Restarting warfarin on the second postoperative day and the use of low risk regimens, such as subcutaneous heparin, if warfarin was discontinued preoperatively, are preferable to minimize the risk of bleeding.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Unfractionated",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      should be stopped four hours before surgery with the expectation that the anticoagulation effect will have worn off at the time of surgery [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/94\">",
"       94",
"      </a>",
"      ]. If LMW heparin has been used, it should be stopped, preferably 24 hours before surgery [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/90\">",
"       90",
"      </a>",
"      ], with the same expectation.",
"      <br/>",
"      <br/>",
"      These recommendations may not apply to patients undergoing minor procedures such as skin biopsy or dental extractions [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/38,44,47\">",
"       38,44,47",
"      </a>",
"      ]. However, it is important to confirm that the INR does not exceed the therapeutic range. Although uninterrupted anticoagulation may be continued in most patients, we and many other clinicians withhold",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      for two to four days prior to the procedure, and reinstitute therapy after the procedure [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/94\">",
"       94",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Elective surgery should be avoided in the first month after arterial thromboembolism. If surgery is essential, preoperative and postoperative",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      therapy is recommended as described above for VTE, but only if the risk of postoperative bleeding is low.",
"     </li>",
"     <li>",
"      In patients receiving",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      as prophylaxis against arterial embolization, such as low risk patients with a prosthetic heart valve or nonvalvular atrial fibrillation, the risk of thromboembolism is not high enough to warrant routine preoperative or postoperative therapy with intravenous",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      , especially in view of the bleeding risk [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/10,95\">",
"       10,95",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If the surgical intervention itself is associated with a high risk of postoperative VTE, the brief use of subcutaneous low-dose",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    or LMW heparin in doses used for prophylaxis against VTE has been suggested [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/94\">",
"     94",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/32/42506?source=see_link&amp;anchor=H13#H13\">",
"     \"Antithrombotic therapy to prevent embolization in atrial fibrillation\", section on 'Temporary cessation of anticoagulation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/52/41802?source=see_link&amp;anchor=H3#H3\">",
"     \"Prevention of venous thromboembolic disease in surgical patients\", section on 'Risk factors for VTE'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The approach is different in high risk patients with atrial fibrillation (eg, prior thromboembolism, rheumatic heart disease, left ventricular dysfunction) or prosthetic heart valves (eg, those with older generation mechanical valves or atrial fibrillation), in whom there is a delicate balance between the risks of bleeding and thromboembolism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/10,95\">",
"     10,95",
"    </a>",
"    ]. In this setting, a number of options exist and the appropriate treatment of such patients is unclear and controversial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/94,95\">",
"     94,95",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, it is our preference in this setting to administer intravenous",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    until five to six hours before the procedure, to be restarted as soon as surgical hemostasis has been assured [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/94\">",
"     94",
"    </a>",
"    ]; the dose is adjusted to achieve an activated PTT that is 2.0 times control.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     Warfarin",
"    </a>",
"    is then reinstituted prior to discharge from the hospital; the INR should be in the therapeutic range for at least 48 hours before heparin is discontinued.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Pacemaker insertion",
"    </span>",
"    &nbsp;&mdash;&nbsp;A substantial number of patients who require the insertion of a permanent pacemaker are receiving oral anticoagulation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    antiplatelet therapy for various reasons. Elective pacemaker insertion is often performed in the outpatient setting and the issue of anticoagulation is an important concern [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/96-98\">",
"     96-98",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One study compared the outcome of 37 patients undergoing outpatient pacemaker implantation while continuing on",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      therapy with 113 patients not receiving warfarin; there was no difference in the incidence of any complications, including those related to the wound [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/97\">",
"       97",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A meta-analysis of six studies, only one of which was a randomized, prospective trial, compared continuation of oral anticoagulation (OAC) versus",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      bridging among patients at high risk of thrombosis undergoing implantation of cardiac rhythm devices [",
"      <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/98\">",
"       98",
"      </a>",
"      ]. There was a significant reduction of pocket hematoma (OR 0.29; 95% CI 0.17-0.49) and hematoma",
"      <span class=\"nowrap\">",
"       drainage/revision",
"      </span>",
"      (OR 0.15; 95% CI 0.04-0.54) in the OAC continuation group versus the heparin bridging group, with no difference in thromboembolic events (OR 0.48; 95% CI 0.07-3.54).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Randomized controlled studies are in progress to determine optimal management of anticoagulation in this setting. Limited available studies suggest that",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    bridging is not necessary, with a preference for continuation of oral anticoagulation during the procedure at an INR in the low end of the therapeutic range (ie, 2.0 to 2.5).",
"   </p>",
"   <p>",
"    The use of a cut-down technique, rather than a subclavian puncture, to gain venous access is preferred, and a catheter electrode with a small cross sectional area and small introducer should be used to reduce the probability of venous damage; pocket hemostasis must be meticulous [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/97\">",
"     97",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Mechanical prosthetic heart valves",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recommendations regarding the perioperative management of anticoagulation in patients with prosthetic heart valves are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/11/18618?source=see_link&amp;anchor=H19#H19\">",
"     \"Antithrombotic therapy in patients with prosthetic heart valves\", section on 'Interruption of warfarin for surgical procedures'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Percutaneous coronary intervention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Management of anticoagulation as well as antiplatelet therapy in patients undergoing percutaneous coronary intervention are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/8/27786?source=see_link&amp;anchor=H32#H32\">",
"     \"Antithrombotic therapy for percutaneous coronary intervention: General use\", section on 'Patients who require warfarin'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25297303\">",
"    <span class=\"h2\">",
"     Insertion and removal of a catheter for neuraxial anesthesia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of bleeding from an epidural site exists both at the time of insertion and removal of an indwelling epidural catheter. Evidence-based guidelines from the American Society of Regional Anesthesia suggest the following when low molecular weight (LMW)",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    is used for anticoagulation in the following two scenarios:",
"   </p>",
"   <p>",
"    When a",
"    <strong>",
"     low-dose",
"    </strong>",
"    LMW",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    regimen is administered (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/24/36233?source=see_link\">",
"     enoxaparin",
"    </a>",
"    40 mg once daily or 30 mg twice daily) perioperatively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/50/35626/abstract/99,100\">",
"     99,100",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Wait at least 24 hours after the last dose of LMW",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      is administered before a",
"      <span class=\"nowrap\">",
"       spinal/epidural",
"      </span>",
"      catheter is placed.",
"     </li>",
"     <li>",
"      Wait at least 6 to 8 hours after catheter removal before resuming treatment with LMW",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      , and when there is adequate surgical site hemostasis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For patients who are receiving",
"    <strong>",
"     higher (therapeutic)",
"    </strong>",
"    <strong>",
"     <em>",
"     </em>",
"    </strong>",
"    <strong>",
"     doses",
"    </strong>",
"    of LMW",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    as bridging anticoagulation (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/24/36233?source=see_link\">",
"     enoxaparin",
"    </a>",
"    , 1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    twice daily), the following guidelines are suggested:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Before surgery, wait at least 24 hours after the last dose of LMW",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      is administered before a",
"      <span class=\"nowrap\">",
"       spinal/epidural",
"      </span>",
"      catheter is placed.",
"     </li>",
"     <li>",
"      After surgery, wait at least 24 hours after catheter removal before resuming therapeutic-dose LMW",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      (applies to once daily and twice daily LMW heparin dosing), and when there is adequate surgical site hemostasis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?14/11/14515?source=see_link\">",
"       \"Patient information: Latest medicines to prevent blood clots (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of thromboembolism in patients who discontinue anticoagulation before an invasive procedure must be weighed against the risk of bleeding if these agents are continued or bridging anticoagulation is employed. Accordingly, the thrombotic and bleeding risks of the patient should be carefully assessed before an informed decision on modifying anticoagulation therapy can be made. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Problem overview'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9732623\">",
"    <span class=\"h2\">",
"     Estimating thrombotic and bleeding risks",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Estimated",
"      <strong>",
"       perioperative thromboembolic risks",
"      </strong>",
"      for patients anticoagulated for various indications (ie, mechanical heart valves, atrial fibrillation, venous thromboembolism) are shown in the table (",
"      <a class=\"graphic graphic_table graphicRef86930 \" href=\"mobipreview.htm?34/24/35212\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Thrombotic risk if anticoagulation is stopped'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Estimated",
"      <strong>",
"       procedural bleeding risks",
"      </strong>",
"      for patients undergoing various surgical procedures are shown in the table (",
"      <a class=\"graphic graphic_table graphicRef86929 \" href=\"mobipreview.htm?39/2/39980\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Bleeding risk if anticoagulation is continued'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9732643\">",
"    <span class=\"h2\">",
"     Use or nonuse of bridging anticoagulation",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Elective surgery should be avoided, if at all possible, in the first month after an acute episode of venous thromboembolism as well as in the first month after arterial thromboembolism. Such patients are at extremely high risk of thromboembolism if anticoagulation is discontinued prior to surgery. If surgery is essential, we suggest the use of bridging anticoagulation rather than perioperative discontinuation of anticoagulation (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Arterial thromboembolism including atrial fibrillation'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H19\">",
"       'Overview'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If acute venous thromboembolism has occurred within the past two to four weeks prior to the planned",
"      <span class=\"nowrap\">",
"       surgery/procedure",
"      </span>",
"      <strong>",
"       and",
"      </strong>",
"      the risk of bleeding precludes perioperative continuation of oral anticoagulant therapy, we suggest a three-step approach: 1) interrupt oral anticoagulation and administer therapeutic-dose LMW",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      bridging (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/24/36233?source=see_link\">",
"       enoxaparin",
"      </a>",
"      1",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      subcutaneously twice daily) before surgery; 2) temporary use of a vena caval filter that can be removed after surgery; 3) resumption of heparin bridging and oral anticoagulation after surgery (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?16/28/16840?source=see_link\">",
"       \"Placement of inferior vena cava filters and their complications\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients at high risk for thrombosis, we suggest the use of bridging anticoagulation with intravenous",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      or LMW heparin over no bridging during temporary interruption of oral anticoagulation (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Clinical judgement is required to determine the dose of these agents (ie, therapeutic, sub-therapeutic, or prophylactic dosing) as the quality of evidence for making this choice is poor. We suggest using a therapeutic-dose bridging regimen (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/24/36233?source=see_link\">",
"       enoxaparin",
"      </a>",
"      1",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      subcutaneously twice daily) or an intermediate-dose bridging regimen (eg, enoxaparin 40 mg subcutaneously twice daily) in patients with atrial fibrillation, or a mechanical heart valve and a prophylactic-dose bridging regimen (eg, enoxaparin, 40 mg once daily) in patients with an episode of VTE that has occurred more than four weeks prior to the planned",
"      <span class=\"nowrap\">",
"       surgery/procedure.",
"      </span>",
"      (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Patients at risk for recurrent venous thromboembolism'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H19\">",
"       'Overview'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients at intermediate risk for thrombosis, the decision as to whether bridging anticoagulation should be used is unclear and depends upon the patient&rsquo;s estimated bleeding risk. Bridging anticoagulation is a reasonable choice if the overall bleeding risk is estimated to be low.",
"     </li>",
"     <li>",
"      For patients at low risk for thrombosis, we suggest that bridging anticoagulation not be employed (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Thrombotic risk if anticoagulation is stopped'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7\">",
"       'Bleeding risk if anticoagulation is continued'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients undergoing low bleeding",
"      <strong>",
"      </strong>",
"      risk procedures, we suggest no alteration of their anticoagulation regimen, provided that their INR is within the therapeutic range (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Type of surgery or procedure'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7\">",
"       'Bleeding risk if anticoagulation is continued'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Guidelines for stopping and restarting",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/39/8825?source=see_link\">",
"       dabigatran",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/16/5384?source=see_link\">",
"       rivaroxaban",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?38/62/39911?source=see_link\">",
"       apixaban",
"      </a>",
"      have been formulated on the known pharmacokinetics of this agent as well as the patient&rsquo;s renal function. These are described in the text. (See",
"      <a class=\"local\" href=\"#H4559905\">",
"       'Dabigatran'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4559912\">",
"       'Rivaroxaban and apixaban'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      In general, the rapid offset and onset of anticoagulation activity with these three agents, particularly in patients with normal or mildly-impaired renal function, obviates the need for bridging anticoagulation with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      or LMW heparin, and studies are ongoing to assess the efficacy and safety of interruption of new oral anticoagulants without the need for heparin or LMW heparin bridging. Until such studies are available, bridging may be considered for selected patient groups, which include: 1) pre-operative bridging with heparin in patients with impaired renal function who should stop",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/39/8825?source=see_link\">",
"       dabigatran",
"      </a>",
"      four to five days before surgery; 2) post-operative bridging with low-dose heparin or LMW heparin in patients who have had major surgery",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      cannot take medications by mouth.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h2\">",
"     Stopping and starting bridging anticoagulation",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      For patients with a high risk of procedural bleeding who are taking a",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?3/25/3479?source=see_link\">",
"       vitamin K",
"      </a>",
"      antagonist, the pre-procedural INR should be &le;1.5. We recommend that patients at low risk for thrombosis stop",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      five days preoperatively rather than for a shorter interval (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ). Once surgical hemostasis has been achieved, we suggest that warfarin therapy be resumed 12 to 24 hours post-surgery, rather than for a shorter or longer interval (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bridging anticoagulation with unfractionated",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      should be stopped four to five hours before surgery. If LMW heparin has been used, it should be stopped 24 hours before surgery. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Anticoagulant drugs and doses used for bridging anticoagulation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      or LMW heparin in therapeutic doses should not be restarted postoperatively until at least 24 hours after surgery and delayed longer if there is any evidence of bleeding (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Anticoagulant drugs and doses used for bridging anticoagulation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest resuming therapeutic-dose LMW",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      48 to 72 hours after surgery instead of resuming LMW heparin within 24 hours after surgery in patients undergoing major surgery or a",
"      <span class=\"nowrap\">",
"       surgery/procedure",
"      </span>",
"      associated with a high risk for bleeding (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/1\">",
"      Douketis JD. Perioperative management of patients who are receiving warfarin therapy: an evidence-based and practical approach. Blood 2011; 117:5044.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/2\">",
"      Spyropoulos AC, Douketis JD. How I treat anticoagulated patients undergoing an elective procedure or surgery. Blood 2012; 120:2954.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/3\">",
"      Torn M, Rosendaal FR. Oral anticoagulation in surgical procedures: risks and recommendations. Br J Haematol 2003; 123:676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/4\">",
"      Kakkar VV, Cohen AT, Edmonson RA, et al. Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. The Thromboprophylaxis Collaborative Group. Lancet 1993; 341:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/5\">",
"      Jaffer AK. Perioperative management of warfarin and antiplatelet therapy. Cleve Clin J Med 2009; 76 Suppl 4:S37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/6\">",
"      Douketis JD, Gu CS, Schulman S, et al. The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism. Ann Intern Med 2007; 147:766.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/7\">",
"      Carrier M, Le Gal G, Wells PS, Rodger MA. Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism. Ann Intern Med 2010; 152:578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/8\">",
"      Lin HJ, Wolf PA, Kelly-Hayes M, et al. Stroke severity in atrial fibrillation. The Framingham Study. Stroke 1996; 27:1760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/9\">",
"      J&oslash;rgensen HS, Nakayama H, Reith J, et al. Acute stroke with atrial fibrillation. The Copenhagen Stroke Study. Stroke 1996; 27:1765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/10\">",
"      Singer DE, Albers GW, Dalen JE, et al. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133:546S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/11\">",
"      Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994; 154:1449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/12\">",
"      Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141:e326S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/13\">",
"      Kearon C, Ginsberg JS, Kovacs MJ, et al. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med 2003; 349:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/14\">",
"      Agnelli G, Prandoni P, Santamaria MG, et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators. N Engl J Med 2001; 345:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/15\">",
"      Agnelli G, Prandoni P, Becattini C, et al. Extended oral anticoagulant therapy after a first episode of pulmonary embolism. Ann Intern Med 2003; 139:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/16\">",
"      Coon WW, Willis PW 3rd. Recurrence of venous thromboembolism. Surgery 1973; 73:823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/17\">",
"      Douketis JD, Foster GA, Crowther MA, et al. Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy. Arch Intern Med 2000; 160:3431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/18\">",
"      Levine MN, Hirsh J, Gent M, et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thromb Haemost 1995; 74:606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/19\">",
"      Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism. Research Committee of the British Thoracic Society. Lancet 1992; 340:873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/20\">",
"      Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med 1997; 336:1506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/21\">",
"      Cardiogenic brain embolism. Cerebral Embolism Task Force. Arch Neurol 1986; 43:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/22\">",
"      Lip GY, Lowe GD. ABC of atrial fibrillation. Antithrombotic treatment for atrial fibrillation. BMJ 1996; 312:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/23\">",
"      Healey JS, Eikelboom J, Douketis J, et al. Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial. Circulation 2012; 126:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/24\">",
"      Garcia DA, Granger CB. Anticoagulation, novel agents, and procedures: can we pardon the interruption? Circulation 2012; 126:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/25\">",
"      Whitlock RP, Sun JC, Fremes SE, et al. Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141:e576S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/26\">",
"      Lip GY. Intracardiac thrombus formation in cardiac impairment: the role of anticoagulant therapy. Postgrad Med J 1996; 72:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/27\">",
"      Loh E, Sutton MS, Wun CC, et al. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med 1997; 336:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/28\">",
"      Nixon JV. Left ventricular mural thrombus. Arch Intern Med 1983; 143:1567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/29\">",
"      Otley CC. Continuation of medically necessary aspirin and warfarin during cutaneous surgery. Mayo Clin Proc 2003; 78:1392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/30\">",
"      Nieuwenhuis HK, Albada J, Banga JD, Sixma JJ. Identification of risk factors for bleeding during treatment of acute venous thromboembolism with heparin or low molecular weight heparin. Blood 1991; 78:2337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/31\">",
"      Levine MN, Raskob G, Landefeld S, Hirsh J. Hemorrhagic complications of anticoagulant treatment. Chest 1995; 108:276S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/32\">",
"      Dunn AS, Turpie AG. Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med 2003; 163:901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/33\">",
"      De Caterina R, Husted S, Wallentin L, et al. Anticoagulants in heart disease: current status and perspectives. Eur Heart J 2007; 28:880.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/34\">",
"      Wysokinski WE, McBane RD 2nd. Periprocedural bridging management of anticoagulation. Circulation 2012; 126:486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/35\">",
"      Wysokinski WE, McBane RD, Daniels PR, et al. Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation. Mayo Clin Proc 2008; 83:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/36\">",
"      Ansell J, Hirsh J, Hylek E, et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133:160S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/37\">",
"      McIntyre H. Management, during dental surgery, of patients on anticoagulants. Lancet 1966; 2:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/38\">",
"      Wahl MJ. Dental surgery in anticoagulated patients. Arch Intern Med 1998; 158:1610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/39\">",
"      Malden N. Dental procedures can be undertaken without alteration of oral anticoagulant regimen. Evid Based Dent 2005; 6:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/40\">",
"      Blinder D, Manor Y, Martinowitz U, Taicher S. Dental extractions in patients maintained on oral anticoagulant therapy: comparison of INR value with occurrence of postoperative bleeding. Int J Oral Maxillofac Surg 2001; 30:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/41\">",
"      Garcia-Darennes F, Darennes J, Freidel M, Breton P. [Protocol for adapting treatment with vitamin K antagonists before dental extraction]. Rev Stomatol Chir Maxillofac 2003; 104:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/42\">",
"      Perry DJ, Noakes TJ, Helliwell PS, British Dental Society. Guidelines for the management of patients on oral anticoagulants requiring dental surgery. Br Dent J 2007; 203:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/43\">",
"      Sindet-Pedersen S, Ramstr&ouml;m G, Bernvil S, Blomb&auml;ck M. Hemostatic effect of tranexamic acid mouthwash in anticoagulant-treated patients undergoing oral surgery. N Engl J Med 1989; 320:840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/44\">",
"      Webster K, Wilde J. Management of anticoagulation in patients with prosthetic heart valves undergoing oral and maxillofacial operations. Br J Oral Maxillofac Surg 2000; 38:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/45\">",
"      Souto JC, Oliver A, Zuazu-Jausoro I, et al. Oral surgery in anticoagulated patients without reducing the dose of oral anticoagulant: a prospective randomized study. J Oral Maxillofac Surg 1996; 54:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/46\">",
"      Patatanian E, Fugate SE. Hemostatic mouthwashes in anticoagulated patients undergoing dental extraction. Ann Pharmacother 2006; 40:2205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/47\">",
"      Kovich O, Otley CC. Thrombotic complications related to discontinuation of warfarin and aspirin therapy perioperatively for cutaneous operation. J Am Acad Dermatol 2003; 48:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/48\">",
"      Alcalay J, Alkalay R. Controversies in perioperative management of blood thinners in dermatologic surgery: continue or discontinue? Dermatol Surg 2004; 30:1091.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/49\">",
"      Nelms JK, Wooten AI, Heckler F. Cutaneous surgery in patients on warfarin therapy. Ann Plast Surg 2009; 62:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/50\">",
"      Omran H, Bauersachs R, R&uuml;benacker S, et al. The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre BNK Online bRiDging REgistRy (BORDER). Thromb Haemost 2012; 108:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/51\">",
"      Hull RD, Raskob GE, Rosenbloom D, et al. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med 1990; 322:1260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/52\">",
"      White RH, McKittrick T, Hutchinson R, Twitchell J. Temporary discontinuation of warfarin therapy: changes in the international normalized ratio. Ann Intern Med 1995; 122:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/53\">",
"      Hylek EM, Regan S, Go AS, et al. Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin. Ann Intern Med 2001; 135:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/54\">",
"      Bern MM, Lokich JJ, Wallach SR, et al. Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann Intern Med 1990; 112:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/55\">",
"      Levine M, Hirsh J, Gent M, et al. Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer. Lancet 1994; 343:886.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/56\">",
"      Collins LJ, Silverman DI, Douglas PS, Manning WJ. Cardioversion of nonrheumatic atrial fibrillation. Reduced thromboembolic complications with 4 weeks of precardioversion anticoagulation are related to atrial thrombus resolution. Circulation 1995; 92:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/57\">",
"      Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 1996; 348:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/58\">",
"      Larson BJ, Zumberg MS, Kitchens CS. A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk. Chest 2005; 127:922.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/59\">",
"      Levy JH, Tanaka KA, Dietrich W. Perioperative hemostatic management of patients treated with vitamin K antagonists. Anesthesiology 2008; 109:918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/60\">",
"      Stangier J, Rathgen K, St&auml;hle H, Mazur D. Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study. Clin Pharmacokinet 2010; 49:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/61\">",
"      van Ryn J, Stangier J, Haertter S, et al. Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost 2010; 103:1116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/62\">",
"      Hankey GJ, Eikelboom JW. Dabigatran etexilate: a new oral thrombin inhibitor. Circulation 2011; 123:1436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/63\">",
"      Warkentin TE, Margetts P, Connolly SJ, et al. Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding. Blood 2012; 119:2172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/64\">",
"      Kovacs MJ, Kearon C, Rodger M, et al. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation 2004; 110:1658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/65\">",
"      Spandorfer JM, Lynch S, Weitz HH, et al. Use of enoxaparin for the chronically anticoagulated patient before and after procedures. Am J Cardiol 1999; 84:478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/66\">",
"      Spyropoulos AC, Frost FJ, Hurley JS, Roberts M. Costs and clinical outcomes associated with low-molecular-weight heparin vs unfractionated heparin for perioperative bridging in patients receiving long-term oral anticoagulant therapy. Chest 2004; 125:1642.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/67\">",
"      POLLER L, THOMSON J. EVIDENCE FOR \"REBOUND\" HYPERCOAGULABILITY AFTER STOPPING ANTICOAGULANTS. Lancet 1964; 2:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/68\">",
"      Palareti G, Legnani C, Guazzaloca G, et al. Activation of blood coagulation after abrupt or stepwise withdrawal of oral anticoagulants--a prospective study. Thromb Haemost 1994; 72:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/69\">",
"      Genewein U, Haeberli A, Straub PW, Beer JH. Rebound after cessation of oral anticoagulant therapy: the biochemical evidence. Br J Haematol 1996; 92:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/70\">",
"      Kluft C, Verheijen JH, Jie AF, et al. The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma. Scand J Clin Lab Invest 1985; 45:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/71\">",
"      Rowbotham BJ, Whitaker AN, Harrison J, et al. Measurement of crosslinked fibrin derivatives in patients undergoing abdominal surgery: use in the diagnosis of postoperative venous thrombosis. Blood Coagul Fibrinolysis 1992; 3:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/72\">",
"      Lip GY, Lowe GD. Fibrin D-dimer: a useful clinical marker of thrombogenesis? Clin Sci (Lond) 1995; 89:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/73\">",
"      Carter CJ. The pathophysiology of venous thrombosis. Prog Cardiovasc Dis 1994; 36:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/74\">",
"      Jaffer AK, Brotman DJ, Bash LD, et al. Variations in perioperative warfarin management: outcomes and practice patterns at nine hospitals. Am J Med 2010; 123:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/75\">",
"      Douketis JD. Contra: \"Bridging anticoagulation is needed during warfarin interruption when patients require elective surgery\". Thromb Haemost 2012; 108:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/76\">",
"      Spyropoulos AC. Pro: \"Bridging anticoagulation is needed during warfarin interruption in patients who require elective surgery\". Thromb Haemost 2012; 108:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/77\">",
"      Douketis JD, Johnson JA, Turpie AG. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Arch Intern Med 2004; 164:1319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/78\">",
"      Dunn AS, Spyropoulos AC, Turpie AG. Bridging therapy in patients on long-term oral anticoagulants who require surgery: the Prospective Peri-operative Enoxaparin Cohort Trial (PROSPECT). J Thromb Haemost 2007; 5:2211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/79\">",
"      Garcia DA, Regan S, Henault LE, et al. Risk of thromboembolism with short-term interruption of warfarin therapy. Arch Intern Med 2008; 168:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/80\">",
"      Malato A, Saccullo G, Lo Coco L, et al. Patients requiring interruption of long-term oral anticoagulant therapy: the use of fixed sub-therapeutic doses of low-molecular-weight heparin. J Thromb Haemost 2010; 8:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/81\">",
"      Spyropoulos AC, Turpie AG, Dunn AS, et al. Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry. J Thromb Haemost 2006; 4:1246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/82\">",
"      Spyropoulos AC, Turpie AG, Dunn AS, et al. Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry). Am J Cardiol 2008; 102:883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/83\">",
"      Steger V, Bail DH, Graf D, et al. A practical approach for bridging anticoagulation after mechanical heart valve replacement. J Heart Valve Dis 2008; 17:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/84\">",
"      Hammerstingl C, Tripp C, Schmidt H, et al. Periprocedural bridging therapy with low-molecular-weight heparin in chronically anticoagulated patients with prosthetic mechanical heart valves: experience in 116 patients from the prospective BRAVE registry. J Heart Valve Dis 2007; 16:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/85\">",
"      Pengo V, Cucchini U, Denas G, et al. Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study. Circulation 2009; 119:2920.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/86\">",
"      Siegal D, Yudin J, Kaatz S, et al. Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates. Circulation 2012; 126:1630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/87\">",
"      Klamroth R, Gottstein S, Essers E, Landgraf H. Bridging with enoxaparin using a half-therapeutic dose regimen: safety and efficacy. Vasa 2010; 39:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/88\">",
"      Hirsh J, Bauer KA, Donati MB, et al. Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133:141S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/89\">",
"      Douketis JD, Woods K, Foster GA, Crowther MA. Bridging anticoagulation with low-molecular-weight heparin after interruption of warfarin therapy is associated with a residual anticoagulant effect prior to surgery. Thromb Haemost 2005; 94:528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/90\">",
"      O'Donnell MJ, Kearon C, Johnson J, et al. Brief communication: Preoperative anticoagulant activity after bridging low-molecular-weight heparin for temporary interruption of warfarin. Ann Intern Med 2007; 146:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/91\">",
"      Strebel N, Prins M, Agnelli G, B&uuml;ller HR. Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery? Arch Intern Med 2002; 162:1451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/92\">",
"      Tafur AJ, McBane R 2nd, Wysokinski WE, et al. Predictors of major bleeding in peri-procedural anticoagulation management. J Thromb Haemost 2012; 10:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/93\">",
"      Skeith L, Taylor J, Lazo-Langner A, Kovacs J. Conservative perioperative anticoagulation management in patients with chronic venous thromboembolic disease: a cohort study. J Thromb Haemost 2012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/94\">",
"      Ansell J, Hirsh J, Poller L, et al. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126:204S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/95\">",
"      Salem DN, O'Gara PT, Madias C, et al. Valvular and structural heart disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133:593S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/96\">",
"      Korantzopoulos P, Letsas KP, Liu T, et al. Anticoagulation and antiplatelet therapy in implantation of electrophysiological devices. Europace 2011; 13:1669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/97\">",
"      Goldstein DJ, Losquadro W, Spotnitz HM. Outpatient pacemaker procedures in orally anticoagulated patients. Pacing Clin Electrophysiol 1998; 21:1730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/98\">",
"      Feng L, Li Y, Li J, Yu B. Oral anticoagulation continuation compared with heparin bridging therapy among high risk patients undergoing implantation of cardiac rhythm devices: a meta-analysis. Thromb Haemost 2012; 108:1124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/99\">",
"      Horlocker TT, Wedel DJ, Rowlingson JC, et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition). Reg Anesth Pain Med 2010; 35:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/50/35626/abstract/100\">",
"      Horlocker TT. Regional anaesthesia in the patient receiving antithrombotic and antiplatelet therapy. Br J Anaesth 2011; 107 Suppl 1:i96.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1312 Version 23.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-115.66.252.144-A6750C7309-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_50_35626=[""].join("\n");
var outline_f34_50_35626=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H31\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PROBLEM OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      THROMBOTIC RISK IF ANTICOAGULATION IS STOPPED",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Patients at risk for recurrent venous thromboembolism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Patients at risk for arterial thromboembolism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2441257\">",
"      Chronic atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Prosthetic heart valves",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4559669\">",
"      Other high risk settings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      BLEEDING RISK IF ANTICOAGULATION IS CONTINUED",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Type of surgery or procedure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7437402\">",
"      - Gastroenterologic procedures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Dental or excisional cutaneous procedures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6637109\">",
"      - Invasive cardiac procedures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Use of heparin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      PERIOPERATIVE INTERRUPTION AND RESUMPTION OF ANTICOAGULATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Interruption of warfarin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Reversing the vitamin K antagonists",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Fully elective surgery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Semi-urgent surgery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Urgent surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2441410\">",
"      Resumption of warfarin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4559905\">",
"      Dabigatran",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4559912\">",
"      Rivaroxaban and apixaban",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4560168\">",
"      Risk of rebound hypercoagulability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2441429\">",
"      BRIDGING ANTICOAGULATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Anticoagulant drugs and doses used for bridging anticoagulation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Unfractionated heparin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - LMW heparin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Postoperative resumption of bridging anticoagulation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2441949\">",
"      - Importance of assessing postoperative wound hemostasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      SPECIFIC SCENARIOS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Venous thromboembolism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Arterial thromboembolism including atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Pacemaker insertion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Mechanical prosthetic heart valves",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Percutaneous coronary intervention",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25297303\">",
"      Insertion and removal of a catheter for neuraxial anesthesia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9732623\">",
"      Estimating thrombotic and bleeding risks",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9732643\">",
"      Use or nonuse of bridging anticoagulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      Stopping and starting bridging anticoagulation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/1312\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/1312|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?0/1/24\" title=\"algorithm 1\">",
"      Perioperative management warfarin therapy and heparin bridging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/1312|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?17/40/18062\" title=\"figure 1\">",
"      Event rates in SPAF III",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?36/37/37469\" title=\"figure 2\">",
"      Low dose warfarin high risk AF",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/1312|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?34/24/35212\" title=\"table 1\">",
"      Perioperative thrombotic risk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?39/2/39980\" title=\"table 2\">",
"      Procedural bleeding risk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?42/14/43243\" title=\"table 3\">",
"      ASGE guidelines for warfarin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?43/43/44731\" title=\"table 4\">",
"      Bleeding risk GI procedure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?40/0/40971\" title=\"table 5\">",
"      Risk GI procedure conditions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?38/14/39148\" title=\"table 6\">",
"      HAS-BLED risk score",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?2/17/2332\" title=\"table 7\">",
"      Anticoagulation and surgery",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/44/7881?source=related_link\">",
"      Anticoagulant, antiplatelet, and fibrinolytic (thrombolytic) therapy in patients at high risk for ocular hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/59/37818?source=related_link\">",
"      Anticoagulants other than heparin and warfarin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/8/27786?source=related_link\">",
"      Antithrombotic therapy for percutaneous coronary intervention: General use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/11/18618?source=related_link\">",
"      Antithrombotic therapy in patients with prosthetic heart valves",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/32/42506?source=related_link\">",
"      Antithrombotic therapy to prevent embolization in atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/19/2362?source=related_link\">",
"      Cataract in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/8/30857?source=related_link\">",
"      Correcting excess anticoagulation after warfarin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/36/6730?source=related_link\">",
"      Drug-induced thrombosis and vascular disease in patients with malignancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/56/7048?source=related_link\">",
"      Indications for antithrombotic therapy in heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/33/21014?source=related_link\">",
"      Management of anticoagulants in patients undergoing endoscopic procedures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?14/11/14515?source=related_link\">",
"      Patient information: Latest medicines to prevent blood clots (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/45/40666?source=related_link\">",
"      Perioperative medication management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/28/16840?source=related_link\">",
"      Placement of inferior vena cava filters and their complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/52/41802?source=related_link\">",
"      Prevention of venous thromboembolic disease in surgical patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/23/27001?source=related_link\">",
"      Risk of embolization in atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/4/43082?source=related_link\">",
"      Treatment of lower extremity deep vein thrombosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_50_35627="Differential diagnosis of posterior heel or calf pain";
var content_f34_50_35627=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F76217&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F76217&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Differential diagnosis of posterior heel or calf pain",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Ankle sprain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Stress fracture",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Calcaneal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Tibial",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tendinopathy of ankle tendons other than Achilles",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Posterior impingement syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Severs lesion (calcaneal apophysitis in adolescents)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Accessory soleus muscle",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Osteoarthritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Neuropathy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Peripheral",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Tarsal tunnel syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vascular claudication",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Deep venous thrombosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rheumatologic disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cellulitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Abscess",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Osteomyelitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bone cyst",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Malignancy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hematoma",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_50_35627=[""].join("\n");
var outline_f34_50_35627=null;
var title_f34_50_35628="Parenteral rx elective PCI";
var content_f34_50_35628=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F64612&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F64612&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Parenteral antithrombotic drugs for elective percutaneous coronary intervention (PCI)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dose",
"       </td>",
"       <td class=\"subtitle1\">",
"        Initiation relative to PCI",
"       </td>",
"       <td class=\"subtitle1\">",
"        Duration of therapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Abciximab",
"       </td>",
"       <td>",
"        0.25 mg/kg IV bolus, then 0.125 mcg/kg/min IV (max 10 mcg/min).",
"       </td>",
"       <td rowspan=\"2\">",
"        10 to 60 min prior to PCI",
"       </td>",
"       <td rowspan=\"2\">",
"        12 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Renal adjustment: none",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        Eptifibatide",
"       </td>",
"       <td>",
"        180 mcg/kg IV bolus x2, 10 min apart (max 22.6 mg each bolus). Start infusion of 2 mcg/kg/min (max 15 mg/hr) after first bolus.",
"       </td>",
"       <td rowspan=\"3\">",
"        Immediately prior to PCI",
"       </td>",
"       <td rowspan=\"3\">",
"        12 to 24 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Renal adjustment of continuous infusion: CrCl* &lt;50 mL/min: 1 mcg/kg/min (max 7.5 mg/hr)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hemodialysis dependent: contraindicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tirofiban",
"       </td>",
"       <td>",
"        Not generally used in elective PCI",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Unfractionated heparin",
"       </td>",
"       <td>",
"        60 to 100 units/kg IV bolus, titrate to ACT 250 to 300 sec (50 to 70 units/kg IV if GP IIb/IIIa used, titrate to ACT 200 to 250 sec).",
"       </td>",
"       <td rowspan=\"2\">",
"        Immediately prior to PCI",
"       </td>",
"       <td rowspan=\"2\">",
"        No additional heparin post-PCI",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Renal adjustment: none",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Enoxaparin",
"       </td>",
"       <td>",
"        Not generally started for elective PCI. For the occasional patient already on drug, it can be continued at prior dose with an additional 0.3 mg/kg IV if 8 to 12 hours since last dose.",
"       </td>",
"       <td rowspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td rowspan=\"2\">",
"        May continue for prior indication",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Renal adjustment: avoid use if CrCl* &lt;30 mL/min or dialysis dependent.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        Bivalirudin",
"       </td>",
"       <td>",
"        0.75 mg/kg IV bolus, then 1.75 mg/kg/hr IV.",
"       </td>",
"       <td rowspan=\"3\">",
"        Immediately prior to PCI",
"       </td>",
"       <td rowspan=\"3\">",
"        Until end of PCI. Continuation of the bivalirudin infusion following PCI for up to four hours post-procedure is optional, at the discretion of the treating physician.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Renal adjustment of continuous infusion: CrCl* 10 to 29 mL/min: 1 mg/kg/hr",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hemodialysis dependent: 0.25 mg/kg/hr",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * CrCl is estimated using Cockcroft-Gault equation. For discussion of Cockcroft-Gault equation, see \"Assessment of kidney function: Serum creatinine; BUN; and GFR\", section on Estimation equations.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permission from: Antiplatelet and anticoagulant drugs. The Medical Letter 2008; 6:29.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_50_35628=[""].join("\n");
var outline_f34_50_35628=null;
var title_f34_50_35629="Contents: Personality disorders";
var content_f34_50_35629=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?41/24/42381\">",
"       Psychiatry",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Personality disorders",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Personality disorders",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/26/42409\">",
"           Antisocial personality disorder: Epidemiology, clinical manifestations, course and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/51/3896\">",
"           Approaches to the therapeutic relationship in patients with personality disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/19/10553\">",
"           Borderline personality disorder: Epidemiology, clinical features, diagnosis, and differential diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/1/42009\">",
"           Borderline personality disorder: Treatment and prognosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/8/20615\">",
"           Establishing and maintaining a therapeutic relationship in psychiatric practice",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/55/40824\">",
"           Personality disorders",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/43/3769\">",
"           Treatment of antisocial personality disorder",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-7904B37A4C-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f34_50_35629=[""].join("\n");
var outline_f34_50_35629=null;
var title_f34_50_35630="Pseudomonas corneal ulcer";
var content_f34_50_35630=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F62192&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F62192&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pseudomonas corneal ulcer in soft contact lens wearer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 320px; height: 236px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    With hypopyon (layering of white cells in the anterior chamber).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_50_35630=[""].join("\n");
var outline_f34_50_35630=null;
var title_f34_50_35631="Craniopharyngioma CT";
var content_f34_50_35631=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F70146&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F70146&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Craniopharyngioma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 313px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Axial CT scan through the midbrain of a 71-year-old woman who presented with bitemporal visual field defects. There is a calcified soft tissue mass arising in the region of the sella turcica (arrows), which proved to be a craniopharyngioma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jonathan Kruskal, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_50_35631=[""].join("\n");
var outline_f34_50_35631=null;
